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Anion sensing is important due to the roles anions play in biological systems and 
the environment. Given the complexity of these environments, selectivity in receptors is 
crucial. Research in the labs of Profs. Darren Johnson and Mike Haley focuses on 
developing novel receptors which use non-covalent interactions to reversibly bind anions 
– ideally for use in sensors. This dissertation presents novel tripodal-structured receptors, 
as well as systems based on a previously established arylethynyl scaffold – a conjugated 
backbone that often provides fluorescent properties to the receptor. 
Chapter I is an introduction of the less commonly utilized non-colvalent 
interactions for anion binding – anion–π interactions and Caryl–H hydrogen bonds. The 
design and synthesis of cryptand and tripodal receptors with electron-deficient arenes 
ideal for anion–π interactions is presented in Chapter II. Chapters III and IV discuss 
work on novel tripodal 1,3,5-tris(arylethynyl)benzene receptors which demonstrate 
either anion–π interactions and Caryl–H⋅⋅⋅X¯ hydrogen bonds. A chloride selective 
bis(urea) arylethynylpyridine receptor is presented in Chapter V. Lastly, Chapter VI 
introduces initial efforts on the synthesis of mono(urea) arylethynyl receptors which 
will be used to further explore the anion–π binding capabilities of these systems and 
may also demonstrate the preference of anion–π binding interactions over Caryl–H 
hydrogen bonding when binding nitrate, as is demonstrated in Chapters III and IV. 
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AN INTRODUCTION TO ANION–ARENE 
INTERACTIONS 
 
Part of the work in Chapter I was published as a review in volume 46 of the 
journal Accounts of Chemical Research in April 2013. Chapter I is composed of a portion of 
this original manuscript, prior to its final editing for publication, as well as an 
unpublished summary of other relevant studies. Mary Collins wrote the original 
version of the main group cation section of the manuscript – the edited final version is 
presented in Appendix A. My advisor and principle investigator Prof. Darren W. 
Johnson conceptualized the original research and provided editorial assistance for this 
publication. The remainder of Chapter I is an unpublished review or assessment of the 
current and past literature to supplement the previously published Account. Chapter II 
consists of entirely unpublished work of my own doing. Lev Zakharov collected and 
solved the crystallographic data. Advisors and principle investigators Profs. Darren W. 
Johnson and Michael M. Haley assisted in the editing of Chapter II. The work in 
Chapter III was published in volume 52 of the journal Angewandte Chemie, International 
Edition in September 2013. Dr. Lev Zakharov collected and solved the diffraction data 
for all of the crystal structures. Profs. Darren W. Johnson and Michael M. Haley 
conceptualized this research and provided editorial assistance for this publication. 
Chapter IV is composed of unpublished co-authored work, which will be submitted to 
the journal Chemical Science later this year. I wrote the document and performed many of 
 2 
the spectroscopic titrations within. This work is supplemented by synthetic advances 
and further titrations performed by an undergraduate student I advised, John 
Houlihan. The crystal structure data were collected and solved by Dr. Lev Zakharov. 
Editing was performed by Profs. Darren W. Johnson and Michael M. Haley. The 
contents of Chapter V are a revised and unpublished manuscript originally written by 
previous graduate student, Jeff Engle. Jeff also performed the original experiments with 
the assistance of an undergraduate, Timothy Robitshek. I have reperformed many 
experiments, expanded on the data contained within, and rewrote the original 
manuscript. Editing was performed by Profs. Darren W. Johnson and Michael M. 
Haley. 
I.1. General Introduction 
Interactions between ions and aromatic rings are now a mainstay in the field of 
supramolecular chemistry.1-3 The prototypical cation–π interaction, first characterized in 
the gas phase, is now well known as an important contributor to protein structure, 
enzyme function, and as a noncovalent force found in many synthetic systems.4-7 The 
complementary “anion–π interaction” – defined as an electrostatic attraction between an 
anion positioned over the centroid of an aromatic ring – has recently emerged as 
another reversible ion–π interaction in supramolecular systems.8,9 Such an interaction 
potentially offers new selectivity in binding poorly basic, strongly solvated anions, and 
may have implications in biological function, structure, and anion transport as well. 
Anion–π interactions fall under the more general “anion–arene interactions,” which 
also includes the more recently highly investigated Caryl–H hydrogen bond, in addition 
to the halogen bond and weak-σ interaction. This work focuses on anion–arene 
interactions with an emphasis in observing anion–π interactions in solution. Many 
molecules presented within also utilize other types of non-covalent interactions to 
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strengthen the overall binding as well as provide spectroscopic handles. The overall 
goal of this research is to further our knowledge on the design and synthesis of 
selective anion receptors for sensor applications. 
I.2. Chapter Introduction 
The Account included within Chapter 1 describes the Darren Johnson group’s 
initial efforts in ion–π interactions in two contexts (Figure 1). A series of self-assembled 
Group 15 (pnictogen)–thiolate complexes is described, featuring prominent cation–π 
interactions between the trivalent pnictogen and an aromatic ring of the ligand 
(Appendix A). In every example, pnictogen–π interactions appear to provide additional 
stability to these surprisingly robust complexes. The latter half of this review highlights 
efforts to characterize the interaction between anions and electron-deficient aromatic 
rings in solution. 
 
Figure 1. Cartoon illustration depicting the two main ion–π interactions focused on 
within the Johnson lab. 
Complementary crystallographic and computational studies suggest off-center 
weak-σ interactions play the dominant role in stabilizing the anion–arene adducts 
unless an acidic C–H bond is present to participate in favorable Caryl–H⋅⋅⋅anion 
hydrogen bonds. Initial solution studies suggest these reversible interactions are weak 
in organic solvents, but perhaps the Hofmeister bias in anion binding is mitigated, if 
not reversed, in the halides using anion–π type interactions. The Account seeks to 
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provide a thorough overview of our work in this field with references to leading reviews 
and related primary literature to guide the interested reader to other elegant work in 
these fields. Chapter 1 has been expanded beyond the Account, to provide a more recent 
and complete background relevant to the subsequent chapters. 
I.3. Historical Overview of Anion–Arene Interactions 
Multiple binding modes of anions with arenes have been demonstrated through 
experimental and theoretical studies. One such complex, known as the ‘Meisenheimer’ 
or a strong σ-complex, has been known since its isolation in 1902. The σ-complex 
results from the nucleophilic addition of an anion to an electron-deficient aromatic ring 
and is an intermediate in the SNAr mechanism (Figure 2).10,11  
 
Figure 2. SNAr reaction with the formation of a Meisenheimer complex intermediate. 
Another type of anion–arene interaction occurs through hydrogen bonding 
(Figure 3a). Similar to the history of anion–π interactions, Caryl–H hydrogen bonds have 
been the source of a large amount of controversy and debate in their lifetime.12-14 The 
prevalence and discussion of Caryl–H hydrogen bonds were limited before the 1960s. 
One convincing study presented IR data 
demonstrating changes in position and 
intensity of the OH absorption bands of 










Figure 3. General representations of (a) 
Caryl–H hydrogen bonding and (b) 
anion–π interactions.	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solvents with good hydrogen bond acceptor atoms versus solvents without these atoms.15 
The first crystallographic analysis of C–H⋅⋅⋅O hydrogen bonding was published in 1962 
and was quickly followed with additional structural details the following year.16,17 Many 
arguments followed these publications, both in support of and against the C–H⋅⋅⋅O 
hydrogen bond, and thus the Caryl–H hydrogen bond.18-21 Ultimately, the Caryl–H 
hydrogen bond was found not only to exist, but also to be of great importance in 
supramolecular and biological chemistry.22,23 
In an early study of Caryl–H hydrogen bonds, gas phase mass spectrometry was 
used to determine binding energies for a series of arenes hydrogen bonded to Cl¯.24 
Hexafluorobenzene was investigated in this same study and, despite the lack of aryl 
hydrogens, a binding energy was surprisingly still found. Follow up research showed 
similar results for Br¯ and I¯. Initial theoretical calculations assigned this binding to 
an interaction of the halide anion over the center of the arene (Figure 3b).25 
Further advances on these studies, at the time deemed “anion–π” interactions, 
were not made until 2002, when several papers inspired renewed interest in the 
interactions between anions and aromatic rings. These reports used theoretical 
calculations to show favorable interactions between anions and 1,3,5-triazine,  
-trinitrobenzene, -trifluorobenzene, hexafluorobenzene, and other perfluorinated 
arenes.26-29 These four theoretical papers spawned new investigations probing anion–
arene interactions, in particular anion–π interactions8,9,30-32 and sparked a lively 
discussion on the nature and definition of the interaction.29,33-35  
I.4. Anion–π Interactions 
I.4.1. Initial Solution Studies 
Enzymes are an excellent example of anion–π interactions being extremely 
relevant and important in nature – even if slightly unfavorable, or barely favorable.36 
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For this, and other, reasons a large effort has focused on observing anion–arene 
interactions in solution, particularly anion–π. The nature of the interaction itself, 
however, makes this a difficult task because binding of anions to the π-system is 
typically too weak for detection via NMR spectroscopy. As a result, systems have been 
investigated which allow observation of such interactions through other techniques.  
An “enforced proximity” approach37 was used to quantify anion–π interactions 
in calix[4]pyrroles (Figure 4).38 A series of p-substituted tetraarylcalix[4]pyrroles were 
synthesized and chloride association constants were determined. A binding event 
observed to be slow on the NMR timescale was concluded to indicate a change in cone-
conformation of the receptor induced by the addition of the anion. When quantified, 
only the R = NO2 substitution showed a small attractive chloride–arene interaction. 
 
Figure 4. (a) Substituted tetraaryl calix[4]pyrroles used to quantify anion–π interactions 
in solution. (b) Crystal structure demonstrating anion–π interactions between the nitro-
substituted receptor and a chloride–tetraethylammonium ion pair. 
A dichloro-substituted tetraoxacalix[2]arene[2]triazine also showed Cl¯ anion–π 
interactions in the solid state. A water molecule is found in the binding pocket in 
addition to the tetraethylammonium ion pair (Figure 5a). While no visible change was 
observed in solution via UV-Vis or 1H NMR spectroscopy – indicating the lack of  
Caryl–H hydrogen bonds – a binding constant was obtained by florescence 
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spectroscopy.39 Highly π-acidic HAT(CN)6 was shown to complex in a 3:2 
stoichiometric ratio with Cl¯, Br¯, and I¯ through charge transfer and anion–π 
interactions in the solid state (Figure 5b,c). The charge transfer complexes were further 
characterized in solution via UV-Vis, 13C, and halogen NMR spectroscopy.40 A 
naphthalenediimide chain with all anion interactions (other than those with the arene 
π-surface blocked by functionalization) showed a preference in solution for chloride and 
nitrate over other halides and oxyanions, respectively.41 The cyano-substituted systems 
of the naphthalenediimide chains posses a highly electron-deficient π-surface and 
demonstrated the noted selectivity through transmembrane transport (Figure 5d). The 
 
Figure 5. Receptors demonstrating anion–π interactions in solution: (a) Crystal 
structure of dichloro-substituted tetraoxacalix[2]arene[2]triazine binding ion-pair 
tetrabutylammonium chloride and a water molecule in its pocket (C: dark grey, H: light 
grey, N: blue, O: red, Cl: green). (b, c) Top and side views, respectively, of the crystal 
structure for HAT(CN)6 indicating one anion–π interaction with Br¯ for every three 
charge transfer interactions with Br¯ (Br: brown). (e) Electrostatic potential surface of 
dicyano-substituted naphthalenediimide determined at MP2/6-311++G**// 
PBE1PBE/6-311G** indicating a favorable interaction between an anion and the π-
surface (positive: blue, negative, red). (f) Density function theory (PBE1PBE/6-311G**) 
optimized structure of the perfluoroaryl-substituted calixarene binding 
tetramethylammonium chloride in a ditopic fashion (F: pink). 
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same group also used transmembrane transport to demonstrate Cl¯ ion transport by a 
perfluorobenzene ditopic calixarene-based receptor (Figure 5e).42 No detectable Cl¯ 
binding was observed via 19F NMR spectroscopy, indicating the weak nature of the 
interaction. Our studies probing anion–arene interactions were performed primarily 
with the goal of quantifying the strength and selectivity of anion–π interactions in 
solution and are highlighted in the following section.  
I.4.2. Interactions Between Anions and Electron-Deficient Arenes: Our 
Investigations Using Combined Crystallographic, Computational, and 
Solution Phase Studies 
Neutral electron-deficient sulfonamide receptor 1 and control receptor 2 were 
synthesized to investigate anion–π interactions in solution (Figure 6a).43 1H NMR 
spectroscopic titrations were used to measure the association constants of receptors 1 
and 2 with tetra-n-butylammonium salts of chloride, bromide, and iodide. The electron- 
deficient ring of 1 encourages a small, but measurable association constant for each of 
the halides. Association constants were determined by monitoring the change in 
chemical shift of the sulfonamide hydrogen. Receptor 2, lacking an electron-deficient 
ring, shows no measurable binding with any of the halides. Receptor 1 binds Cl¯, Br¯, 
and I¯ in a 1:1 fashion with binding constants of 30 ± 3, 20 ± 2, and 36 ± 6 M-1, 
 
Figure 6. (a) Molecular structures of neutral sulfonamide receptors. (b) One of two 
minimum geometries of 1 with chloride optimized at HF/6-31+G*. 
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respectively. In comparison to receptor 2, the electron-deficient arene clearly 
encourages or assists in the binding of the halides; therefore, the interaction between a 
halide and pentafluorobenzene is less repulsive than with benzene. While Hartree-Fock 
calculations found a centered anion–π interaction as one of two local minima (Figure 
6b), no direct experimental evidence classifies the interaction as anion–π. Our future 
studies served as a reminder for the existence of other binding modes between anions 
and arene rings. Even with this in mind, neither charge transfer nor weak-σ complexes 
have been demonstrated for perfluoroarenes thus far. A more systematic change of the 
substituents may provide more insight on the nature of the anion–arene interaction 
present in this system. 
Further investigation into anion–π interactions led to the study of 1,2,4,6-
tetracyanobenzene (TCB) in the presence of halides.44 Crystal structures of the halide 
salts KBr, KI, and NaI with 18-crown-6 binding TCB demonstrated three of the four 
binding modes possible between anions and electron-deficient arenes (Figure 7). Two 
charge transfer, or weak-σ, complexes were formed above the arene plane and along the 
periphery of the ring situated nearest to the C–CN bond (3) and the C–H bond (4). The 
third interaction was a Caryl–H hydrogen bond within the plane of the arene (5). The 
local environment around the anion in the crystal structure for each of the halides was 
surprisingly similar. Interestingly, no centered anion–π interaction (6) was found as 
 
Figure 7. MP2/aug-cc-pVDZ optimized geometries for chloride complexes with TCB 
demonstrating the four modes of binding between anions and arenes. 
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part of the crystal structure. Calculations of 1:1 complexes between TCB and F¯, Cl¯, 
and Br¯ at the MP2/aug-cc-pVDZ level of theory were used to evaluate the relative 
energy differences between the three geometries listed above in addition to the anion–π 
complex (Figure 7). Receptors 3-5 were found as minima for each of the halides, with 
the exception of 3 for Br¯. The centered anion–π configuration (6) was not found as a 
minimum on the potential energy surface for any of the three halides, but the binding 
energy of each halide for 6 was calculated by imposing C2ν symmetry. These results 
were the first example in which non-covalent anion–π complexes with Cl¯ and Br¯ 
were not found as minima on the potential energy surface. Global minima 
corresponded to complex 4 for each of the halides. Bond distances of less than 2 Å and 
a binding strength of -53.06 kcal mol-1 for F¯ in complex 4 indicated a strong-σ or 
Meisenheimer complex. Cl¯ binds more strongly than Br¯ by 1.12 kcal mol-1 with 
binding energies of -29.80 and -28.68 kcal mol-1, respectively. This study demonstrated 
the weak nature of anion–π interactions and their less favorable formation in 
comparison to other anion–arene modes of binding – at least for extremely electron-
deficient arenes. 
Equipped with this knowledge, our next studies sought to reduce the  
weak-σ interaction to practice in solution, in a designed synthetic receptor. Neutral 
tripodal receptors utilizing only electron-deficient aromatic rings were shown to bind 
halides in a 1:1 stoichiometry by 1H NMR spectroscopic titrations and DFT calculations 
(Figure 8).45 An unsubstituted receptor designed as a negative control failed to bind 
halides. These results demonstrate the binding of anions to receptors by interaction 
with only electron-deficient arenes in solution through either weak-σ or Caryl–H⋅⋅⋅X¯ 




Figure 8. (a) Structures of tripodal anion receptors 7-9 and optimized geometries of 7 
and 8 complexed with bromide at the B3LYP/DZVP level of theory. 
relative stabilities for such interactions in solution. While 7 and 8 are structural 
isomers, the substitution pattern of 8 does not allow for Caryl–H hydrogen bonding 
interactions due to the steric hindrance the nitro groups provide. 
Titration experiments were performed with tetra-n-heptylammonium halide salts 
in C6D6 at 27 °C and the determined 1:1 association constants are shown in Table 1. 
Titration of 7 vs 8 with Cl¯, Br¯, and I¯ yielded larger changes in chemical shifts (as 
well as color changes) for 7, despite having association constants of the same magnitude 
as 8. The difference in Δδ between receptors 7 and 8 is indicative of the modes by 
which each receptor binds the anion. Since 7 is able to bind anions through a stronger 
Caryl–H hydrogen bond interaction, a larger overall chemical shift is observed. DFT 
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Table 1. Average[i] Ka (M-1) values for receptors 7-9[ii] binding halides[iii] 
 Cl¯ (M-1) Br¯ (M-1) I¯ (M-1) 
7 26 18 11 
8 53 35 26 
9 <1[iv] <1[iv] <1[iv] 
[i] Average Ka is reported from two or three titration experiments, except for receptor 9. 
[ii] All titrations 
were performed in C6D6 with initial receptor concentrations at ~2 mM; errors are estimated at ± 10 %. 
[iii] 
Tetra-n-heptylammonium halide salts were used as halide sources and titrations were performed at 27 °C 
to account for the insolubility of NHep4
+I¯ at room temperature. [iv] Changes in chemical shift for control 
receptor 9 were too small to determine Ka values. 
calculations of the two receptors binding Br¯ confirm this finding (Figure 8b). Control 
receptor 9 shows no measurable binding in C6D6, demonstrating the need for the 
electron deficient arene rings in this receptor series. 
While in these studies we have been unable to quantify or definitively display 
purely centered (electrostatic) anion–π interactions, we have learned much about the 
interaction of anions with electron-deficient arenes. Our efforts have served as a 
reminder of the various types of anion–arene interactions possible, of which purely 
electrostatic anion–π seems to be the least favored with the arenes we have studied. 
Nevertheless, these remain an important component in ligand design for anions, and 
understanding the preferred geometry of the various interactions for receptor 
optimization is critical. Subsequent sections and chapters will take note of this 
expanding field and include more recent references regarding its development, 
including our work on the design of new receptors – utilizing hydrogen bonds to  
Caryl–H groups or electrostatically favorable pyridinium moieties – to test the selectivity 
of these interactions in solution for a variety of anions. 
I.4.3. Recent Advances in Solution Studies of Anion–π Interactions 
The importance of anion–π interactions in biologically relevant systems was 
originally postulated with the crystal structure of a chloride-ion channel – arguing 
weak, nearly unfavorable interactions play critical roles in enzymes.36 Recently, with 
the investigation of more examples, computational and experimental results further 
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demonstrated the importance of anion–π interactions in proteins and enzymes, 
including their inhibition mechanisms.46-50 An anion–π interaction was found in urate 
oxidase with both an inhibitor and substrate.46 The interaction is proposed to be crucial 
in the inhibition of the enzyme via either an aromatic inhibitor or by cyanide anions 
interacting with the π-face of the uric acid substrate (Figure 9). 
 
Figure 9. Representation of the active site of urate oxidase, crystalized with the (a) uric 
acid substrate and a cyanide inhibitor and (b) inhibitor 8-azaxantine and dioxygen. 
The establishment of anion–π interactions as important and relevant 
supramolecular interactions has turned studies towards further utilization in synthetic 
ion transporters,51,52 vesicles,53 generation of radical anions and dianions on π-acidic 
surfaces,54,55 catalysis,56,57 and coordination chemistry.58,59 Calixarene- and calixpyrrole-
based anion receptors have continued to play a significant role in the establishment of 
anion–π interactions.60,61 Two-walled calix[4]pyrroles were recently designed and 
synthesized to ideally bind nitrate.52 The bis(3,5-dinitroaryl)calix[4]pyrrole (Figure 10a) 
demonstrated anion–π interactions while binding nitrate, evidenced by the observed 
changes in chemical shift during 1H NMR spectroscopic titrations and energy 
comparisons to variously bis-substituted calix[4]pyrroles. The anion–π interactions were 
also supported through crystal structures – two binding conformations were found, 
perpendicular and pseudo-parallel (Figure 10b,c). The pseudo-parallel structure was  
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Figure 10. Dinitroaryl-substituted calix[4]pyrrole (a) molecular structure and solid-state 
binding structures of the receptor binding tetramethylammonium nitrate in a (b) 
perpendicular and (c) pseudo-parallel geometry. 
concluded to be most similar to what is observed in solution. This system was then used 
to show selective transport of nitrate in vesicles. 
Several papers have designed experiments to quantify anion–π interactions and 
compare them to previously calculated free energies of association. Gas phase and 
theoretical studies26,29,32,44,62,63 have determined binding energies up to 20 kcal mol-1 
while experimental solution results38,52,64-67 have indicated energies of 0.1 – 2.1 kcal  
mol-1 for favorable interactions. Recent investigations have also focused on the 
thermodynamic contributions of some of these anion–π interactions.65,67 
Tren-substituted nitroso-amino-pyrimidine compound (Figure 11a) previously 
shown to bind inorganic and adenosine phosphate anions,64,68,69 demonstrated anion–π 
binding energies of approximately 2 kcal mol-1 for select inorganic anions, including 
sulfate, via pH-metric titrations and isothermal titration calorimetry (ITC) experiments  
 
Figure 11. Molecular structure of the (a) tren-substituted nitroso-amino-pyrimidine 

















in water.65 The ITC experiments also provided the thermodynamic breakdown of the 
contributions of enthalpy and entropy. To determine the values related to just an 
anion–π interaction, a non-tren-substituted system was also investigated (Figure 11b). 
This system found large entropic contributions attributed to “the reduced hydrophobic 
pyrimidine surface exposed to water after anion aggregation, and the consequent 
reduced disruptive effect on the dynamic water structure.”65 
A study released shortly following the pyrimidine investigation found the 
opposite result.67 Once again, “two-walled” substituted-bis(aryl)calix[4]pyrroles were 
employed to quantify anion–π interaction energies and also their thermodynamics. In 
comparison, halide anions were more weakly associated than in the pyrimidine 
investigation; however, the enthalpic parameter was determined to be much more 
influential on the binding energies in chloroform and related to the increase in 
electrostatic surface potential value at the ring centroid. 
I.4.4. Anion–π Interaction Section Conclusions 
Ion–π interactions continue to play a prominent role in supramolecular 
chemistry. The Accounts article highlighted our group’s efforts on the design of ligands 
and receptors featuring prominent ion–π interactions in their complexes. Early work in 
the Johnson lab, described within, focused on efforts to understand and to quantify 
anion–arene interactions in solution. Our work has revealed a variety of interactions 
between anions and electron-deficient arenes as favorable, including weak-σ and  
Caryl–H⋅⋅⋅anion hydrogen bonds. Purely centered anion–π interactions remained elusive 
in the systems studied here, although they presumably comprise a portion of the 
attractive forces in these complexes. The projects have developed to other receptor 
syntheses which took advantage of ionic interactions with a pyridinium core. These 
systems have been further expanded to neutral based receptors allowing varied types of 
anion–arene interactions, which will be discussed in the following section. 
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I.5. Interactions of Anions and Arene Edges: N+–H and Caryl–H Hydrogen Bonds 
I.5.1. Solution Studies of Caryl–H Hydrogen Bond Interactions 
Through the last decade, use of Caryl–H hydrogen bond interactions has 
expanded into anion receptors. Computational work established the ability of Caryl–H 
hydrogen bond interactions to match 50 – 100 % the strength of OH and NH hydrogen 
bonds depending on the substitution of the arene ring.70,71 A benzene strapped 
calix[4]pyrrole (Figure 12) introduced in 2002 demonstrated strong binding of 
tetrabutylammonium chloride in DMSO via ITC experiments.72 The solid state showed 
chloride resides within the cavity with a Caryl⋅⋅⋅Cl¯ distance of 3.793 Å, indicating a 
strong Caryl–H⋅⋅⋅Cl¯ hydrogen bond.73 This class of compounds was expanded upon,74,75 
including receptors designed to specifically address the strength of a Caryl–H⋅⋅⋅Cl¯ vs. a 
Naryl–H⋅⋅⋅Cl¯ hydrogen bond.75 Previously synthesized benzene-strapped calix[4]pyrrole 
was studied with newly introduced pyrrole- and furan-strapped calix[4]pyrroles as 
comparisons for an N–H donor and a negative control with no donor, respectively 
(Figure 12).75 An order of magnitude difference in chloride 1:1 association constant was 
found in acetonitrile via ITC between the pyrrole and benzene systems as well as  
 
Figure 12. Molecular structure (left) and corresponding association constants (right) of 
the strapped calix[4]pyrrole receptors. Association constants were determined at 25 °C in 

















Ka = 2.2 x 106 M-1
1.8 x 107 M-1
1.9 x 105 M-1
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between the benzene and furan control. In further support of the solution data, the 
crystal structure of the pyrrole-strapped receptor showed a 0.63 Å smaller interaction 
with chloride than the corresponding benzene system. 
To further establish the strength and ability of Caryl–H groups to hydrogen bond 
to anions, a purely C–H hydrogen bonding macrocyclic receptor was synthesized 
containing phenyl and triazole rings (Figure 13a).76 Downfield shifts were observed 
during 1H NMR titrations in CD2Cl2 with tetrabutylammonium chloride. A 1:1 
association constant of 1.0 x 105 M-1 for chloride, the anion selected to best fit the 
proposed pocket of the macrocycle, was determined through UV-Vis titrations in 
CH2Cl2. Another all C–H hydrogen bonding macrocycle recently synthesized was 
shown to bind anions and form [3]rotaxanes with dialkylphosphates (Figure 13b).77 This 
receptor, named “cyanostar”, is well known predominately due to its high yielding, one 
pot synthesis but also its ability to strongly bind large, typically weakly associating 
anions. Based on UV-Vis titrations in 2:3 MeOH:CH2Cl2, BF4¯, ClO4¯, and PF6¯ bind 
cyanostar at association constants of K1:1 > 105 M-1 and β2 > 1011 M-2. The cavity of the 
macrocycle is extremely electropositive due to the electron-withdrawing cyano groups  
 
Figure 13. Molecular structure of (a) the phenyl and triazole-based macrocycle shown 
to bind chloride and (b) the cyanostilbene macrocycle shown to strongly bind typically 










































on the periphery of the receptor. While the receptors presented within this dissertation 
do not solely use Caryl–H hydrogen bonds to bind anions, some do utilize the 
interaction within the binding pocket. 
I.5.2. Our Work Using Crystallographic and Solution Studies 
Previously, the Haley and Johnson lab modified an arylethynyl scaffold for use in 
supramolecular assemblies. Molecules with a rigid arylethynylpyridine scaffold showed 
an electronic response when protonated upon coordination of a guest via interaction 
with a lone pair on the heterocycle or induced changes in geometry.78,79 Sulfonamide 
and urea receptors (Figure 14) show interesting fluorescent properties. In CHCl3, the 
bisurea methoxyphenyl and nitrophenyl compounds had opposite results, which was 
postulated to result from the switch between an electron-donating and electron-
withdrawing substituent. While both systems went from essentially colorless to yellow 
upon the addition of HCl in chloroform, the methoxyphenyl bisurea switched from the 
“on” state to the “off” state, and the nitrophenyl switched from “off” to “on” with 
regards to fluorescence.79 Both of these urea receptors were investigated in vitro for 
signaling ability using NIH3T3 murine embryo fibroblasts. The methoxy-substituted 
bisurea moiety showed fluorescence in cells when treated with a high [Cl¯] buffer 
(Figure 15).80 To solubilize and transport the bisureas into cells, a 10 % aqueous DMSO  
 

















Figure 15. Images of NIH3T3 murine embryo fibroblasts with the methoxy-substituted 
phenylurea incubated in high chloride concentrated 10 % aqueous DMSO buffer (left), 
low chloride concentrated 10% aqueous DMSO buffer (middle), and with straight 
DMSO (right) as a control. 
buffer was utilized, which ultimately results in apoptosis of cells. As a result, this 
project turned to focus on designing more water-soluble receptors. 
Initial studies into water-soluble arylethynylpyridine receptors focused on 
polyethylene glycol (PEG) substitutions on the “arms” of the parent urea receptors. 
Compounds shown in Figure 16 were synthesized and investigated for their ability to 
bind anions, but more importantly, for their solubility in water.81 Unfortunately, none 
of these systems were solubilized by water, and demonstrated simple PEG additions are 
not sufficient to transfer these receptors into aqueous environments. Focus has shifted 
to varying substitution on the pyridine core, as it allows for the addition of water 
solubilizing groups through simple SNAr reactions, as well as tuning of the pyridine 
pKa. Protonation of the pyridine receptors has been a requirement of the strong 
fluorescent response to chloride throughout the development of this class of 
receptors.79,82 However, neutral receptors have long been coveted for the application of 
sensors, particularly to remove the dependence of the receptor’s properties on the pH of 
the solution or media used. Tuning the pyridinium to a higher pKa is ideal for 
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Figure 16. Molecular structures of four previously investigated PEG-substituted 
pyridine-based receptors. 
applications in cells, particularly to a pKa greater than physiological or neutral pH – 
this would allow for the pre-protonation step of the receptors to be forgone as the 
receptors would protonate upon their addition to aqueous solutions. This will be 
discussed further in Chapter V. 
Other efforts have focused on moving to neutral receptors to further expand 
upon this class of compounds as well as to assess the need for the pyridine in both 
strength of binding and fluorescent response. In addition to the neutral tripodal 
compounds discussed in Chapter III and IV, a phenyl analogue of the 
arylethynylpyridine bisurea has been synthesized (Figure 17a), which takes advantage of 









































Figure 17. (a) Molecular structure of the phenyl analogue to the arylethynylpyridine 
bisurea receptor. (b) Crystal structure of the receptor binding chloride (green). 
Tetrabutylammonium cation and chloroform molecule were removed for clarity. 
CDCl3 indicated the phenyl-based receptor binds chloride with urea and Caryl–H 
hydrogen bonds through large downfield shifts of the respective proton resonances. A 
solid state structure of the receptor binding tetrabutylammonium chloride in the pocket 
demonstrated a 3.579(3) Å and 169° Caryl–H⋅⋅⋅Cl¯ hydrogen bond (Figure 17b). 
Investigations into the fluorescent properties of this new compound class is underway 
as well as a study looking at the effects of para-subsitution on the phenyl ring on 
strength of binding and fluorescent response. 
I.6. Conclusions 
Both anion–π interactions and Caryl–H hydrogen bonds have had controversial 
histories – as is quite common for emergent phenomena. Anion–π interactions still 
remain a somewhat debated topic to this day, however. After further studies better 
established these non-covalent interactions, many researchers moved on to take 
advantage of both within supramolecular chemistry. Anion receptor chemistry has 
benefited greatly through these systems, specifically with regards to ion transport, 
sensing, and catalysis. 
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I.7. Bridge to Chapter II 
Chapter I represented a short synopsis of past and current work in the fields of 
anion–π interactions and Caryl–H⋅⋅⋅anion hydrogen bonds, most specifically for the 
design of receptors for binding or transporting anions. The following chapters will 
touch on the topics discussed in Chapter I – if only briefly for some. Chapter II 






EXPLORATION OF ARENE–Π INTERACTIONS AS A 
MODE OF BINDING FOR PUTATIVE ANION SENSORS 
 
Chapter II consists of work of my own doing which is unpublished. Lev 
Zakharov collected and solved the diffraction data of the crystal structure. Advisors and 
principle investigators Profs. Darren W. Johnson and Michael M. Haley assisted in the 
editing. 
II.1. Chapter Introduction 
The basic structures of most anion receptors are crown complexes, porphyrins, 
cryptands, calixarenes, and tripods. Typically these receptor classes contain arenes; thus, 
anions bind through the previously mentioned modes: anion–π, weak σ-bond, halogen 
bonding, and Caryl–H hydrogen bond interactions, among other typical hydrogen bonds. 
To expand on our previous work and further elucidate anion–π interactions in solutions 
utilizing enforced proximity and/or electron-
deficient arenes a new series of cryptands 
were envisioned (Figure 1). This system takes 
advantage of multiple arene rings, which 


















X = H, F, CN
Figure 1. Proposed cryptand anion 
receptor comprised of triazine and 
substituted benzene rings. 
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Definitions of cryptand vary in source, however here we use the most general of 
definitions: bicyclic structures composed of two “caps” and three “bridges”, as depicted 
in Figure 2a. Specifically, the resulting internal cavity must be capable of encapsulating 
guests such as anions in order to be deemed a cryptand. Most cryptands designed for 
anionic guests utilize multiple hydrogen-bonding functionalities.1 Importantly, the 
limited conformational freedom of cryptands leads to predictable interactions with 
guests, yet still allows enough flexibility to permit their inclusion.  
 
Figure 2. (a) Cartoon depicting the general molecular structure of cryptands consisting 
of three bridges (pink) and two caps (blue), where X = Y or X ≠ Y. (b) An example 
cryptand utilizing benzene caps and diamido-pyridine bridges. 
Examples in which the cryptand has aryl bridges as well as caps are rare. 
However, one such compound with 1,3,5-triethylbenzene caps and 2,6-pyridine diamide 
bridges (Figure 2b), exhibits high binding with nitrate and acetate.2 The bridging 
functionality binds anions through hydrogen bonding via the amide hydrogens.2 No 
mention of anion–π interactions with regards to the benzene caps is made in the paper. 
A system utilizing more electron-deficient caps may have seen variation in binding 
strength or selectivity. 
While anion receptors are typically equipped with hydrogen bonding motifs 
acting to bind the anion within the receptor cavity, proposed within is a series of 
receptors utilizing multiple electron-deficient π-systems instead of hydrogen bonding 
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motifs. An investigation into the association of anions to this cryptand would follow 
successful synthesis – providing a fundamental understanding of not only the anion 
binding capabilities, but also the selectivity of this class of host. 
II.2. Results and Discussion 
II.2.1. Cryptand 
A series of cryptand receptors with bis(mercaptomethyl)benzene bridges and 
triazine caps were designed to serve as anion hosts utilizing anion–π interactions 
(Figure 1). As discussed, the preorganized structure provided by the cryptand makes 
them interesting targets for anion binding. Certain building blocks have continuously 
been implemented in receptors to investigate and promote anion–arene interactions. 
For example, 1,3,5-triazine is a versatile synthon well known for its participation in 
supramolecular interactions and is often a part of theoretical, solid state, and solution-
based anion–π investigations.3-12 
This proposed system utilizes thiol linkages to the triazine caps. Thiols were 
primarily chosen due to their ease of reactivity 
with halo-substituted functionalities and the 
familiarity of such systems in the Johnson lab. 
Electron density maps of trithiocyanuric acid and 
1,3,5-triazine (Figure 3) demonstrate the presence 
of the sulfur atoms induces no significant change 
in the electron density of the π-cloud. Fluorinated 
arenes are also known to be highly electron-
deficient and are commonly observed to partake 
in anion–π interactions in theoretical and 
solution studies.5,13-15 
Figure 3. Electron density maps of 
1,3,5-triazine (left) and 
trithiocyanuric acid (right) 
calculated at RHF/6-31G**. Color 
scheme: positive, blue and negative, 
red. 
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Molecular modeling of the unsubstituted receptor (RHF/6-311+G**) indicates 
the cryptand cavity can fit anions as large as bromide, while perchlorate is most likely 
too large to be favorably accommodated (Figure 4). Computational attempts to 
investigate the flexibility of the cage to allow an anion to enter proved unsuccessful due 
to structure distortion when holding distances constant. The results obtained are thus 
inconclusive as the distortion is likely due to the constraints imposed. 
 
Figure 4. Modeling of the unsubstituted cryptand with bromide (left) and perchlorate 
(right) in the binding pocket. Top images: cryptand side-view. Bottom images: cryptand 
above-view with upper triazine removed. Atom colors: carbon, dark gray; hydrogen, 
light gray; sulfur, yellow; nitrogen, blue; bromine, dark red; chlorine, green; oxygen, 
red. 
Synthesis of the unsubstituted parent cryptand was based on literature 
procedures (Scheme 1).16,17 Simultaneous slow addition of trithiocyanuric acid and base 
(KOH or DIPEA) in THF and p-xylylene dibromide in THF with high dilution under 
N2 will provide the parent, unsubstituted cryptand. Synthetic approaches using a 
syringe-pump system were made, and while 1H NMR indicated the presence of a new 
compound, separation of the reaction products and starting material proved 
problematic. Insoluble polymer was also obtained from the reaction due to the
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Scheme 1. General reaction for cryptand synthesis. 
 
introduction of an air bubble in one of the syringes. A more precise, air-free set-up 
would be required for a more high yielding synthesis of the cryptand. Due to the 
known difficulties in synthesizing cryptands in general and their low yields, this project 
evolved to examine the simpler, uncapped or tripodal version of the proposed cryptand. 
II.2.2. Tripod 
Before continuing to hone-in on the synthesis of the cryptand, a proof of 
concept receptor was designed which utilized the same aryl rings but in a tripodal 
scaffold in order to determine if measurable or observable binding is feasible in this 
general receptor class. New tripodal receptor 1, based on the original cryptand, was 
realized. The synthesis of 1, based on literature procedure for a similar compound,16 
was performed in one step as shown in Scheme 2. Reflux of trithiocyanuric acid with 
an excess of pentafluorobenzyl bromide and DIPEA provided 1 in 77 % yield. The 
white solid product was fully characterized by 1H, 19F, and 13C NMR as well as mass 
spectrometry (Appendix B).  
Single crystals of 1 were obtained by slow evaporation from a concentrated 
solution in CHCl3. The solid state structure shows the three arms of a single monomer 
orient away from each other with one nearly perpendicular to the triazine plane and 




























Scheme 2. Synthesis of tripodal receptor 1. 
 
contacts of 3.38 Å exist between one monomer and another rotated 180° in 
conformation from the first. (Figure 5b). No solvent molecules are contained within the 
crystal packing (Figure 5c). 
Originally we thought UV-Vis spectroscopic titrations might provide the best 
visualization of anion binding due to the density of aromatic rings in the structure and 
the corresponding lack of proton handles. Unfortunately, the λmax of the peak showed 
no significant shift upon the addition of excess Cl¯ or I¯ as tetrabutylammonium salts 
(TBA) (Figure 6a). The change in intensity upon the addition of iodide proved to be an 
artifact of iodine itself and not a charge transfer complex with the arene rings. 1H 
NMR spectroscopy was next investigated to monitor binding. In these studies Br¯ and 
I¯ were both added in excess upon a single addition, while Cl¯ was titrated in a few 
increments. Minimal shifts of the single proton resonance were observed upon the 
addition of TBACl (Figure 6b). While this result is not surprising given the weak 
nature of anion–π interactions, the peak shifts are not necessarily attributable to 
binding as the change in ionic strength of the solution could also produce a shift. Since 


































77 % yield 1
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Figure 5. Solid state structure of 1 displaying its (a) monomer geometry, (b) dimer 
interaction with short S–S interactions, and (c) packing down the b (left) and c (right) 
axes of the repeated unit cell. 
 
Figure 6. Characterization spectra for monitoring anion binding of 1: (a) UV-Vis 
spectra of host 1 before and after the addition of excess tetrabutylammonium chloride 
or iodide ([1] = 8.4 μM). (b) 1H NMR spectra from the titration of TBACl into a 5.0 mM 
solution of 1, displaying a linear trend of shifts even past 100 equivalents of guest. (c) 
19F NMR spectra before and after the addition of excess chloride to 1. 
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likely the case. Both bromide and iodide produced smaller peak shifts than chloride. In 
addition, highly symmetric 1 possesses only a single 1H NMR spectroscopic handle, 
which is not an aromatic proton. If anion–π interactions occur this benzylic proton 
would not be greatly affected due to its distance from the aromatic ring. Experiments 
with 19F NMR spectroscopy were also performed to monitor anion binding. Similar 
studies have shown 19F NMR to be a suitable spectroscopic handle to observe anion–
π interactions, with changes in chemical shift ranging between approximately 0.5 – 3 
ppm.18-23 Unfortunately, our results showed essentially no change in chemical shift 
(Δδmax ≈ 0.01) when internally referenced to hexafluorobenzene for additions of TBACl 
(Figure 6c), nor TBABr with external reference to trifluoroacetic acid. Finally, attempts 
to obtain crystals of the host interacting with anions provided only host. Overall, no 
spectroscopic methods gave indication of 1 binding anions through anion–π or other 
anion–arene interactions. At this time, more promising alternatives for binding anions 
through arene interactions were initiated using the arylethynyl scaffold as will be 
discussed in Chapter III. 
II.2.3. Altering Substitutions of the Tripod 
In the interest of expanding upon this tripodal system and utilizing other 
anion–arene interactions, a series of receptors 2-7 were envisioned (Figure 7). It is 
possible these receptors could still lead to observation of anion–π interactions – most 
likely in the solid state – through an enforced proximity approach. Receptors 2, 4, and 
6 posses iodo-substitutions to allow for halogen bonding interactions to the arene while 
3, 5, and 7 lack a substitution at the para, meta, and ortho positions respectively allowing 
for Caryl–H hydrogen bond interactions in solution. For all of the proposed receptors, 
original tripod 1 can serve as a control. 
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Figure 7. Proposed tripodal triazine receptor series with iodo-substitutions or no 
substitution in the para, meta, and ortho positions. 
Based on geometry, meta-substituted and unsubstituted tetrafluorobenzyl 
substituted receptors 4 and 5 were synthesized first (Scheme 3 and 4). 
Tetrafluoroiodobenzyl chloride precursors were previously prepared from 
tetrafluorobenzyl halides with p- and m-iodo substitutions through reaction with butyl 
lithium and iodide.18 Complications arose in the butyl lithium reaction during the 
synthesis of 4 due to side product formation resulting from homo-coupling of the 
benzyl chloride to the arene. Changing from the literature procedure’s required -78 °C 
temperature to a colder -95 °C diminished the amount of unwanted side product. 
Reaction of crude 2,4,5,6-tetrafluoro-3-iodochloromethylbenzene with thiocyanuric acid 
was performed at room temperature and yielded receptor 4 in ~90 % yield. Initial 
experiments with tetrabutylammonium anion salts in chloroform showed no color 
changes of 4, indicating strong charge-transfer complexes are not occurring. 
Receptors capable of Caryl–H interactions are interesting for this system as it 
gives a better spectroscopic handle by which to monitor anion binding. Initial attempts 





















2  X = I, Y = F, Z = F
3  X = H, Y = F, Z = F
4  X = F, Y = I, Z = F
5  X = F, Y = H, Z = F
6  X = F, Y = F, Z = I
7  X = F, Y = F, Z = H
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Scheme 3. Synthesis of 2,4,5,6-tetrafluoro-3-iodochloromethylbenzene – precursor to 
receptor 4. 
 
Scheme 4. Synthesis of tripodal receptors 4 and 5. 
 
reaction at reflux in comparison to at room temperature will provide better yields. This 
compound has not been purified for investigation with anions as of yet. 
II.3. Conclusions 
Receptors were designed with no hydrogen bonding functionalities, except 
where specifically desired. The original ideas behind this project focused on 
engineering receptors with detectable binding through anion–π interactions. The 
preorganization of the cryptand has the potential to maximize weak interactions, 
although synthesis attempts proved nonproductive. To better realize the goals of the 
project, a tripodal equivalent with electron-deficient arenes was synthesized. As of yet, 
no experimental evidence has indicated binding of any form with anions. Ways to 
expand this project beyond anion–π interactions includes the aryl halogen and 































General Methods. 1H, 13C, and 19F NMR spectra were obtained on a Varian 
Mercury 300 MHz spectrometer (1H: 300.09, 19F: 282.33 MHz), Inova 500 MHz 
spectrometer (1H: 500.10 MHz, 13C: 125.75 MHz, 19F: 470.53 MHz), or Bruker Avance 
III HD 600 MHz NMR Spectrometer with Prodigy multinuclear broadband BBO 
CryoProbe (1H: 600.02 MHz, 13C: 150.89 MHz). 1H and 13C NMR spectra were 
referenced to residual solvent peaks while 19F NMR spectra were referenced to an 
internal standard of 1 % C6F6 in CDCl3 (19F -164.9 ppm) or an external standard of  
100 % trifluoroacetic acid (19F -76.55 ppm). Chemical shifts (δ) are expressed in ppm 
downfield from tetramethylsilane (TMS) using non-deuterated solvent present in the 
bulk deuterated solvent (CDCl3: 1H 7.26 ppm, 13C 77.16 ppm; d6-DMSO: 1H 2.50 ppm 
13C 39.52 ppm). All NMR spectra were processed using MestReNova NMR processing 
software. All materials were synthesized following literature procedures or were 
obtained from TCI-America, Sigma-Aldrich, or Acros and used as received. X-ray 
crystal data were obtained on a Bruker Apex CCD or a Bruker Apex2 CCD 
diffractometer. 
Perfluoro-tripodal triazine 1. In an oven dried round bottom flask 
thiocyanuric acid (0.3 g, 1.69 mmol) and DIPEA (1 mL, 5.92 mmol) were dissolved in 
THF (35 mL). The solution was placed under N2. Pentafluorobenzyl bromide (0.84 mL, 
5.92 mmol) was added and the solution was allowed to reflux overnight under N2 
followed by dilution with ethyl acetate, washes with water (3x) and brine, drying over 
MgSO4, and removal of solvent in vacuo provided the crude product. Purification with 
flash chromatography over silica gel with 3:2 Hex:DCM yielded the product as a white 
solid (0.94 g, 77 %). The compound is further purified by crystallizing from DCM 
through the addition of hexanes. 1H NMR (600 MHz, CDCl3): δ 4.44 (s). 19F NMR (282 
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MHz, CDCl3, C6F6 internal ref.): δ -164.79 (m, 2F), -157.36 (t, J = 20.8 Hz, 1F), -143.43 
(m, 2F). 19F NMR (282 MHz, CDCl3, TFA external ref.): δ -162.49 (m, 2F), -155.08 (t,  
J = 20.9 Hz, 1F), -141.15 (m, 2F). 13C NMR (151 MHz, CDCl3): δ 21.73 (s), 110.64 (td,  
J = 17.3, 4.0 Hz), 137.74 (dt, J = 255.9, 16.3 Hz), 143.14-139.02 (m), 147.31-143.39 (m), 
178.71 (s). MS (APCI+) m/z = 718 [M+H]+, 720 [M(34S)+H]+. 
m-Iodo-substituted trisperfluoroaryl triazine 4. In an oven dried round 
bottom flask thiocyanuric acid (50.0 mg, 0.28 mmol) and DIPEA (0.17 mL, 0.99 mmol) 
were dissolved in dry THF (5 mL). The solution was placed under Ar. 2,4,5,6-
tetrafluoro-3-iodochloromethylbenzene18 (0.34 g, 0.99 mmol) was added and the 
solution was allowed to stir at room temperature overnight. Purification with flash 
chromatography over silica gel with gradient Hex:DCM yielded the product as an off 
white solid (0.26 g, 90 % crude). Small impurities present. 1H NMR (300 MHz, CDCl3) 
δ 4.43 (s). 19F NMR (471 MHz, CDCl3)a δ -97.07 (d, J = 9.9 Hz), -112.40 (dd, J = 22.8, 
6.9 Hz), -132.11 (dd, J = 20.9, 6.8 Hz), -160.88 (td, J = 21.8, 9.9 Hz). 13C NMR (126 
MHz, CDCl3) δ 178.62 , 155.64 (ddt, J = 245.1, 8.2, 3.5 Hz), 152.59–150.57 (m), 150.48–
148.38 (m), 136.80 (dtd, J = 253.5, 17.1, 5.2 Hz), 110.48 (ddd, J = 21.3, 16.4, 3.7 Hz), 66.14 
(ddd, J = 32.2, 26.8, 4.7 Hz), 22.21. 
m-Unsubstituted tristetrafluoroaryl triazine 5. In an oven dried round 
bottom flask thiocyanuric acid (0.13 g, 0.72 mmol) and DIPEA (0.44 mL, 2.52 mmol) 
were dissolved in dry THF (15 mL). The solution was placed under Ar. 2,4,5,6-
tetrafluorochloromethylbenzene (0.34 mL, 2.52 mmol) was added and the solution was 
allowed to stir at room temperature overnight. Purification with flash chromatography 
over silica gel with gradient Hex:DCM yielded the product (80.5 mg, 16 % crude). 
Impurities present. 1H NMR (300 MHz, CDCl3) δ 6.80 (tdd, J = 9.5, 5.9, 2.3 Hz, 3H), 
4.43 (s, 6H). 19F NMR (282 MHz, CDCl3)a δ -115.95 (t, J = 10.3 Hz), -132.07 (dt,  
J = 21.2, 7.8 Hz), -132.97 (dd, J = 21.0, 5.9 Hz), -164.39 (tdd, J = 20.9, 11.2, 5.9 Hz). 
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II.5. Notes 
 a  No reference was utilized in the 19F NMR spectra. 
II.6. Bridge to Chapter III  
This chapter focused on my initial project designs to better understand and 
isolate anion–π interactions in solution studies. Chapter III will introduce the project 






SELECTIVE NITRATE BINDING IN COMPETITIVE 
HYDROGEN BONDING SOLVENTS: DO ANION–Π 
INTERACTIONS FACILITATE NITRATE SELECTIVITY? 
 
The work in Chapter III was published in volume 52 of the journal Angewandte 
Chemie, International Edition in September 2013. Dr. Lev Zakharov collected and solved 
the diffraction data for the crystal structure of 1, 1•NO3¯, and 1•Cl¯. My advisors and 
principle investigators, Profs. Darren W. Johnson and Michael M. Haley, 
conceptualized this research and provided editorial assistance for this publication. 
III.1. Introduction 
Anions are increasingly recognized as problematic environmental contaminants. 
For example, excess nitrate in soil from over-fertilization has led to contamination in 
water sources worldwide.1 Nitrate run-off into water sources causes algal blooms, a 
process known as eutrophication, which ultimately deprives water of oxygen and leads 
to dead zones in the world’s lakes and oceans. Given the negative impact nitrate has on 
water sources, there has been considerable interest in the design and synthesis of 
receptors capable of sensing the molecule in solution. A number of studies have 
reported synthetic neutral receptors capable of binding nitrate in solution; however, 
most exhibit low affinity.2-8 Some reports have shown enhanced nitrate binding in 
polar solvents, such as CHCl3,9-12 and even a few demonstrate high nitrate binding in 
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more competitive solvents;13-19 however, selectivity for nitrate remains rare.2,4,8,18,19 We 
report new tripodal receptor 1 that exhibits strong binding of nitrate in polar, 
competitive solvents and shows modest selectivity for nitrate over common interferents, 
such as chloride. Control receptor 2, lacking an electron-deficient aromatic ring, 
exhibits no such selectivity for nitrate. A close contact between nitrate and an alkyne 
within the receptor suggests an anion–π-type interaction may enhance nitrate binding. 
Recently, examples indicating the presence of anion–π interactions in solution 
have emerged, often accompanied by complementary solid-state evidence. A 
functionalized naphthalenediimide chain has shown a high selectivity for transporting 
nitrate over acetate in vesicles.20 Similarly, a perfluorobenzene calixarene-based ditopic 
receptor showed chloride ion transport across a lipid membrane, despite a lack of 
detectable chloride binding from 19F NMR spectroscopy.21 Attempts to quantify non-
charge-transfer anion–π interactions have proved difficult because of their innate 
weakness; however, an “enforced proximity” approach has been used to quantify a small 
but favorable anion–π interaction in a nitro-substituted octamethyl calix[4]pyrroles.22 
Most recently, nitrate–π interactions have been further quantified for a series of 
disubstituted calix[4]pyrroles in which nitrate is likely sandwiched between two 
electron-deficient aryl substituents.23 Two such receptors showed selectivity for the 
transport of nitrate over chloride across lipid membranes.23 The work presented herein 
suggests an influence of anion–π-type interactions in the observed nitrate selectivity.a 
III.2. Results and Discussion 
We have previously modified a bis(arylethynyl)pyridine scaffold to make a series 
of receptors studied for their anion-binding capabilities.24-27 Binding of these systems 
has been characterized through an electronic response by fluorescence. In the work 
presented herein, we sought to design and synthesize a three-fold symmetric receptor 
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(1) for binding nitrate. Molecular models suggested the tripodal structure and urea 
functionalities are likely to bind trigonal planar anions. Nitrate should be able to 
accommodate six hydrogen bond donors, which is more easily accomplished with 
diprotic donors, such as ureas.28,29 Furthermore, the electron-deficient central arene of 
1 would enhance the chances of a three-fold symmetric binding motif. For comparison, 
an unsubstituted, more electron-rich analogue (2) was synthesized. The 1,3,5-
trifluorobenzene core (3) was obtained in 93 % yield through a Sonogashira cross-
coupling at 70 °C between 1,3,5-trifluoro-2,4,6-triiodobenzene30 and 4-tert-butyl-2-
ethynylaniline (Scheme 1).27,31 Similarly, the unsubstituted core (4) was synthesized in 
60 % yield from triiodobenzene.32,33 Subsequent reaction of 3 and 4 with p-
nitrophenylisocyanate in toluene provided receptor 1 in 67 % yield and 2 in 57 % yield, 
respectively. 
Scheme 1. Synthesis of tripodal receptors 1 and 2. 
 
Single crystals of 1 were obtained by vapor diffusion of pentane into acetone. 
The solid state structure shows a tight dimer held together by an intricate network of 
hydrogen bonds (Figure 1). Two monomers stack on top of each other through slip-
stacked π–π interactions of the central benzene. Two urea arms on one host molecule 
bind two urea arms on the second host with one as the donor, the other as the acceptor. 
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Figure 1. Crystal packing of 1 (left) showing a dimer capped by a total of eight acetone 
molecules and (right) showing these dimers are mostly discrete, interacting with each 
other through only π-stacking (solvent omitted for clarity). 
molecules. The third arm of each monomer sticks out of the plane defined by the core 
and the other two arms. The dimer is capped on each side by a total of eight acetone 
molecules. Each dimer interacts with another through π-stacking of the third 
protruding arm. 
Interaction of 1 with anions in solution was investigated by 1H NMR 
spectroscopy. Initial titration experiments were performed at 0.5 mM of 1 in d6-acetone 
owing to its limited solubility in other solvents, despite the potential solvent 
competition as a hydrogen bond acceptor. Addition of tetrabutylammonium (TBA) salts 
of chloride, bromide, and nitrate resulted in a downfield shift of both urea protons Ha 
and Hb (labels refer to assignments shown in Scheme 1). Changes in chemical shifts of 
phenyl protons Hc and Hd were also observed, but to a lesser extent, with Hd moving 
upfield (Figure 2). Large downfield shifts of the urea protons indicate hydrogen bonds 
of the ureas to the anion as the main mode of binding. Change in chemical shift 
corresponding to the addition of NO3¯ or Br¯ begins to maximize at approximately 0.5 
equiv. of guest, indicating a possible 2:1 binding model in acetone. Non-linear 
regression analysis34 of these data failed to provide reproducible binding constants with 
1:1 or 2:1 models for NO3¯ or Br¯. The sharp transition seen in the binding curves often  
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Figure 2. Example of a stacked 1H NMR spectra for the titration of nitrate into a  
1 mM solution of receptor 1 in 10 % d6-acetone. 
indicates strong binding with Ka > 104 M-1, which is typically too large to be accurately 
determined by NMR spectroscopy.b Titrations with Cl¯ showed the Δδ maximizing 
closer to 1 equiv. of guest. Non-linear regression analysis34 of these data provided a 1:1 
binding constant for Cl¯ of 8620 ± 1170 M-1. This evidence alone is not enough to 
demonstrate the proposed stronger binding of NO3¯ or Cl¯ for 1; however, it does 
indicate a strong binding of NO3¯ in acetone and suggests a lower limit for the NO3¯ 
association constant.c For comparison, to the best of our knowledge, the largest 
association constants previously reported in the literature for nitrate binding of neutral 
receptors in acetone are 3470 M-1 for a p-ureapyridine-based receptor16 and 910 M-1 for a 
1,4-diaryl triazole oligomer.15  
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Preferential binding of chloride and nitrate to 1 over the competitive solvent 
acetone was also demonstrated in the solid state (Figure 3). Single crystals of 1 binding 
TBACl and TBANO3 were grown through vapor diffusion of pentane into acetone. 
Comparison of the solid state structures shows the packing of 1 with Cl¯ (Figure 3b,d) 
and with NO3¯ (Figure 3f,h) to be remarkably similar. A single host molecule binds two 
anions through hydrogen bonds to the ureas of two arms (Figure 3a,e). The hydrogen 
bonds between 1 and NO3¯ are shorter than those of 1 and Cl¯, with Nurea⋅⋅⋅Onitrate 
distances of 2.874(6) and 3.089(6) Å for one urea and 3.008(5) and 2.887(5) Å for the 
other, compared to Nurea⋅⋅⋅Cl¯ distances of 3.324(3) and 3.244(3) Å for one urea and 
3.175(3) and 3.314(3) Å for the other. Each anion is located over the alkyne of a single 
monomer. Once again, NO3¯ is held closer to the monomer than Cl¯, as seen in Figure 
3c,g. The closest interaction of Cl¯ to the monomer is to one alkyne carbon with a 
distance of 3.796 Å. However, for nitrate the anionic π-system appears to align with  
 
Figure 3. Crystal packing of 1 with (a-d) TBACl and (e-h) TBANO3, highlighting the 
overall 1:1 interactions between host and anionic guest in the (a,e) monomer, (b,f) 
stacked column, and with the conjugated π-system (c,g). Cation (blue) and solvent 
(orange) interactions are shown in d and h. 
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the π-system of the receptor, supporting some intermolecular distances less than 3.7 Å 
(Figure 3g). Crystal packing shows an overall 1:1 binding where the host and anion are 
arranged in an infinite chain of host–guest–host–guest, and so on (Figure 3b,f). As 
mentioned, the anion is bound to the host through hydrogen bonds to both urea 
hydrogens on a single arm of the structure. The urea carbonyl of the same arm is 
hydrogen bonded to an arm on the receptor, which shares binding to the anion. TBA 
countercations form solvent-separated ion pairs with both Cl¯ (Figure 3d) and NO3¯ 
(Figure 3h) and are in approximately the same location in each crystal structure. 
To simplify the mode of binding in these receptors, as well as to lower the 
association constant of nitrate and bromide to a measurable amount, other solvent 
systems were investigated. Low solubility of the tripodal receptors limited the solvent 
possibilities. We also aimed to maintain competition between binding of the anion and 
solvent molecules to provide further evidence for the strong binding of nitrate in 
competitive solvents, a critical feature for applications in environmental monitoring. 
Increasing concentrations of DMSO in chloroform have been shown to simplify 
binding models by breaking up self-association and, as a result, higher order 
binding.15,18,19,35 Furthermore, DMSO is a strong hydrogen-bond acceptor, and thus a 
lower association constant would be expected.d Initial upfield shifts, followed by 
downfield shifts of the urea protons, were observed upon the addition of TBANO3 to  
1 mM solutions of 1 in 2 % d6-DMSO/CDCl3 and 5 % d6-DMSO/CDCl3. The titration 
curves indicate a more complicated system than a 1:1 model (Figure 4 and Figure 5); 
however, the data still could not be fit to a standard model.e Raising the DMSO 
concentration to 10 % d6-DMSO/CDCl3 decreased the overall change in chemical shift 
of the urea protons (Figure 6), but a smooth binding curve is observed, indicating self-
association (and likely ion-pairing) is no longer occurring. As suspected, titrations of 
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Figure 4. Example of stacked 1H NMR spectra for the titration of nitrate into a 1 mM 
solution of receptor 1 in 2 % d6-DMSO/CDCl3. 
 
Figure 5. Example of stacked 1H NMR spectra for the titration of nitrate into a 1 mM 
solution of receptor 1 in 5 % d6-DMSO/CDCl3. 
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Figure 6. Example of a stacked 1H NMR spectra for the titration of nitrate into a  
1 mM solution of receptor 1 in 10 % d6-DMSO/CDCl3. 
TBA salts of nitrate, bromide, chloride, and iodide fit to a 1:1 model when performed in 
10 % d6-DMSO/CDCl3 (Table 1). 
Titrations in 10 % d6-DMSO/CDCl3 were performed at a constant 1 mM 
concentration of 1. The change in chemical shift was monitored throughout the 
titration and fit to a 1:1 model using non-linear regression analysis.34 Titrations of 
NO3¯, Cl¯, and Br¯ performed with 1 showed Δδ level off at approximately 1 equiv. of 
guest, while I¯ began to maximize closer to 3 equiv. (Appendix C). The binding 
constants of each anion investigated and the calculated total Δδ values based on the 
determined constant are presented in Table 1. The largest changes in chemical shift for 
each anion are observed in the urea protons of 1, namely Ha and Hb. Hb moves farthest 
downfield, demonstrating a stronger hydrogen bond between the anion and this proton.  
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Table 1. Association constants (Ka, M–1) of 1 and 2 in 10 % DMSO-d6/CDCl3 
determined by monitoring urea protons Ha and Hb and p-NO2C6H4 protons Hc and Hd 








–1) [iv] Ha [iii] Hb [iii] Ha [iii] Hb [iii] Hcore [v] 
NO3¯
 0.26 0.39 24100 (1050) 0.19 0.27 <0.01 11800 (1570) 
Cl¯ 0.21 0.99 12200 (934) 0.12 0.97 0.31 63700 (814) 
Br¯ 0.16 0.62 8320 (876)    ―[vii] 
I¯ [vi] 0.12 0.29 755 (85)    ―[vii] 
[i] Determined at 25 °C. [ii] Anions added as tetrabutylammonium salts. [iii] Averaged calculated values are based on the 
determined binding constants. [iv] Values are an average of three titrations. Standard deviation is given in 
parenthesis. All errors are < 15 %. [v] Averaged values from the observed changes in chemical shift. [vi] Δδ(H) values 
are over a larger equivalency range for iodide than nitrate, chloride, or bromide. [vii] Not determined. 
Chloride has the largest shift in Hb but its measured Ka of 12,200 M-1 was not the 
highest observed association with 1. 
The largest association constant of 24,100 M-1 was obtained with NO3¯, which 
also had the largest observed shift in Ha, Δδ = 0.26 ppm versus Δδ = 0.21, 0.16, and 0.12 
ppm for Cl¯, Br¯, and I¯, respectively. Comparing the other values of Ha with the 
binding constants, a trend is observed – the larger shift in Ha, the higher the measured 
1:1 association constant. Not only is 1 capable of binding anions out of competitive 
media, the binding of nitrate is significantly higher than chloride.f The only 
comparison in 10 % d6-DMSO/CDCl3 these authors are aware of is a neutral tripodal 
cyclic peptide with a 1:1 NO3¯ binding constant of 126 M-1 and no selectivity for NO3¯ is 
observed.14 Selectivity for NO3¯ over Cl¯ and I¯ has been demonstrated in 100 % d6-
DMSO for a NHBoc-substituted macrocyclic triamide with a NO3¯ association constant 
of 20 M-1.18,19 To the best of our knowledge, tripodal host 1 exhibits the strongest nitrate 
binding for a neutral receptor in competitive solvents, and an anion–π interaction 
appears to facilitate, if not enhance, this binding.  
More detailed analysis of the binding modes of anions with 1 and the selectivity 
of NO3¯ in this system will be investigated in the near future; however, some 
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observations are worth noting. The trend in binding constants corresponds to the 
observed Δδ values of Ha. A larger value of Δδ would typically indicate a stronger and 
shorter hydrogen bond of the urea proton to the anion, which would correspond to the 
anion being in closer proximity to the aryl core. This presents an argument for the 
presence of an anion–π interaction. The crystal structure of the nitrate-bound host 
supports this hypothesis, and reveals a clear interaction between the nitrate anion and 
the π-system of the aryl core and the alkyne (for example, see Figure 3g showing 
N/Onitrate⋅⋅⋅Calkynyl contacts distances of 3.596 and 3.650 Å). As previously discussed, the 
distances of NO3¯ to the aryl core and alkyne are significantly shorter than those of 
Cl¯. An electrostatic potential map of 1 indicates a lack of electron density in the arene 
as well as the conjugated alkynes (Appendix C). The question arises as to why nitrate 
would have a stronger interaction with the π-system than chloride. Nitrate itself 
possesses a conjugated π-system, so this could be suggestive of a favorable π–π type 
interaction; nevertheless, one of the partners in this interaction is anionic making this 
a clear example of an anion–π interaction of some type or a “π–π-assisted anion–π” 
interaction. 
To further investigate this claim, unsubstituted and more electron-rich receptor 
2 was synthesized for comparison to electron-deficient 1. Along with the change in the 
electronics providing weakened anion–π interactions, the extra proton in 2, Hcore, could 
provide further insight into the binding mode. 
Similar to 1, host–guest complexes of 2 were investigated through 1H NMR 
spectroscopy titrations in 10 % d6-DMSO/CDCl3. Titrations were performed at 
approximately 1 mM 2 with TBA salts of Cl¯ and NO3¯. The urea protons (Ha and Hb), 
nitrophenyl protons (Hc and Hd), and core proton (Hcore) were monitored throughout the 
titrations. For consistency, only Ha, Hb, Hc, and Hd were used to fit the data to a 1:1 
model, as was done with 1. All changes in chemical shift began to level off near 1  
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equiv. of anion and are presented in Table 1 with association constants corresponding to 
NO3¯ and Cl¯. The values reported for Ha and Hb are averages derived from the 
individual association constants of each titration, while the values for Hcore are averaged 
from the observed changes during the titration. 
Replacing the fluorine atoms with hydrogens changes not only the electronics, 
but also the number of hydrogen bond donors. This combination leads to a loss in 
selectivity for NO3¯ over Cl¯. Chloride binding is now enhanced, with an association 
constant for 2 of 63,700 M-1, whereas nitrate binding is weakened to 11,800 M-1. Any 
anion–π interactions would be weakened or now repulsive owing to the change in 
electronics within the central ring, so weakening of the binding would be expected, as 
seen with NO3¯. The large increase in Ka for Cl¯ can be attributed to the addition of a 
hydrogen bond with Hcore,36 assigned from the titration of 2 (Figure 7). This hydrogen 
bond is observably stronger (Δδ = 0.31 ppm versus Δδ = 0.12 ppm) than that of Ha, 
which correlated to Ka for 1. The association constant for NO3¯ with 2 trends with the 
noted correlation and indicates 2 may bind NO3¯ by a similar mode as 1, but binds Cl¯ 
through a different mode. More importantly, no significant shift of Hcore occurs upon 
the addition of nitrate to 2 (Figure 6), thus there is no hydrogen bonding of the anion 
to Hcore, indicating an anion–π interaction may still be the preferred mode of binding, 
despite the more electron-rich arene. Three important results stem from the 
investigation of 2: nitrate selectivity is lost, the association constant of nitrate is 
diminished, and nitrate binds via a different mode than chloride. These data support a 
model in which nitrate binds to the receptor through an anion–π-type interaction 
regardless of the electronics, while chloride prefers to bind through a hydrogen bond to 
the core of 2 rather than to the π-system, effectively raising the association constant. 
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Figure 7. Stacked 1H NMR spectra for the titration of Cl¯ (left) and NO3¯ (right) into a 1 mM solution of receptor 2 in 10 %  
d6-DMSO/CDCl3. 
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III.3. Conclusions  
The tripodal receptors presented herein demonstrate preferential binding of 
anions over competitive hydrogen bonding solvents, namely d6-acetone and 10 %  
d6-DMSO/CDCl3. The binding of nitrate and bromide to 1 in d6-acetone could not be 
accurately determined. The association of chloride to 1 is actually higher in the 10 % 
d6-DMSO/CDCl3 solution than in d6-acetone, whereas the association of both bromide 
and nitrate are lower. Receptors 1 and 2 bind anions out of 10 % d6-DMSO/CDCl3 in a 
1:1 stoichiometry. A strong affinity for the anions is observed even in the presence of  
d6-DMSO and the binding of 1 trends: NO3¯ > Cl¯ > Br¯ > I¯, with a moderate 
selectivity for nitrate possibly resulting from an anion–π interaction. Binding studies of 
2 support the existence of a favorable anion–π interaction by demonstrating a loss in 
nitrate selectivity and indicating an anion–π-type interaction still is the preferred mode 
of binding for nitrate. We intend to expand the investigation of 1 and 2 to other 
anionic substrates as well as further probing the influence of an anion–π interaction. 
III.4. Experimental 
Trifluorobenzene/trianiline core 3. In a sealable flask 1,3,5-trifluoro-2,4,6-
triiodobenzene (2.824 g, 5.54 mmol) was dissolved in DIPA (100 mL) and THF (100 
mL), then CuI (0.105 g, 0.551 mmol) was added. The mixture was purged with Ar for 
30 min, then Pd(PPh3)4 (0.510 g, 0.441 mmol) was carefully added. An Ar-purged 
solution of 4-tert-butyl-2-ethynylaniline (4.80 g, 27.7 mmol) in DIPA (40 mL) and THF 
(40 mL) was then transferred into the flask via cannula. The flask was sealed and 
heated to 70 °C overnight. After cooling, the solvent was removed in vacuo, and the 
residue run through a plug of silica using CH2Cl2. The crude product, suitable for 
continuation, was obtained by precipitation out of the CH2Cl2 solution using hexanes. 
Pure product 3 was obtained by column chromatography (4:1 CH2Cl2:hexanes) as an 
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off-white solid (3.33 g, 93 % yield.) 1H NMR (600 MHz, CDCl3) δ 7.40 (d, J = 2.2 Hz, 
3H), 7.25 (dd, J = 8.5, 2.2 Hz, 3H), 6.71 (d, J = 8.5 Hz, 3H), 4.26 (s, 6H), 1.30 (s, 27H). 
13C NMR (151 MHz, CDCl3) δ 160.83 (dt, J = 251.9, 7.1 Hz), 146.15, 140.99, 128.64, 
128.44, 114.57, 106.13, 100.35 (m), 97.79, 79.29, 34.08, 31.51. LRMS (ESI) m/e 646.3 
(M+,100), 323.7 (60). HRMS (ESI) for C42H43N3F3 [M+]: calcd 646.3409, found 646.3387. 
Benzene/trianiline core 4. Following the procedure for synthesis of 3, 1,3,5-
triiodobenzene (0.364 g, 0.80 mmol) was reacted with 4-tert-butyl-2-ethynylaniline 
(0.691 g, 4.00 mmol) in the presence of THF (5 mL), DIPA (5 mL), CuI (0.015 g, 0.078 
mmol) and Pd(PPh3)4 (0.075 g, 0.065 mmol). Pure product 4 was obtained as an off-
white solid by precipitation out of CH2Cl2 using hexanes (0.285 g, 60 % yield.) 1H 
NMR (600 MHz, CDCl3) δ 7.67 (s, 3H), 7.41 (d, J = 2.3 Hz, 3H), 7.23 (dd, J = 8.5, 2.3 
Hz, 3H), 6.71 (d, J = 8.5 Hz, 3H), 4.20 (s, 6H), 1.32 (s, 27H). 13C NMR (151 MHz, 
CDCl3) δ 145.73, 141.03, 133.50, 128.92, 127.65, 124.34, 114.53, 107.01, 92.79, 88.00, 
34.03, 31.51. LRMS (ESI) m/e 592.4 (M+, 100), 296.7 (65). HRMS (ESI) for C42H46N3 
[M+]: calcd 592.3692, found 592.3674. 
Receptor 1. In oven dried glassware, trisaniline 3 (0.300 g, 0.465 mmol) and p-
nitrophenyl isocyanate (0.457 g, 2.787 mmol) were dissolved in freshly distilled toluene 
(75 mL). The reaction mixture was stirred overnight, quenched with acetone, and 
product 1 was precipitated cleanly with hexanes (0.354 g, 67 % yield). 1H NMR (600 
MHz, DMSO-d6) δ 9.95 (s, 3H), 8.45 (s, 3H), 8.12 (d, J = 9.2 Hz, 6H), 7.89 (d, J = 8.7 
Hz, 3H), 7.65 (d, J = 9.2 Hz, 6H), 7.55 (dd, J = 8.7, 2.4 Hz, 3H), 7.49 (d, J = 2.4 Hz, 
3H), 1.28 (s, 27H). 13C NMR (151 MHz, DMSO-d6) δ 161.36 (dt, J = 261.1, 7.4 Hz), 
151.82, 146.05, 146.01, 141.13, 137.48, 128.65, 128.26, 125.08, 121.45, 117.50, 111.54, 99.57 
(m), 96.78, 78.75, 39.52, 34.07, 30.89. LRMS (ESI) m/e 1138.4 (M+, 90), 242.3 (100). 
HRMS (ESI) for C63H55N9O9F3 [M+]: calcd 1138.4075, found 1138.4045. 
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Receptor 2. In oven dried glassware, trisaniline 4 (85 mg, 0.144 mmol) and p-
nitrophenyl isocyanate (0.148 g, 0.862 mmol) were dissolved in freshly distilled toluene 
(15 mL). The reaction mixture was stirred overnight, quenched with acetone, and 
product 2 was obtained cleanly by repeated precipitation from acetone with hexanes (89 
mg, 57 % yield). 1H NMR (600 MHz, DMSO-d6) δ 10.20 (s, 3H), 8.46 (s, 3H), 8.10 (d,  
J = 8.8 Hz, 6H), 8.07 (s, 3H), 8.03 (d, J = 8.7 Hz, 3H), 7.69 (d, J = 8.9 Hz, 6H), 7.57 (d, 
J = 2.4 Hz, 3H), 7.50 (dd, J = 9.0, 2.4 Hz, 3H), 1.31 (s, 27H). 13C NMR (151 MHz, 
DMSO-d6) δ151.78, 146.07, 145.44, 141.07, 137.28, 134.27, 128.94, 127.34, 125.05, 123.52, 
120.25, 117.49, 111.37, 92.99, 87.45, 34.05, 30.97. LRMS (ESI) m/e 1084.4 (M+, 98), 208.0 
(100). HRMS (ESI) for C63H58N9O9 [M+]: calcd 1084.4358, found 1084.4368. 
III.5. Notes 
 a  We recognize the observed interaction between nitrate and the π-system may simply 
be π-stacking between nitrate and an arylalkyne; however, such an interaction 
might still be broadly described as “anion–π” since one partner in the association is 
anionic. 
b  Values obtained using the 1:1 Thordarson fitting program consistently gave 
association constants on the order of 104 M–1 for bromide and 105 M-1 for nitrate, 
albeit high errors and poor overall fit. 
c  Given the possibility of 2:1 binding modes for NO3¯ or Br¯ in d6-acetone, and 
evidence of solid state dimerization, self-association of 1 in acetone was investigated. 
The data obtained could not be fit to a self-association/dimerization model (even 
when dimerization was assumed). While this evidence provides little assistance in 
fitting NO3¯ or Br¯ titration data, it shows the receptor aggregates in acetone. This, 
coupled to the potential for association constants larger than 104 M-1, led us to 
investigate the binding in other solvents. 
d  No changes in chemical shift were observed upon titration of nitrate into 1 in neat 
d6-DMSO. 
e  Results indicate a 2:1 binding model breaking up to 1:1 upon the further addition of 
anion. The 2:1 model likely results from self-aggregation of the receptor in these 
polar solvent mixtures. 
f  Statistical significance determined by a t-test comparing the values obtained for 
nitrate binding versus those of chloride binding. The difference between the two 




III.6. Bridge to Chapter IV 
Chapter III introduced tripodal tris-urea receptors which bound anions in a 
competitive solvent system. These systems demonstrated binding through anion–π 
interactions in solution, a notoriously difficult task. This interaction was demonstrated 
to be pivotal for the selectivity of nitrate over chloride in the fluoro-substituted 
receptor. Chapter IV expands on this receptor series with a methoxy-substitution on the 
phenyl urea moieties. In addition, the anion binding studies are continued to include 






ANION BINDING PROPERTIES OF TRIPODAL 
ARYLETHYNYL-BASED RECEPTORS 
 
Chapter IV is comprised of unpublished co-authored work, which will be 
submitted to the journal Chemical Science later this year. I wrote the document and 
performed many of the spectroscopic titrations within. This work is supplemented by 
synthetic advances and additional titrations performed by an undergraduate student I 
advised, John Houlihan. The crystal structure data was collected and solved by Dr. Lev 
Zakharov. Editing was performed by my advisors and principle investigators, Profs. 
Darren W. Johnson and Michael M. Haley. 
IV.1. Introduction 
Anions are ubiquitous in the environment and biological systems – naturally 
occurring or as contaminants. Many of our bis(urea) receptors have taken advantage of 
a chloride selective turn-on fluorescent response, often in conjunction with aggregation, 
for future applications in biological sensors.1-4 A water-soluble version of these 
bis(ureas) will be discussed in Chapter V. While most of these compounds are studied 
for potential applications in cell imaging, some versions of our arylethynyl receptors 
have potential applications in sensing anions in the environment, including nitrate and 
phosphates. Over fertilization in agriculture results in excess nitrates and phosphates 
running off into rivers and streams, ultimately leading to eutrophication of larger water 
bodies. As a result, the UN lists nitrate as the number one contaminant in the world’s 
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aquifers.5 Levels of perchlorate in the environment can be traced back to fireworks and 
fuel propellants,6 while pertechnetate is released in the processing of nuclear fuel.7 Due 
to the radioactivity of pertechnetate, perrhenate is often used as a model for binding 
studies. Accurate sensing of these and other pertinent anions depends significantly on 
selectively binding a single anionic species of interest. 
Previously, we synthesized two tris(urea) arylethynyl receptors with a 
trifluorobenzene- and phenyl-based core (1 and 2, Figure 1).8 Anion binding properties 
of both receptors were reported for nitrate and chloride, as well as bromide and iodide 
with 1. The arene-based core was determined to bind nitrate, in part, using anion–π 
type interactions, regardless of the 
electron density of the arene. More 
electron-deficient core 1 was selective for 
nitrate over the halogens due to this 
phenomenon. When the core was 
switched to benzene (2) from 
trifluorobenzene (1), the electron-density 
of the arene was increased and this 
selectivity was lost. Receptor 2 binds 
chloride more strongly than receptor 1 via 
a hydrogen bond interaction between the 
halide and proton on the core arene.  
To expand further on this receptor series, methoxy substituted analogues were 
envisioned in place of the nitro substitution of 1 and 2. Receptor 3 possesses an 
electron-donating group on the peripheral arenes which will affect the binding of the 
ureas as well as possibly change the fluorescent properties of the receptor class. While 
receptors 1 and 2 are non-fluorescent with and without the presence of a guest, 3 is 

















Y Ha Hb Hc
Hd
1  X = F, Y = NO2
2  X = Hcore, Y = NO2
3  X = Hcore, Y = OMe
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inherently fluorescent. Unfortunately, this fluorescence is also not affected by the 
presence of guest thus far. Additionally, we sought to further investigate the selectivity 
of our system by expanding our anion set. 
IV.2. Synthesis 
The synthesis of receptors 1 and 2 were previously reported in Chapter III.8 
Synthesis of 3 is performed in the same manner as the prior receptors through reaction 
of the unsubstituted trisaniline core with p-methoxyphenyl isocyanate in toluene with a 
57 % yield (Appendix D). A fourth receptor with X = F, Y = OMe was synthesized, 
however purification proved problematic. 
IV.3. Crystal Structure of 2 
Crystals of diffraction quality were obtained through slow evaporation of either 
acetone or DMSO. The structure of 2•DMSO is disordered throughout the solvent 
molecules and within the t-butyl groups. Monomers of 2•DMSO and 2•Acetone mirror 
each other with one arm essentially in the plane of the central arene and the other two 
arms oriented above and below the plane, similar what is also observed in the crystal 
structure of 1 (Figure 2). The main difference between 1 and 2 observable in the 
monomer is the extent to which the arms are oriented out of the plane of the central 
arene. The arm directed furthest from the plane sits 52.8°, 60.4°, and 53.4° in  
 
Figure 2. Solid state conformation of the (a) 1•Acetone, (b) 2•Acetone, and (c) 
2•DMSO monomers. 
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1•Acetone, 2•Acetone, and 2•DMSO, respectively. The remaining two arms of 
1•Acetone has two arms close to the plane of the central arene with dihedral angles of 
9.81° and 7.55°. In contrary, solvates of 2 have one arm close to the plane with dihedral 
angles from the central arene of 9.21° and 12.8°, while the last arm extends further 
from the plane by 22.0° and 29.0° for 2•Acetone, and 2•DMSO, respectively. The 
differences in the orientation of monomers 1 and 2 (clearly shown in Figure 2) may 
result from the dimer formed by 1 (see Chapter III), which is not observed in 2. While 
not dimerized, monomers are connected via Caryl–H⋅⋅⋅Ourea, Nurea–H⋅⋅⋅Onitro, and Caryl–
H⋅⋅⋅Onitro hydrogen bonds in an infinite network, with the remaining interactions 
associated with π-stacking (Figure 3). While the solvates of 2 are similar in orientation 
with regards to the monomer structure, the intermolecular interactions of 2•DMSO are 
minimized in the crystal lattice in comparison to 2•Acetone. Only Caryl–H⋅⋅⋅Ourea 
hydrogen bonds and π-stacking interactions are found in the crystal packing of 
2•DMSO (Figure 4). A large volume of solvent molecules are present in 2•DMSO 
which accept hydrogen bonds from 2, occupying all the donating sites of urea moieties. 
This aligns with previous solution results for 1 which demonstrate the weakening of 
intramolecular hydrogen bonding in DMSO in comparison to acetone. Crystal growth 
of 2 with anions has only yielded structures of solvates of 2 thus far. 
IV.4. 1H NMR Titrations 
Following with the previous study, titrations were typically performed in 10 % 
d6-DMSO/CDCl3 at a constant concentration of 1 mM. This study includes titrations of 
receptors 1, 2, and 3 – expanding upon the anions already investigated. The changes in 
chemical shift of Ha, Hb, Hc, Hd, and Hcore (when applicable) were monitored 
throughout the titration. In each case, four protonsa were globally fit to a 1:1 model  
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Figure 3. Crystal packing of 2•Acetone highlighting (a) the hydrogen bond network 
(Caryl–H⋅⋅⋅Ourea: pink, Nurea–H⋅⋅⋅Onitro: blue, Caryl–H⋅⋅⋅Onitro: green) and (b) the π-stacking 
of the arms. (Acetone molecules not shown for clarity) 
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Figure 4. Crystal packing of 2•DMSO highlighting (a) the hydrogen bond network (Caryl–H⋅⋅⋅Onitro: green) and (b,c) the layers of 
host molecules which have no interaction due to their separation by DMSO molecules (not shown for clarity).  
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using non-linear regression analysis.9 A summary of the determined 1:1 association 
constants and the corresponding Δδ values are presented in Table 1. 
IV.4.1. 1H NMR Titrations of 1 
Initial investigation of this class of receptors focused on the binding of nitrate in 
comparison to halogens, particularly chloride, as receptors are rarely selective for 
nitrate over chloride. In this chapter, we seek to expand upon the anions investigated to 
determine the selectivity of 1 with regards to oxyanions. Beyond those previously 
determined, association constants of TBA hydrogen sulfate, sulfate, acetate, dihydrogen 
phosphate, perchlorate and perrhenate were sought. Tris(urea) receptors have been 
demonstrated to bind tetrahedral anions more effectively than trigonal planar ones via 
computations.10 This study explored binding configurations by simplifying the receptor 
to the configuration of urea groups and did not consider the potential effect of the 
tethering moiety.  
Titrations of hydrogen sulfate performed in 10 % d6-DMSO/CDCl3 produced 
steep changes in chemical shifts of Ha, Hb, Hc, and Hd (Figure 5a), similar to those seen 
in the titrations of nitrate in acetone, indicating strong association. Large error across a 
set of triplicate titrations further established the inability to determine a 1:1 binding 
constant for 1•HSO4¯ in 10 % d6-DMSO/CDCl3. Following with our previous study, the 
concentration of DMSO was increased to weaken association and minimize competing 
equilibria. The curve produced by the change in chemical shift of Hb in 15 % d6-
DMSO/CDCl3 is indicative of multiple equilibria, while a 20 % volume ratio of DMSO 
results in a 1:1 fit (Figure 5a,b). As previously observed, downfield shifts result from the 
addition of anion to 1 for the Ha, Hb, and Hd peaks and an upfield shift for Hc. The 
association constant for hydrogen sulfate is 7240 M-1 in 20 % DMSO. To best compare 
binding strength, a nitrate association constant was also determined at this 
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Table 1. Association constants (Ka, M–1) of 1, 2, and 3 in volume ratios of DMSO-d6/CDCl3 determined by a global fit using 









 1  2  3 
   
Ka (M
-1)[ii]  
Δδ (ppm)[iii]  
Ka (M
-1)[ii]  




   Ha  Hb  Ha  Hb  Hcore   Ha  Hb  Hcore  
Cl¯  10  25  12200 ± 930  0.21  0.99  63700 ± 810  0.12  0.97  0.31  1300 ± 180  0.16  1.10  0.40 
Br¯  10  25  8320 ± 880  0.16  0.62  9130 ± 1540[iv]  0.04  0.52  0.24  700 ± 70[v]  0.06  0.49  0.22 
I¯  10  25  760 ± 90  0.12  0.29  330 ± 50  0.02  0.22  0.13  30 ± 2  0.03  0.43  0.13 
NO3¯ 
 10  25  24100 ± 1050  0.26  0.39  11800 ± 1570  0.19  0.27  ~0  1080 ± 60  0.18  0.35  0.04 
 20  25  2200 ± 300  0.15  0.22  —  —  —  —  —  —  —  — 
ClO4¯  10  25  400 ± 90
[iv]  -0.01  -0.15  110 ± 15  -0.03  -0.14  ~0  —  —  —  — 
ReO4¯  10  25  530 ± 135
[vi]  0.04  -0.13  250 ± 50[iv]  0.03  -0.13  -0.02  —  —  —  — 
HSO4¯ 
 10  25  —[vii]  0.23[viii]  0.35[viii]  —  —  —  —  —  —  —  — 
 20  25  7240 ± 650  0.17  0.24  —[vii]  0.23[viii],[ix]  0.11[viii],[ix]  0.08[viii],[ix]  —  —  —  — 
 30  25  —  —  —  (660)[ix]  0.19[ix]  0.11[ix]  0.09[ix]  —  —  —  — 
SO4
2¯ 
 10  25  —[x]  —[x]  —[x]  —[x]  —[x]  —[x]  —[x]  —  —  —  — 
 10  -20  —[x]  —[x]  —[x]  —  —  —  —  —  —  —  — 
AcO¯ 
 10  25  —[vii]  0.96[viii],[ix]  1.89[viii],[ix]  —[vii]  1.28[viii],[ix]  1.94[viii],[ix]  ~0  —  —  —  — 
 10  30  —  —  —  —[vii]  1.19[viii],[ix]  1.87[viii],[ix]  ~0  —  —  —  — 
 20  25  —[vii]  0.89[viii],[ix]  1.76[viii],[ix]  —  —  —  —  —  —  —  — 
 50  25  —[vii],[xi]  0.79[viii],[ix]  1.56[viii],[ix]  —  —  —  —  —  —  —  — 
H2PO4¯ 
 10  25  —[x]  0.57[viii],[ix]  —[x]  —[vii]  0.89[viii],H  1.95[viii],[ix]  —[xii]  —  —  —  — 
 20  25  —  —  —  —[vii]  0.86[viii],[ix]  1.82[viii],[ix]  —[xii]  —  —  —  — 
[i] Anions added as tetrabutylammonium salts. [ii] Values are an average of at least three titrations. All errors are < 15 % unless otherwise noted. [iii] 
Averaged from the calculated values based on the determined binding constants, unless otherwise noted. [iv] An average of > 5 titrations. Error 15 - 
23 %. [v] Determined with Ha, Hb, Hd, and Hcore. [vi] Not a final value, more titrations still need to be performed. [vii] Does not fit well to a 1:1 model. 
[viii] Averaged values from the observed changes in chemical shift. [ix] Results are from a single titration. [x] Cannot be determined due to broadening. 





Figure 5. Example plots of observed Δδ (points) upon the titration of 
tetrabutylammonium hydrogen sulfate in (a) 10 %, (b) 15 %, and (c) 20 %  
d6-DMSO/CDCl3 with calculated 1:1 fits (lines: dotted represent unreliable fits, solid 
represent data used to determine association constants). 
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volume ratio. Overall, 1:1 nitrate binding with 1 in 20 % d6-DMSO/CDCl3 is weaker 
than hydrogen sulfate with an association constant of 2200 M-1, thus suggesting 
tetrahedral ligands bind this tripodal series more strongly. 
With strong association to hydrogen sulfate even at 20 % DMSO, we were 
interested if we could obtained measurable binding with 1 to perchlorate or perrhenate 
in 10 % d6-DMSO/CDCl3. Perchlorate and pertechnetate anions are problematic 
environmental contaminants which are also known for their weak association. Typically 
perchlorate is even used as a control or non-bonding anion in binding studies. Upon 
the addition of TBA perchlorate to 1, all four proton resonances produced 1:1 titration 
curves, albeit with minimal shifts in the case of Ha (Fig). Hc and Hd shifted downfield 
and upfield, respectively, as is typical throughout this receptor class. Hb and Ha, 
however, both moved upfield whereas the other anions studied thus far cause downfield 
shifts in these two protons. Similarly, the titration of TBA perrhenate also produced 1:1 
binding isotherms. In the case of perrhenate (as a model for pertechnetate) we still 
observe a deviation from the Δδs in comparison to previous results – Hb once again 
moves upfield while Ha returns to its typical trend of shifting downfield. Both anions 
require the addition of at least 7 equivalents of guest to reach saturated 1:1 binding, 
with similar association constants of 400 and 530b M-1 for perchlorate and perrhenate 
respectively.  
Investigation of sulfate binding with 1 produced intriguing results. We were 
interested to compare the binding of HSO4¯ to SO42¯ and determine if binding would 
be affected by the increase in negative charge or if a variation in binding equilibria 
would occur. Titration of 1 with SO42¯ in 10 % d6-DMSO/CDCl3 at 25 °C, however, 
resulted in a large degree of peak broadening for both the host and 
tetrabutylammonium proton resonances (Appendix D). To resolve what is occurring in 
solution, a titration monitoring both 1H and 19F spectra was performed at -20 °C. Low 
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temperature spectra indicated complete loss of symmetry of tripodal receptor 1 at half of 
an equivalent of TBA2SO4, based on broad 1H peaks which appear to be six 
inequivalent urea resonances (Figure 6a). In addition, the singlet 19F resonance 
observed at 25 °C split into four signals at 0.5 equivalents of sulfate suggesting an 
exchange process now slow on the NMR time scale (Figure 6b). Continual addition of 
sulfate results in further symmetry change of 1, and at a large excess (8 equiv.) the urea 
peaks are no longer discernable (Appendix D).  
 
Figure 6. Example stacked 19F (left) and 1H (right) NMR spectra taken at -20 °C during 
the titration of tetrabutylammonium sulfate to 1 in 10 % d6-DMSO/CDCl3. Spectra 
shown represent 1 at -20 °C with no guest present (bottom) and after the addition of 0.5 
equiv. of TBA2SO42¯ (top). 
Addition of acetate produced the largest observed Δδ values thus far in this class 
of receptors indicating a strong association in 10 % d6-DMSO/CDCl3, with Δδ(Ha) ≈ 1.0 
ppm and Δδ(Hb) ≈ 1.9 ppm. Broadening of Hb occurs upon the first addition of 
TBAOAc, although the peak is still distinguishable, and sharpens once saturation of 
the receptor is achieved. In addition, Δδ(Hc) is sigmoidal in shape throughout the 
titration, indicating more than the 1:1 equilibrium is present in solution at a 10 % 
DMSO volume ratio to CDCl3. Once again, increasing concentrations of DMSO were 
used to diminish the presence of competing equilibria and elucidate a 1:1 association 
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constant. Titration in 20 % d6-DMSO/CDCl3 results in diminished competition; 
however, a reasonable fit of the binding isotherm to a 1:1 model is still not obtained. 
DMSO was further increased up to 50 % v/v and while fitting results are improved 
with regards to error in the 1:1 isotherm fit, new peaks appear during the progress of 
the titration. We believe the data obtained at 20 % DMSO could fit to a 1:1 model but 
the binding strength is too large to be determined utilizing NMR spectroscopy. Thus, 
UV-Vis titrations may provide reliable association constants for acetate. 
The final anion we were interested in investigating was dihydrogen phosphate. 
Upon initial addition of TBAH2PO4 to 1, broadening of the Hb and Ha peaks is 
observed (Appendix D). As the titration proceeds to 1 equiv. of guest, broadening of 
both peaks increases until Hb is no longer discernable from the baseline. Broadening 
also occurs with the remaining peaks of 1, but proton resonances corresponding to the 
tetrabutylammonium cation remain sharp throughout the titration. A binding constant 
cannot be determined via NMR spectroscopy at this time. 
IV.4.2. 1H NMR Titrations of 2 
In the previous publication (Chapter III), the 1:1 association constants of 2 with 
chloride and nitrate were determined for comparison to 1. Results showed the change 
in electron density of the central arene not only weakens anion–π interactions as 
anticipated for nitrate, but also demonstrated a loss of selectivity due to a change in 
binding mode from anion–π to Caryl–H hydrogen bonding with chloride. To further 
compare the effect of the electron-richness of the arene to 1, titrations of 2 were 
continued to include all the anions also investigated with 1. Of great interest with this 
system is the continued determination for preference of binding mode – either an 
anion–π interaction or Caryl–H hydrogen bond to the central arene. 
Firstly, the halogen series was completed. Addition of TBA bromide or iodide to 
a 1 mM 10 % d6-DMSO/CDCl3 solution of 2 results in downfield shifts of Ha, Hb, and 
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Hc with Hd moving upfield as previously observed. Examination of Hcore shows it again 
posseses a larger Δδ than Ha, indicating a stronger hydrogen bond, but weaker than 
that of Hb. 1:1 association constants were determined as 9130 M-1 and 330 M-1 for 
bromide and iodide, respectively. In comparison to the results previously obtained for 
2, these values fit in the typical binding strength trend of Cl¯ > Br¯ > I¯, all of which 
appear to bind 2 through the same binding mode – urea and Caryl–H hydrogen bonds. 
Interestingly, the association constant of Br¯ is of similar strength to the binding of 
NO3¯, which was previously established to bind 2 through a different mode – urea 
hydrogen bonds and an anion–π interaction to the extended conjugated core. Since 
bromine and iodide bind the core via a hydrogen bond in 2, we anticipated the binding 
strength to be greater than that of 1, which would bind the anions via anion–π and 
urea hydrogen bonds or solely through the ureas. Interestingly, bromide binds 1 and 2 
to the same degree within error, while iodide is held more strongly to 1 than 2. Seeing 
as the shift of the core proton is small in comparison to the urea, any hydrogen bond is 
weak (likely possessing a X¯⋅⋅⋅H-Caryl angle much less than 180°) or a σ-complex may 
dominate (Figure 7). 
 
Figure 7. Possible binding modes for halogen association with 2. 
Based on the binding strength with 1 and for comparison purposes, hydrogen 
sulfate was titrated into 2 as a solution in 20 % d6-DMSO/CDCl3. Initial results 
indicate a 1:1 binding model may not provide the best fit for this data (Figure 8a). As 
before, the volume ratio of DMSO was further increased to 30 % to elucidate a 1:1 
H
Anion–π σ-Complex Hydrogen Bond
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association constant (Figure 8b). While data from a single titration did provide a better 
fit with regards to error, further titrations need to be performed to report a reliable 
value.c The most intriguing result from both of these titrations is the relative Δδs. In all 
other titrations with this class of receptors, the proton shifts of Hb have always resulted 
in a larger change due to the addition of anions than Ha; whereas the addition of 
hydrogen sulfate to receptor 2 specifically induces a larger change in the Ha urea 
resonance than Hb. A ~0.1 ppm shift of Hcore is observed throughout either titration. 
 
Figure 8. Example plots of observed Δδ (points) upon the titration of 
tetrabutylammonium hydrogen sulfate into a solution of 2 in (a) 20 % and (b) 30 %  
d6-DMSO/CDCl3 with calculated 1:1 fits. 
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Association of perchlorate and perrhenate were also determined for 2. The same 
trend is observed in this system as in 1 – Hb moves upfield upon the titration of either 
anion and Ha moves upfield with the addition of perchlorate and downfield with 
perrhenate contrary to the shifts resulting from the addition of all other anions. 
Association of each anion is weaker for 2 than 1, with 110 M-1 and 250 M-1 1:1 binding 
for perchlorate and perrhenate, respectively, in 10 % d6-DMSO/CDCl3. Due to the 
opposite trend in shifts, binding of TBA could be occurring in these systems. 
Examination of the Δδ values of the TBA proton resonances shows the largest change 
in peak shift is ~0.02 ppm, which is rather insignificant compared to other anions but 
is on par with Δδ of both Ha and Hcore for perchlorate and perrhenate additions. 
Binding of TBA can be further elucidated by titration with a TBA salt of a larger non-
coordinating anion such as BArF4¯. 
The binding response of acetate, sulfate, and dihydrogen phosphate was also 
investigated with 2. As the errors in the 1:1 fit of 1•AcO¯ were postulated to, in part, 
result from binding strength, we expected binding with 2 to be more easily elucidated 
as the association would be weakened if it followed the trend of the halogens. Initial 
titration in 10 % d6-DMSO/CDCl3 resulted in broadening of the proton resonances of 
2, although the peaks could still be followed throughout the titration. The binding 
isotherm does not fit well to a 1:1 model. To sharpen the spectra throughout the 
titration, and ideally weaken the equilibria, the titration temperature was raised to 30 
°C. Higher temperatures beyond this were not required for further resolution of the 
peaks. The addition of acetate with 2 at 30 °C provided resolution for Hc, Hd, and Hcore 
throughout the titration, while Ha and Hb still broadened into the baseline at the 
initial addition of acetate and resharpened once binding reached saturation at ~ 1 
equiv. of guest. Unfortunately, errors from the 1:1 fit of the binding isotherm are still 
high. 
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2•Sulfate binding was investigated at 10 % d6-DMSO/CDCl3 and 25 °C. Similar 
to the results observed with 1•H2PO4¯, broadening and coalescence of the receptor 
peaks occurred as the equivalents of anion were increased. Once again, the TBA proton 
resonances remained sharp throughout the titration. As a result of the broadening, the 
changes in chemical shift were unable to be followed or fit to a binding model. Change 
in temperature during titration with sulfate provided no resolution for the peaks of 2. 
Titration of 2 with dihydrogen phosphate in 10 % DMSO gave an interesting 
response with regards to Hcore. While the other proton resonances monitored through 
the addition of H2PO4¯ produced typical binding isotherms, Hcore shifted downfield and 
then back upfield producing a parabolic shape when plotted against the equivalents of 
anion (Figure 9). Once again, the proton resonances of 2 broaden as the titration 
progresses with the ureas disappearing into the baseline. The volume ratio of DMSO 
was increased with this system to 20 % DMSO, however the same parabolic trend of 
Hcore as well as broadening of the proton resonances of 2 was still observed (Appendix 
 
Figure 9. Example plot of observed Δδ (points) upon the titration of 
tetrabutylammonium dihydrogen phosphate into 2 in 10 % d6-DMSO/CDCl3 with the 
calculated 1:1 fit. 
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D). A slightly different trend of Ha and Hb is observed in the larger concentration of 
DMSO solution: both broaden into the baseline, but resharpen at ~1 equiv. of H2PO4¯, 
only to immediately begin to broaden back and eventually are undetectable in the 
noise. In both 10 % and 20 % DMSO titrations, Hc and Hd coalesce at high 
equivalencies of guest. This was also observed in the binding of chloride and bromide 
with 1. 
IV.4.3. 1H NMR Titrations of 3 
Due to the previous issues observed with many of the oxyanions investigated, 
the binding properties of receptor 3 were only determined for nitrate and the halogens. 
We expect the ureas to be weakened as hydrogen bond donors as a result of the 
electron-donating character of the methoxy substituents, thus diminishing binding with 
anions overall. All four anions induced the typical changes in chemical shift previously 
observed in this series of receptors with Hb shifting the furthest over Ha, Hc, Hd, and 
Hcore. 
Association constants of 3 followed the Hofmeister series with Cl¯ > NO3¯ > Br¯ 
> I¯. As expected, binding of all the anions investigated is weaker with 3 in comparison 
to 1 and 2. Binding was fit to a 1:1 more for 3, with determined association constants of 
1300, 700, 30, and 1080 M-1 for TBA chloride, bromide, iodide, and nitrate, respectively. 
Overall, approximately an order of magnitude difference is observed when nitro (2) is 
replaced with methoxy (3) for the binding of bromide, iodide, and nitrate whereas 
chloride binding is considerably weaker in comparison (Table 1). Titration of all four 
anions results in the characteristic changes in chemical shift, with Δδ(Hb) as the most 
significant. In fact, chloride induces a calculated 1.10 ppm overall peak shift in Hb of 3, 
which is slightly more than the shifts determined for titration with 1 or 2. Once again 
chloride induces the largest change in chemical shift for Hcore, which lessens (or 
weakens) down the series of halogens as a result of size. While a shift of the Hcore peaks 
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can be observed upon the titration of nitrate, the overall change is minimal indicating 
an anion–π-type interaction is still present with receptor 3.  
IV.5. Conclusions 
The titration data for receptors 1, 2, and 3 is summarized in Table 1. Of the 
association constants elucidated, tripodal receptor 1 binds hydrogen sulfate the 
strongest. Acetate appears to have a strong association constant with 1 as well, and 
future titrations monitored with UV-Vis spectroscopy may provide a reliable binding 
constant. Weak but measurable associations of 1 and 2 were determined with 
perchlorate and perrhenate, however these associations need to be confirmed to result 
from the anion and not the TBA cation. Both changes in temperature and variation in 
the volume ratio of DMSO were utilized in the study presented herein to isolate 1:1 
equilibria and clarify the solution state binding. While this proved successful with 
hydrogen sulfate, binding with several of the other oxyanions studied remained 
unclear. Evidence was presented herein of multiple binding equilibria in solution 
throughout the titrations. In the case of 1•SO42¯, a loss of three fold symmetry is 
apparent in both 1H and 19F NMR spectra when the sample containing 0.25 equivalents 
of guest is cooled to -20 °C. 
Based on the associations determined, receptor 2 binds all anions weaker than 1 
with the exception of chloride. This is still suspected to be the result of a strong 
hydrogen bond to the core Caryl–H, demonstrating once again the influence of binding 
pocket size (which is ideal for chloride) on binding strength. One of the most 
perplexing results with receptor 2 was the effect of hydrogen sulfate on the overall 
changes of the proton resonances – a greater shift of Ha over Hb was observed for the 
first time. We have not yet elucidated the implications this provides with regards to the 
binding geometry in solution. A second intriguing and yet unexplained result was 
 71 
observed for the addition of dihydrogen phosphate. Titrations in 10 or 20 % DMSO 
produced what appears to be the transition between two binding modes of 2, where 
Hcore at first participates in binding as its proton resonance moves downfield, and then 
the biding geometry changes where Hcore no longer interacts with dihydrogen phosphate 
and moves back upfield. 
Receptor 3 was titrated with our originally studied anions (nitrate and the 
halogens) for comparison with regards to electron density of the urea moieties. Binding 
was weakened across the board in comparison to 2, and showed no deviation from the 
Hofmeister bias. While the binding of many of the anions investigated within remains 
unclear, overall trends were still observed and interpreted. Future work with this 
system truncated to a one-armed receptor (Chapter VI), may provide simplified binding 
with fewer arms. The anion–π binding nature of these systems with nitrate and other 
anions can also be further elucidated. 
IV.6. Notes 
 
a  In all cases, Ha, Hb, Hc, and Hd were fit except when one of the four protons (Ha 
and Hd) could not be accurately followed; Hcore was used in place of this proton. 
Titrations providing accurate values for all five protons were fit using various 
proton resonances and provided the same association constant within error. 
b  Not a final association constant. Average of three titrations, however more need 
to be performed to improve the error for perrhenate. 
c  Ka of the single titration at 30 % d6-DMSO/CDCl3 was 660 M-1 regardless of 
whether Ha, Hb, Hc, and Hd or Ha, Hb, Hc, and Hcore were used to determine the 
global fit. 
IV.7. Bridge to Chapter V 
Chapter IV continued our investigation of tripodal analogues of our traditional 
arylethynyl receptors. Chapter V will look at a water soluble analogue of the bis(urea) 





“OFF-ON” AGGREGATE-BASED FLUORESCENT 
SENSOR FOR THE DETECTION OF  
CHLORIDE IN WATER 
 
Chapter V is a revised and unpublished manuscript draft originally written by 
previous graduate student, Jeff Engle. Jeff also performed the original experiments with 
the assistance of undergraduate Timothy Robitshek. I have reperformed many 
experiments, expanded on the data contained within, and rewrote the original 
manuscript. Cell lysate experiments were performed by Chris Vonnegut and HeLa cells 
were prepared by Aaron Docter. Editing was performed by Profs. Darren W. Johnson 
and Michael M. Haley. The final manuscript will be submitted to the journal Organic 
and Biomolecular Chemistry later this year as an invited article.  
V.1. Introduction 
Interest in supramolecular sensors for the detection of anions has received 
considerable attention over the past two decades.1,2 Such systems exploit non-covalent 
interactions between a guest molecule and a host molecule to induce a change in the 
host (e.g., NMR shift, color, fluorescence, electrochemical behavior, etc.). 
Supramolecular sensors are advantageous when compared to chemodosimeters because 
non-covalent interactions are reversible, providing dynamic monitoring of an analyte. 
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Arguably the most powerful of these sensors exploit a fluorescence change due to their 
inherent sensitivity.3  
“Aggregation induced emission” (AIE) or dye aggregates with active 
photophysical properties typically contain highly conjugated backbones with moieties 
capable of having their inherent rotational freedom restricted by non-covalent 
interactions or crystal packing forces.4,5 Often acting through J-aggregation, these 
systems have been known since 1935.5 However, AIE or dye aggregate molecules have 
more recently been exploited as fluorophores for analytes.5,6 Under most conditions the 
molecules rotate freely and are non-fluorescent, but upon application of an external or 
internal stimuli, such as changes in solvent or temperature, rotational freedom becomes 
restricted.4 Ultimately the molecules aggregate together and an atypical turn-on 
fluorescent response occurs. AIE has been used as a sensing platform for analytes, such 
as cyanide,7 carbohydrates,8 amino acids,9 CO2,10 and electron deficient aromatics.11 
Aggregation-based fluorescence responses could allow for turn-on fluorescence sensors 
to be further developed for use in detecting analytes typically viewed as quenching 
agents, such as halides.4 
Our previously reported bisethynylpyridine based compounds have shown 
considerable promise towards selective turn-on anion sensing, as discussed in Chapter 
I.12-15 This chapter reports the synthesis and characterization of a turn-on sensor (1+) 
activated by aggregation with anions and selective for chloride over other biologically 
relevant anions in water under acidic conditions. To the best of our knowledge this is 
the first example of a fully organic turn-on fluorescence sensor selective for chloride in 
water. Chloride’s importance in biology is increasingly appreciated as more studies 
demonstrate its involvement in biological processes, including regulation of cellular 
volume and nerve transduction.16-18  
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Existing fluorescent organic sensors for halides are either based upon a 6-
methoxyquinolinium scaffold19-21 or modified yellow fluorescent proteins.22,23 Both 
classes of sensors undergo collisional quenching in the presence of halides and the 
concentration of chloride can be determined using a Stern-Volmer relationship.24 
While these sensors are widely used and available commercially, it would be desirable 
to have a turn-on sensor to allow for improved spacial resolution. Furthermore, existing 
sensors are susceptible to interference from other halides, “pseudohalides”, and 
dissolved oxygen making more selective alternatives desirable.19,24 
V.2. Results and Discussion 
Synthesis of receptor 1 is achieved through a typical Sonogashira cross-coupling 
reaction (Scheme 1). Reaction of two equivalents of urea 225 with 2,6-dibromo-4-
nitropyridine in the presence of Pd(0) and Cu(I) provides precursor 3 in 84 % yield. 
SNAr reaction of 3 with 2-dimethylaminoethanol and potassium carbonate produces 1 
in 67 % yield. Previous results with similar pyridine receptors12-14 demonstrated the 
dependence of the turn-on fluorescent response to chloride and other anions on the 
protonation of the host. The addition of more than two equivalents of trifluoroacetic 
acid (TFA) in acetonitrile provides the final water-soluble chloride sensor, denoted here 
as 1+ (the plus sign symbolizes only the protonated state of the receptor, not the charge  


























84 % 67 %
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of the receptor complex). Unprotonated receptor 1 is not soluble in aqueous solutions; 
however, pre-protonated 1+ is soluble in water with 1 % TFA up to ~0.5 mM; solubility 
is diminished without the presence of 1 % TFA to ~0.1 mM. 
V.2.1. Fluorescent Response to Anions 
To first determine selectivity of 1+, excess equivalents (>500) of various anions 
were added to 0.5 mM aqueous solutions of 1+ as sodium salts in the presence of 1 % 
TFA (Figure 1). Dihydrogen phosphate is excluded from these results due to its 
protonation state at the pH of these solutions, as well as experimental evidence 
indicating its ability to deprotonate the receptor (V.2.4). Upon addition of a sodium salt 
to 1+, a visible color change was observed from pale to dark yellow. Excitation at 365 
nm via a hand-held long wave UV lamp demonstrated the selective response of the 
protonated host to chloride – a blue to bright yellow-green fluorescence is observed 
dependent on concentration or equivalents of chloride (Figure 1). 
A notable feature is the presence of aggregates in the samples which 
demonstrate turn-on fluorescence (Figure 1c). Most of the other anions investigated 
produced little to no turn-on response, except for sodium fluoride and sodium 
perchlorate – critical with regards to their environmental impact but not typically 
biologically relevant with regards to the applications of this receptor series for sensing 
chloride in a cellular environment. This selectivity is further highlighted in the 
emission spectra collected when the complexes are excited at λmax(1+•Cl¯) = 425 nm 
(Figure 1a,b) – the intensity ratio of 1+•Cl¯ is four times larger than the next most 
fluorescent anion complex, 1+•ClO4¯. In addition, 1+•Cl¯ is red-shifted by 75 nm in 
comparison to 6-methoxyquinolinium derivatives currently commercially used, making 
it more amenable for use in cells.  
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Figure 1. Emission profiles of host 1+ with various anions depicted through (a) 
fluorescence spectra, (b) intensity ratios in comparison to 1+ without the presence of 
anion, and (c) visual emission under a long-wave, 365 nm fluorescent lamp. 
V.2.2. Fluorescent Character of 1+•Cl¯ Aggregates 
To demonstrate the emission and aggregation of 1+ in the presence of chloride 
the percent volume of water was varied with a solvent capable of solubilizing 1+•Cl¯. 
Aggregation was observed when mixing 1+ with a source of chloride in nearly all 
solvents investigated, except for DMSO. Due to the highly solubilizing nature of 
DMSO, the AIE character was determined at relatively high concentrations of 1+ and 
equivalents of chloride. A series of 0.5 mM 1+ and 1.5 M LiCl solutions were made with 
the volume ratio of water ranging from 0 % to 90 % in 1% TFA/DMSO. The 
concentration of TFA and 1+ were held constant throughout the solutions and the 
equivalencies of chloride are nearly identical. A change in the yellow intensity of the 
solutions under visible light is, once again, observable upon mixture with chloride. 1+ 
possesses a blue fluorescence in DMSO but switches closer to a white fluorescence 
upon the addition of chloride (Appendix E). As water is introduced to the DMSO 
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solution up to 70 % this fluorescence is quenched (Figure 2). At 80 % water in DMSO, 
1+•Cl¯ begins to aggregate and fluorescence is dramatically turned on. Once 90 % water 
is reached, the solution is still highly fluorescent and the visible concentration of 
aggregates is further increased (Figure 2b); however, the measured fluorescence at 
excitation 425 nm is quenched in comparison to the 80 % water solution (Figure 2a). 
This observation could be caused by the large concentration of aggregates (which 
typically results in quenching for non-AIE active compounds) and may not be observed 
if the solution was at less of a large excess of chloride or below the concentration limit 
of 1+ in water. 
 
Figure 2. Emission profiles of 1+•Cl¯ in solutions of 1 % TFA in H2O/DMSO mixtures 
with water ranging from 0 - 90 % depicted through a plot of the total intensity from 
440-740 nm determined from the fluorescence spectra excited at 425 nm (a) and the 
visual emission under a long-wave, 365 nm fluorescent lamp (b). 
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V.2.3. Aggregate Structure of 1+•Cl¯ 
Samples of 1+•Cl¯ were visualized under a Scanning Electron Microscope (SEM) 
(Figure 3). A 0.3 mM solution of 1+ in water spiked with 1 % TFA was distributed into 
two samples with ~103 equivalents and ~2 x 103 equivalents of chloride (NaCl). Would 
there be a difference in aggregate shape or size based on the equivalents of guest? 10 μL 
of each solution was pipetted onto an untreated silica wafer and allowed to dry. The 
excess of NaCl produced many crystalline structures on the surface of the dried 1+•Cl¯. 
The latter sample with a larger concentration of chloride produced only flat translucent 
sheets amidst the NaCl crystals. These sheets were previously observed during SEM on 
a treated silica wafer on a sample prepped from a suspension of 1 in water after the 
addition HCl gas (no TFA present) (Figure 3a). When the sample with 103 equivalents 
 
Figure 3. SEM images of aggregated samples evaporated onto silica wafers: (a) HCl gas 
bubbled through a suspension of 1+ in water. (b-d) Addition of ~103 equiv. of NaCl to 1+ 
in 1 % TFA/water. 
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of chloride was visualized, a river delta or dendritic formation was observed (Figure 3b). 
Closer inspection this pattern (Figure 3c) revealed small featureless nano-sized 
particles. This formation also terminated into the translucent sheets previously 
observed, which assembled into larger featureless clusters (Figure 3d). Sensitivity of the 
energy-dispersive X-ray spectrometer, particularly with regards to resolution, has 
prevented the confirmation of chloride present in the particles or sheets thus far. 
V.2.4. 1H NMR Spectroscopic Titrations of 1+ 
While aggregation in this class of receptors is beneficial for their fluorescent 
turn-on responses to anions such as chloride, it is often detrimental in the 
determination of association constants, making it difficult to compare the strength of 
binding to current receptors. The overall weak association in strong hydrogen bonding 
solvents and the time-dependent nature of the fluorescent response of 1+•Cl¯, lead to 
the investigation of binding in d6-DMSO monitored via 1H NMR spectroscopy. 
Titration experiments were typically performed at 1.5 mM of 1 in d6-DMSO 
spiked with 0.5 % H2O. Water was added to minimize the effect of DMSO’s natural 
absorption of water throughout the titration. Addition of TBA salts of nitrate, iodide, 
hydrogen sulfate, and perchlorate resulted in little to no change in chemical shift of 
any protons. Dihydrogen phosphate, as mentioned previously, deprotonates the host – 
indicated by the immediate loss of the R3N+H resonance upon the first addition of salt 
and the change of chemical shifts to match 1 at the end of the titration (Appendix E). 
Titration of TBA chloride and bromide result in the downfield shift of four proton 
resonances on 1+: R3N+H, HNurea, H2Nurea, and HCPy. These four shifts were fit to 1:1 
association using the Thordarson fitting program.26 
The protonated ethanolamine (R3N+H) moiety produces the largest change in 
chemical shift observed for chloride (Δδ ≈ 1.0 ppm) with the pyridine proton (HCPy) 
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Figure 4. Example (a) stacked 1H NMR spectra and (b) plot of Δδ for the titration of TBACl into 1+. 
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resonance producing the second largest shift (Δδ ≈ 0.3 ppm) (Figure 4). The titration of 
the seemingly 1:1 chloride association ends at ~15 equivalents. Beyond 15 equivalents 
new peaks appear in the 1H NMR spectra indicating the presence of an additional 
equilibrium, slow on the NMR time scale. Bromide also appears to fit well to a 1:1 
association, but exhibits a weaker association than chloride, with the largest changes in 
chemical shifts also corresponding to R3N+H and HCPy (Δδ ≈ 0.2 ppm for both 
resonances). In the case of bromide, however, a new peak appears before the titration is 
finished at ~30 equivalents (Appendix E). Unfortunately, error between titrations is 
currently too high to report binding constants for chloride or bromide. The difficulties 
with this system correspond to the possible additional equilibria, weak association 
overall (Ka ≤ 100 M-1), and the degradation of 1+ as a solid.a Results may be more easily 
obtained if the host is freshly protonated before each titration. 
V.2.5. Binding Conformations of 1+ 
We believe most of our bisurea systems, particularly the pyridine- and phenyl-
based receptors, bind in a typical U conformation.14,27,28 This precluded us to 
hypothesize receptor 1+ would also posses a similar U conformation with a five-point 
binding site involving the electrostatic pyridinium moiety (Figure 5). Keeping in mind, 
however, that crystal and solution studies have also demonstrated the existence of W 
and S conformations in this general class of bisurea arylethynyl receptors.29 
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Firstly, binding conformation would be affected by the protonation state of 1+. 
Two sites on 1+ are available for protonation: the pyridine and the ethanolamine 
moiety. While this chapter focuses on the theory in which both are protonated, data 
only provides confirmation of the protonated amine (via 1H NMR spectroscopy as 
previously discussed). However, the observed change in yellow intensity upon addition 
of excess TFA for protonation in solution and when 1+ is isolated as a solid provides 
indication for the presence of pyridinium, based on our previous receptors of this 
class.14,15 Overall, two conformations can be envisioned for 1:1 binding: U and S/W (the 
second arm would freely rotate in solution essentially providing either an S or W type 
arrangement). 
Based on the observed changes in 1H chemical shift for both bromide and 
chloride, we can begin to speculate further upon the binding conformation of 1+ with 
chloride or bromide (U, S, or W, Figure 5) – at least for a solution in DMSO. Seeing as 
the most significant proton shifts, and therefore likely the strongest hydrogen bonds, 
occur with R3N+H and HCPy, conformation 1:1 U is highly unlikely (Figure 5). 
Chloride must sit inside the cleft formed from an S or W arrangement in order to 
hydrogen bond to the R3N+H and HCPy protons, similar to what is observed when our 
bipyridine-based receptor binds chloride or bromide (referred to as the Z 
arrangement).29 As discussed, additional equilibria appear to come into play during the 
titration of bromide or chloride into 1+, likely indicating a competing 1:2 interaction. 
What is unclear is whether this secondary equilibrium occurs with the pyridinium NH 
proton (1:2 S) or CH proton (1:2 W). While the binding conformation is of interest, the 
important aspect of this system lies within its fluorescence response. 
 83 
V.2.6. Chloride Detection in Cell Lysates 
For initial proof of concept of 1+ sensing chloride in cells, we turned to a study 
with HeLa cell lysates (Figure 6). A 0.12 mM solution of 1+ in water was diluted to 0.08 
mM with a HeLa cell lysate suspension. Upon mixture of the lysate suspension with 1+,  
turn on fluorescence was observed (cellular concentration of chloride is ~50 mMb). 
Addition of further excess chloride as NaCl increases the fluorescent response, 
demonstrating the dependence of the sensor on equivalents of chloride to induce more 
aggregation and therefore more emission.c Fluorescence emission spectra were obtained 
of each sample by exciting at 316 nm.d While the data obtained cannot be considered 
quantitatively, it clearly indicates the ability of 1+ to sense chloride in a cellular 
environment. A time-lapse fluorescent study was performed which demonstrated the 
stability of the turn-on response over an hour (Appendix E). While initial signal 
depression began around 30 min., loss of fluorescence was slow and minimal in 
comparison to its magnitude. 
 
Figure 6. Fluorescence emission spectra obtained at excitation wavelength 316 nm 
demonstrating the ability of cell lysates with a inherent chloride concentration of 50 
mM to turn on fluorescence of 1+ even when dilute. 
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V.2.7. Potential Counter-Cation Dependence 
In preparation for the demonstration of AIE character of 1+•Cl¯, a problem was 
encountered with regards to the solubility of sodium chloride in DMSO which had 
been used in all experiments thus far. Other more soluble chloride salts were 
investigated to verify they would elicit the same positive turn-on response with 1+. A 0.3 
mM solution of 1+ in water spiked with 1 % TFA was mixed with preweighed amounts 
of sodium chloride, potassium chloride, lithium chloride, and magnesium chloride 
corresponding to more than 2,000 equivalents of chloride anion. Results indicated all 
four salts induced aggregation and turned on fluorescence in comparison to the 
protonated receptor (Figure 7). Interestingly, differences in fluorescence intensity were  
 
Figure 7. Emission profiles of host 1+ with various chloride salts depicted through (a) 
fluorescence spectra when excited at 425 nm, (b) intensity ratios in comparison to 1+ 
without the presence of anion, and (c) visual emission under a long-wave, 365 nm 
fluorescent lamp. 
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evident even by the eye between the various cations (Figure 7c), despite the chloride 
equivalents being essentially held constant.e Most surprisingly, sodium chloride – the 
salt used throughout all our initial fluorescent investigations – produced the weakest 
fluorescent intensity of all the chloride salts tested. Each chloride salt was shown to be 
more than fives times more fluorescent overall than the protonated host at this 
concentration and equivalency range. This experiment should be performed with 
higher quality salt sources to minimize interfering analytes and a more consistent 
chloride equivalency to confirm these findings. Regardless, this is an intriguing initial 
result. 
V.3. Conclusions  
The detection of chloride has proved problematic with existing sensor 
technologies. Fully organic sensors for aqueous chloride typically undergo fluorescence 
quenching or suffer from competition with other anions. By using chloride as a 
template for fluorophore aggregation, 1+ makes advances to overcome these obstacles. 
Other biologically relevant anions investigated appear to template non-emissive or 
significantly blue shifted aggregates, when produced. While this receptor still suffers 
from consistency likely dependent on pH or analyte and sensor concentration, 1+ 
provides proof of concept towards the further design of aggregation-based turn-on 
chloride sensors.  
V.4. Notes 
 a  1+ degrades or further reacts with itself as a solid. Therefore cannot be stored as a 
protonated solid. We have verified its stability in DMSO for over 6 months. We 
have not yet confirmed the stability of 1+ in water for extended periods of time. 
b  Cellular concentration of chloride varies according to cell type: mammalian 
embryonic motorneurons = ~50 mM,30 Jurkat T-cells = 58 mM,31 and epithelial 
cells = ~40 mM.32 
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 c  Varying the concentration of 1+ from 0.1 to 0.4 mM and observing the fluorescent 
response with 500 equivalents of chloride has also demonstrated this dependence 
(Appendix E). 
d  Early results directed fluorescent emission scans to be performed at both excitation 
of 316 and 425 nm. Overall 425 nm excitation was determined to best demonstrate 
the selectivity and intensity of 1+. However the initial lysate studies presented here 
were performed at the early 316 nm excitation. 
e  Equivalents of chloride from the sodium, potassium, and magnesium salts were 
~2,200, whereas the lithium salt was higher with ~2,700 equivalents. 
V.5. Bridge to Chapter VI 
Chapter V focused on a bis(urea) receptor which was designed for selectively 
binding chloride in water. Chapter VI will introduce another form of our arylethynyl 
urea receptors – a single-armed mono(urea) receptor which is based off the studies seen 






FUTURE WORK OF A ONE-ARMED UREA RECEPTOR 
 
Chapter VI consists of unpublished work conceptualized by my advisors, Profs. 
Darren Johnson and Mike Haley, and myself. My advisors also performed editing. 
VI.1. Introduction 
In Chapter III, anion–π interactions were shown to influence selectivity for 
nitrate over chloride in our newly developed tripodal class of receptors. Chapter IV 
expanded upon these receptors through additional substitution and anionic guests. 
Next, we would like to determine if the tripodal tris(urea) structure of this receptor 
class is necessary to observe the preference for anion–π over Caryl–H hydrogen bond 
interactions. A series of simplified one-armed 
arylethynyl urea receptors (Figure 1) is being 
synthesized to address this question. The basic 
structure of the one-armed receptors will 
provide a more easily tuned central arene to 
further enhance our selectivity for nitrate over 
chloride, as well as provide selectivity over 
tetrahedral anions which typically bind more 
strongly to tripodal structures.  
 
1 X = F, Y = F
2 X = NO2, Y = H
3 X = CF3, Y = H
4 X = H, Y = NO2
5 X = H, Y = CF3









Figure 1. Proposed one-armed 
arylethynyl receptors. 
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VI.2. Receptor Design 
The one-arm receptor is modeled after our series of arylethynyl receptors and is 
similar in design to the original perfluoroarylsulfonamide receptor.1 Initial one-armed 
receptors 1-6 are proposed for comparison to our tripodal and phenyl bis(urea) receptor 
classes. 1, 4, and 5, with Y substitutions, prevent hydrogen bonding to the phenyl core, 
thus encouraging more anion–π interactions. The substitution pattern on 2, 3, and 6 
leaves these hydrogen bonding locations open to allow for competition between the two 
interactions, provided the sterics of the adjacent substituents do not prevent hydrogen 
bonding to anionic guests. Receptor 6 will provide the most equivalent core to our 
unsubstituted tripodal receptor for comparison. 6 could also be modified with X = F to 
best compare to our trifluoro-based tripodal system. 
Receptor 2 has been initially synthesized but additional synthesis is currently 
underway to study the anion binding properties of 2. Sonogashira cross coupling of 4-
tert-butyl-2-ethynylaniline and 3,5-dinitroiodobenene provides the dinitro one-arm core 
7 (Scheme 1). Subsequent reaction with p-nitrophenyl isocyanate provides receptor 2. 
Both reactions require further optimization with regards to purification and yield. 
Scheme 1. Synthesis of receptor 2. 
 
VI.3. Conclusions 
The design and synthesis of single-armed receptors probes multiple fundamental 























similar selectivity and fluorescence responses to those previously noted? To what extent 
is strength of binding lost or gained with respect to the loss of urea moieties and 
addition of electron-deficient π-surfaces? And, can anion–π interactions be observed in 
solution with a single urea-binding site? 
VI.4. Experimental 
3,5-Dinitro aniline core 7. In a round bottom flask 3,5-dinitroiodobenzene 
(0.30 g, 1.02 mmol) was dissolved in DIPA (5 mL) and THF (5 mL), then CuI (19.4 mg, 
0.102 mmol) was added. The mixture was purged with Ar for 30 min, then Pd(PPh3)4 
(94.3 mg, 0.082 mmol) was carefully added. An Ar-purged solution of 4-tert-butyl-2-
ethynylaniline (2.65 g, 1.53 mmol) in DIPA (5 mL) and THF (5 mL) was then 
transferred into the flask via cannula. After stirring at room temperature overnight, the 
solvent was removed in vacuo, and the residue run through a plug of silica using a 
gradient of Hexanes/CH2Cl2. Crude product, suitable for continuation, was obtained by 
precipitation out of the CH2Cl2 solution using hexanes (0.21 g, 62 % crude yield.) 1H 
NMR (300 MHz, CDCl3) δ 8.95 (t, J = 1.9 Hz, 1H), 8.64 (d, J = 2.0 Hz, 2H), 7.40 (d, J = 
2.2 Hz, 1H), 7.28 (dd, J = 8.7, 2.3 Hz, 1H), 6.72 (d, J = 8.5 Hz, 1H), 4.22 (s, 2H), 1.30 (s, 
9H). (Figure 2) 
Receptor 2. In oven dried glassware, aniline 7 (0.150 g, 0.442 mmol) and p-
nitrophenyl isocyanate (0.110 g, 0.663 mmol) were dissolved in freshly distilled toluene 
(40 mL). The reaction mixture was stirred overnight, quenched with acetone, and crude 
product 2 was precipitated with hexanes. 1H NMR (300 MHz, Acetone-d6) δ 9.05 (s, 
1H), 8.94 – 8.85 (m, 1H), 8.76 (d, J = 2.0 Hz, 2H), 8.18 (d, J = 9.7 Hz, 1H), 8.11 (d, J = 
9.3 Hz, 2H), 7.76 (s, 0H), 7.72 (d, J = 9.1 Hz, 2H), 7.61 (d, J = 2.1 Hz, 1H), 7.48 (dd, J = 
9.0, 2.3 Hz, 1H), 1.32 (s, 6H). (Figure 3) 
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Figure 2. 1H NMR of dinitro core 7, 300 MHz. 
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MAIN GROUP CATION–ARENE INTERACTIONS 
 
This appendix consists of the rest of the published review in volume 46 of the 
journal Accounts of Chemical Research in April 2013. Chapter I was comprised of a portion 
of this original manuscript, prior to its final editing for publication, as well as an 
unpublished summary of other relevant studies. Mary Collins wrote the original 
version of this main group cation section of the manuscript. I rewrote and edited this 
portion of the manuscript as it appears in the publication. My advisor and principle 
investigator Prof. Darren W. Johnson conceptualized the original research and 
provided editorial assistance for this publication. 
A.1. Main Group Supramolecular Coordination Chemistry – Group 15 
Over the last two decades, a diverse compilation of supramolecular coordination 
complexes emerged from self-assembly between a d-block, or less commonly an f-block 
metal, and a multidentate ligand. The resulting metal–ligand self-assemblies typically 
have square-planar, tetrahedral, or octahedral coordination geometries. Development of 
self-assembled complexes featuring main group metalloid ions has received less 
attention, perhaps due to the unusual and sometimes unpredictable coordination 
geometries of main group elements. The result is a lack of highly specific chelators for 
toxic ions such as arsenic (As). With this in mind, we launched a program in 2004 to 
investigate a “supramolecular approach” to toxic metal coordination chemistry and 
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initially targeted arsenic by employing stabilizing secondary bonding contacts, more 
specifically, an ion–π interaction, to direct self-assembly. 
A.2. Brief Overview of Interactions between Main Group Cations and Aromatic 
Rings 
Recently the role of weak intermolecular forces for complex formation between 
arenes and heavier metals of Groups 13-16 was highlighted.1 In low-oxidation states, 
post-transition metals with stereochemically active lone pairs, such as As, Sb, and Bi, 
produce stable arene complexes. Recent measurements of binding enthalpies between 
SbCl3 and neutral arenes (ca. 5-10 kcal mol-1) are in the typical range for other “weak 
interactions”,1 suggesting these interactions might serve as a motif for directing the 
formation of supramolecular self-assemblies. This weak, predominately electrostatic 
interaction has been described both as a traditional Lewis acid (main group metalloid) 
to π-base (arene ring) interaction1 (Figure 1) and as an electron transfer between As 
(lone pair) and the π-aryl ring.2 In the latter description, calculations show the intrinsic 
molecular dipole of AsCl3 induces polarization in the arene ring upon complexation, 
revealing a weak sharing of electrons between the As center and each C atom of the 
arene ring (Aslone-pair–πaryl interactions). In the 
Lewis acid to π-base interaction, sometimes 
referred to as “Menshutkin complexes”, donor 
orbitals on the arene interact with acceptor 
orbitals on the metal center. Such a 
description explains the shortening of the 
metalloid–π distances in ECl3•arene complexes 
(E = As, Sb, Bi), as the metalloids become 
more Lewis acidic going down the group. 
Figure 1. Illustrative depiction of 
pnictogen–π interactions in 
supramolecular assemblies. (a) View 
down the As–As axis of As2(L)3 
showing the possibility of interactions 
(red arrows) between the π-systems of 
the arene spacers and the σ* orbitals 
of As. (b) Locations of σ* orbitals in 
the primary coordination sphere about 
an As(III) center. 
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Along with this, it is important to note dispersion forces may become dominant for 
heavier congeners of the Group.3 
The evidence illustrating the significance of πaryl interactions upon complexation 
with Group 15 metal cations sparked our interest in applying this weak and reversible 
force as part of a design strategy for forming self-assembled supramolecular main group 
coordination complexes. The self-assembly of the macrocycles, cryptands, and 
metallocycles described below all proceed with the apparent assistance of stabilizing As–
πaryl interactions. 
A.3. Pnictogen–π Interactions and “Supramolecular” Ligand Design 
Our supramolecular design strategy focuses on the self-assembly of an As(III) 
source and an organothiol ligand (Chart 1). The As–thiolate bond is attractive due to its 
lability and reversibility, as well as the predictable trigonal-pyramidal coordination 
geometry of As(III)–thiolates. Our first approach for self-assembled As(III)–
organothiolate complexes exploiting a stabilizing As–π interaction utilized a rigid, 
multidendate 1,4-bis(mercaptomethyl)benzene (H2L) ligand.4 When treated with 
stoichiometric amounts of AsCl3 and KOH in THF/methanol, a discrete dinuclear 
As2L3 complex emerges, with As positioned endo relative to the ligands, allowing for the 
stereochemically active lone pair to be directed inside the small cavity of the cryptand 
(Scheme 1). The crystal structure revealed six short As–Caryl contacts with distances 
between 3.18 and 3.33 Å, indicating a stabilizing metal–π interaction between the arene 
and the As lone pair (Figure 2). DFT calculations of this weak force in an AsCl3–
benzene dimer suggest the As–π interaction is strong (7.3 kcal mol-1), with a shallow 
potential for its preferred geometry. 
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Chart 1. Ligands used to prepare pnictogen-containing supramolecular assemblies. 
 














































































In the absence of base, a 
macrocyclic As2L2Cl2 complex forms 
as a mixture of syn and anti 
diastereomers as seen by 1H NMR 
spectroscopy.5 However, either 
stereoisomer can be selectively 
isolated by altering crystallization 
conditions (Figure 3). Structural analysis of the anti conformer displays two As–Cl bonds 
pointing in opposite directions. In the anti conformation, the aromatic rings are parallel 
and the As(III) centers twist, allowing each As(III) center, providing a short As1–As1a 
separation (4.65 Å) and decreased As–Caryl distances (3.16 Å, far smaller than the sum of 
the van der Waals radii of 3.70 Å). In the syn-As2L2Cl2 diastereomer, both As–Cl bonds 
point in the same direction. In contrast to the case of its diastereomeric partner, the 
two As(III) centers in the syn conformation align along the ligand axis (As1–As1a = 5.02 
Å), and correspondingly longer As–π interactions were observed (avg. As–Caryl = 3.25 Å). 
When molecular mechanics modeling was examined, both syn-As2L2Cl2 and anti-
As2L2Cl2 macrocycles were shown to have 
more torsional freedom to shift the As 
ion away from the aryl rings than the 
As2L3 cryptand.6 Nevertheless, both 
macrocycles show closer As–π contacts 
than those for the cryptand, indicating 
As–π interactions might play a more 
significant role in the self-assembly of the 
macrocycle than the apparently more 
Figure 2. (a) ORTEP representation of the X-
ray crystal structure of As2L3. (b) Wire frame 
representations with arsenic atoms shown as 
space-filling spheres. 
Figure 3. ORTEP representation of the 
single crystal X-ray structure of syn-
As2L2Cl2 and anti-As2L2Cl2 macrocycle with 
50 % probability ellipsoids and hydrogen 
atoms omitted. 
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thermodynamically stable cryptand. Interestingly, 1H NMR spectroscopy reveals a slow 
equilibrium between syn and anti, slightly favoring the formation of the anti macrocycle 
(diastereomeric ratio ca. 5:4). This suggests the shorter As–π interaction observed in the 
solid state might persist in solution to provide a stronger stabilization to the anti 
macrocycle. 
The directing role of As–π interactions was further investigated by expanding 
the choice of organothiol ligand to achiral, isomeric bis(mercaptomethyl)naphthalene 
ligands (H2Lnap1,4, H2Lnap1,5, H2Lnap2,6).7 As before, a secondary As–π interaction directs 
the formation of each syn and anti macrocycle; however, the choice of naphthalene 
ligand dictates the syn-to-anti ratio. The variation in substitution pattern alters the 
environment of the As–Cl bond upon complexation and directs formation of the major 
diastereomer: the isomer that places the chlorine ligands farthest from the electron-rich 
arene ring is favored. Given this repulsive interaction, crystallization gave the following 
expected isomers as the preferred products: a nearly equal mixture of anti-
As2(Lnap2,6)2Cl2 and syn-As2(Lnap2,6)2Cl2, primarily anti-As2(Lnap1,5)2Cl2, and last, syn-
As2(Lnap1,4)2Cl2, all of which minimize the unfavorable steric interactions (Figure 4). 
The As–As distances vary (7.45, 5.64, 4.66 Å) for each macrocycle, but the As–Caryl 
distances remain comparable (3.30, 3.22, 3.14 Å). 
We also sought to explore the host–guest chemistry of macrocycles featuring 
larger interior cavities assembled from extended ligands (e.g., biphenyl, stilbene, 
anthracene linkers). The assembly expansion revealed no effect on the As–π interaction, 
although the presence of the interaction itself may inhibit guests from fitting entirely 
within the cavity.8 In each case, the macrocycles were too small to completely surround 
a guest molecule but were large enough to accommodate one or two guests on the 
periphery of the macrocyclic cavity (Figure 5). Each macrocycle displays multiple 
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Figure 4. ORTEP (30 % probability ellipsoids) and wire frame representations of 
single-crystal X-ray structures for (a) anti-As2(Lnap2,6)2Cl2, (b) anti-As2(Lnap1,5)2Cl2, and (c) 
syn-As2(Lnap1,4)2Cl2 macrocycles. 
intramolecular As–π interactions. Self-
assembly of H2LOMe1,4 and AsCl3 provided a 
macrocycle wide enough to host a guest due 
to the protruding methoxy substituents 
(Figure 6). When crystallized from a solvent 
that serves as a suitable guest, such as p-
xylene, the macrocycle forms a homodimer 
Figure 5. (a) Packing diagram of [anti-
As2(Lstilbene)2Cl2•benzene] along the 
macrocyclic axis. (b) Space-filling 
representation of inclusion complex. 
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Figure 6. ORTEP (30 % probability ellipsoids) representation of single-crystal X-ray 
structure of (a) anti-As2(LOMe1,4)2Cl2. Stick representation showing the packing from (b) 
side and (c) top views. 
[(syn-As2(LOMe1,4)2Cl2)2•p-xylene], where the ligand walls of one macrocycle tilt out of 
parallel allowing one end of the cavity to open and share a guest molecule with the 
cavity of a second macrocycle (Figure 7). A slight tilt of one ligand from parallel with 
the other clearly indicates guest inclusion in the macrocyclic dimeric “capsule” does not 
destroy the As–π interaction, and therefore, the guest alone may control the 
diastereoselectivity during the crystallization. When no suitable guest molecules are 
present, the anti macrocycle is crystallized exclusively and the As–π interaction is 
shorter than in any other macrocycles reported to date (As–Caryl = 3.11 Å), presumably 
due to the increased π-basicity of H2LOMe1,4. 
To expand preliminary work probing the role of steric repulsions in self-
assembly of the macrocycles, two types of dimethyl-substituted phenyl ligands were 
synthesized: H2LMe2,5 and H2LMe2,3.9 Each showed facile formation of the anti 
macrocycle, indicating the bulky methyl groups do not disrupt the apparently strong 
directing effect of the As–π interaction. In the crystal structure of anti-As2(LMe2,5)2Cl2, 
the two chloride ligands point away from the methyl groups, avoiding unfavorable 
steric repulsions while maintaining favorable As–π interactions (Figure 8a,c). 
Preferential formation of the sterically disfavored anti-As2(LMe2,3)2Cl2 macrocycle was 
surprising, since one of the anti-conformers has one chloride ligand folded into the 
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Figure 7. ORTEP (30 % probability ellipsoids) and space-filling representations of 
single-crystal X-ray structures of (a,b) [(syn-As2(LOMe1,4)2Cl2)2•p-xylene] and (c,d) [(syn-
As2(LOMe1,4)2Cl2)2•toluene]. 
cavity of the macrocycle to avoid steric 
repulsions with the methyl groups (Figure 
8b,d). Rather than participating in 
potential weak anion–p interactions, this 
“folded in” chloride ligand participates in 
secondary bonding interactions (SBIs) with 
an As center in an adjacent macrocycle. As 
anticipated, this conformation does not 
disrupt intramolecular As–π interactions, 
maintaining As–Caryl distances of 3.27 and 
3.32 Å with the thiol ligand (Figure 9). 
Figure 8. Molecular structures in stick 
and space-filling representations of (a,c) 
As2(LMe2,5)2Cl2 and (b,d) As2(LMe2,3)2Cl2. 
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Figure 9. Fragment of the crystal packing structure of As2(LMe2,3)2Cl2 showing As-Cl, 
As-S, and S-S SBIs (dash lines). 
Another example where this interaction imparts stereochemical direction upon 
self-assembly of organo–arsenic coordination complexes is in the structure of a 
tetranuclear arsenic(III) As4(Ltet)2Cl4 S4 metallacyclophane (Chart 1 and Figure 10).10 
This unusual S4-symmetric coordination complex co-crystallizes with two cis- and trans-
As2LtetCl2 intermediates in a single crystal. The S4-symmetry complex houses four As–π 
interactions per aryl ring (As–Caryl range: 3.24 and 3.45 Å), with the four As(III) 
metalloids pointing their lone pairs directly into the cavity, in an endo configuration. 
Surprisingly, no intramolecular As–π contacts were observed in the cis- and trans-
As2LtetCl2 complexes (Figure 10). 
These supramolecular approaches to coordination chemistry helped us develop 
generalized rules for designing ligands for specific arsenic(III) coordination.11,12 
However, it was uncertain if the ligands always needed to be as rigid as those 
previously described. To probe this constraint, diphenylmethane ligand H2Ldpm (4,4΄- 
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Figure 10. Wire frame representations of the three discrete complexes observed in a 
single crystal: (a) trans-[As2LtetCl2], (b) cis-[As2LtetCl2], and (c) the [As4(Ltet)2Cl4] 
metallacyclophane. 
dimercaptomethyl-diphenylmethane) was utilized,12 where the methyl spacer between 
the two phenyl rings would possibly lengthen the cavity of the cryptand and the added 
flexibility might also widen it. The solid state structure of As2(Ldpm)3 reveals a distorted 
mesocate in which the three ligands are unevenly distributed around the metalloid 
centers. The diphenylmethane aryl rings are twisted to direct their edges toward the 
inner cavity, resulting in an “imploded” cryptand that fills its own cavity interior 
(Figure 11). Despite the distorted geometry, the structure still maintains multiple 
intramolecular As–π interactions, with one ligand folded into the cavity shortening the 
metal–metal distance to 9.19 Å. 
Successful incorporation of arsenic into 
supramolecular self-assemblies led us to explore 
other Group 15 metalloids. Early work in our lab 
revealed two dinuclear complexes, Sb2L3 
cryptand and Sb2L2Cl2 macrocycle, can be 
formed upon treatment of H2L with SbCl3, 
featuring intramolecular Sb–π contacts (Sb–Caryl 
contact distances range from 3.20 to 3.61 Å).13 
Self-assembly of related bismuth- and antimony-containing cryptands, E2(Lnap1,4)3 was 
Figure 11. Molecular structure of 
As2(Ldpm)3 shown as a wire frame; 
spheres represent arsenic atoms. 
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achieved using H2Lnap1,4, DIPEA, and ECl3 (E = Bi, Sb).14 The metalloid–metalloid (E–
E) distances decrease from As2(Lnap1,4)3 (5.11 Å) to Sb2(Lnap1,4)3 (4.83 Å) to Bi2(Lnap1,4)3 
(4.68 Å) to compensate for longer E–S bonds and smaller S–E–S angles, thus allowing 
the ligands to retain near identical positions in each cryptand. Previous research1,15-17 
reports E–π interactions to be stronger for larger pnictogens, typically resulting in a 
decrease in the E–Caryl distance. Due to the constraints of the cryptand structure, the 
trend is reversed; the shortest observed E–Caryl distance increases slightly from As (3.30 
Å) to Sb (3.34 Å) to Bi (3.36 Å) complexes. This does not necessarily indicate a 
weakening of the E–π interactions, but an increasing ionic radius of E giving the 
longer E–S bond lengths and constricted metal coordination inside the cavity. In 
addition to E–π interactions, all of the cryptands formed from H2Lnap1,4 maintain 
favorable intramolecular edge-to-face aromatic interactions, giving the complex a 
propeller twist (Figure 12). 
 
Figure 12. Stick and space-filling representations of the molecular structures of 
symmetric cryptands (a,d) As2(Lnap1,4)3, (b,e) Sb2(Lnap1,4)3, and (e,f) Bi2(Lnap1,4)3. 
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The dynamic solution behavior of these supramolecular complexes allowed us to 
experimentally measure the relative stability of each complex by subjecting each 
pnictogen cryptand to a different trivalent Group 15 metalloid. Upon addition of AsCl3 
to dissolved crystals of the Sb2(Lnap1,4)3 cryptand, a transmetalation reaction was 
observed to provide the As2(Lnap1,4)3 cryptand within a week. The weaker Sb–Cl bonds 
likely help drive the formation of the more thermodynamically stable As cryptand. This 
“transmetalation” reaction has since allowed us to synthesize a new phosphorus-
containing supramolecular complex, which was unattainable by direct methods (Figure 
13).14 The P2(Lnap1,4)3 crystal structure reveals the same endohedral coordination as the 
As, Sb, and Bi cryptands with the phosphorus lone pairs directed inside the small 
cryptand cavity. Despite close P–Caryl contacts (3.54 Å, sum of the van der Waals radii: 
3.50 Å), the presence of P–π interactions is not apparent. Such interactions are typically 
only observed in more Lewis acidic cationic phosphorus complexes.18 
 
Figure 13. (a) Transmetalation of Sb2(Lnap1,4)3. (b,c) Stick and space-filling 
representations of the molecular structures of symmetric cryptands P2(Lnap1,4)3. 
Surprisingly, closer inspection of the homometallic cryptands E2(Lnap1,4)3 (E = 
As, Sb, Bi) in solution identified the presence of a second, less symmetric species, asym-
E2-(Lnap1,4)3, in which one ligand has “flipped”, perturbing the C3 symmetry of the 
complex (Figure 14).19 Each conformer maintains numerous intramolecular E–π 
interactions. The asymmetric species is in equilibrium with the C3h-symmetric cryptand 
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in solution and is increasingly favored in 
the heavier pnictogens (< 5 % component 
for As, 47 % for Sb, 60 % for Bi). 
We also have pursued a systematic 
study of E2L3 cryptands formed from a 
variety of different organic ligand 
backbones, each with small structural 
alterations to change the electronics, 
cavity size, and flexibility of the aromatic 
framework (H2Lanth, H2Ltolane, H2Lstilbene, 
H2Ldpm, H2Ldpe; Chart 1).20 Despite the 
diversity of the ligands, each of the 
cryptands synthesized showed clear As–π 
interactions, with varied metal–metal distances depending on the distance between the 
two thiolate functional groups (5.03-12.28 Å). Again, the same somewhat surprising 
trend appears in comparing these As2L3 cryptands to their Sb2L3 congeners: the Caryl–E 
contacts are approximately the same distance in the arsenic complexes (3.25-3.31 Å) as 
in the antimony cryptands (3.31-3.36 Å), despite the higher Lewis acidity of Sb. As a 
comparison, while the S–S distances in H2L and H2Lnap1,4 are identical, the Sb–Sb 
distances in the corresponding cryptands vary dramatically (Figure 15b,d): 4.30 Å for 
Sb2L3 compared to 4.83 Å for Sb2(Lnap1,4)3. This greater than 0.5 Å difference is even 
more remarkable when one considers that the As–As distances in As2L3 and 
As2(Lnap1,4)3 vary by less than 0.1 Å. The result is a profound helical twist in the Sb2L3 
cryptand (Figure 15). 
  
Figure 14. Cartoon representations of (a) 
symmetric E2(Lnap1,4)3 (left) and asym-
E2(Lnap1,4)3 (right), in which the ligands are 
represented by arrows. The DFT-calculated 
structure of asym-Bi2(Lnap1,4)3 is shown in (b) 
a stick and (c) a space-filling representation. 
The “flipped” ligand is indicated in red; 
blue arrows indicate the protons correlated 
by their NOEs in solution. 
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Figure 15. Stick representations of the molecular structures of previously reported E2L3 
cryptands: (a) As2L3, (b) Sb2L3, (c) As2(Lnap1,4)3, (d) Sb2(Lnap1,4)3. 
The observed endohedral directionality of the As centers in our complexes can 
perhaps be attributed to the intramolecular As–π interaction, meaning its stability 
(whether endo or exo at the metal center for similar systems with stereochemically active 
lone pairs) depends on the macrocycle's ring size and the steric strain imposed. The 
presence of such short interactions in the pnictogen macrocycles and cryptands could 
result from strong mechanical coupling in the self-assembled complex due to the 
constraints imposed by the rigid ligand framework. Interestingly, the endo 
conformation also appears to be the more stable geometry in de novo designed and 
native proteins that bind As(III) as well, suggesting another mechanism for outer 
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B.1. Characterization Data of 1 
 
















Figure 5. Low resolution ESI mass spectrum of 1. 
 




















Figure 11. 19F NMR spectrum of 4 in CDCl3, 282 MHz. 
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B.2. X-Ray Crystallography Data 
Table 1. Crystal data and structure refinement for 1. 
Identification code  mwatt3 
Empirical formula  C24 H6 F15 N3 S3 
Formula weight  717.50 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 21.460(2) Å a= 90°. 
 b = 4.6550(5) Å b= 107.970(2)°. 
 c = 26.363(3) Å g = 90°. 
Volume 2505.1(4) Å3 
Z 4 
Density (calculated) 1.902 Mg/m3 
Absorption coefficient 0.432 mm-1 
F(000) 1416 
Crystal size 0.32 x 0.28 x 0.11 mm3 
Theta range for data collection 1.07 to 27.00°. 
Index ranges -27<=h<=27, -5<=k<=5, -33<=l<=31 
Reflections collected 15747 
Independent reflections 5417 [R(int) = 0.0210] 
Completeness to theta = 27.00° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9540 and 0.8741 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5417 / 0 / 430 
Goodness-of-fit on F2 1.077 
Final R indices [I>2sigma(I)] R1 = 0.0342, wR2 = 0.0883 
R indices (all data) R1 = 0.0403, wR2 = 0.0980 
Largest diff. peak and hole 0.352 and -0.263 e.Å-3 
 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 1. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
Atom X Y Z U(eq)
S(1) 7839(1) 11698(1) 800(1) 26(1) 
S(2) 9640(1) 4913(1) 487(1) 26(1) 
S(3) 9288(1) 5366(1) 2371(1) 30(1) 
N(1) 8776(1) 8163(3) 696(1) 23(1) 
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Table 2 Continued.  
Atom X Y Z U(eq)
N(2) 9396(1) 5249(3) 1420(1) 24(1) 
N(3) 8580(1) 8445(3) 1537(1) 24(1) 
C(1) 8465(1) 9163(4) 1024(1) 22(1) 
C(2) 9236(1) 6194(4) 924(1) 22(1) 
C(3) 9052(1) 6506(4) 1709(1) 23(1) 
C(4) 7857(1) 12498(4) 128(1) 28(1) 
C(5) 7365(1) 10882(4) -307(1) 25(1) 
C(6) 7538(1) 8836(4) -619(1) 28(1) 
C(7) 7085(1) 7409(4) -1024(1) 32(1) 
C(8) 6429(1) 8036(5) -1134(1) 36(1) 
C(9) 6236(1) 10100(5) -839(1) 35(1) 
C(10) 6701(1) 11473(4) -432(1) 29(1) 
C(11) 10245(1) 2488(4) 907(1) 28(1) 
C(12) 10745(1) 3887(4) 1367(1) 24(1) 
C(13) 10808(1) 3170(4) 1892(1) 29(1) 
C(14) 11257(1) 4495(5) 2317(1) 33(1) 
C(15) 11660(1) 6591(4) 2225(1) 32(1) 
C(16) 11624(1) 7320(4) 1712(1) 28(1) 
C(17) 11171(1) 5962(4) 1294(1) 24(1) 
C(18) 8735(1) 7505(5) 2622(1) 35(1) 
C(19) 8787(1) 6472(4) 3173(1) 25(1) 
C(20) 8382(1) 4343(4) 3256(1) 32(1) 
C(21) 8422(1) 3362(5) 3757(1) 44(1) 
C(22) 8875(1) 4510(6) 4190(1) 47(1) 
C(23) 9285(1) 6636(6) 4130(1) 45(1) 
C(24) 9238(1) 7581(5) 3621(1) 32(1) 
F(1) 8173(1) 8181(3) -534(1) 36(1) 
F(2) 7274(1) 5387(3) -1306(1) 46(1) 
F(3) 5984(1) 6642(3) -1522(1) 54(1) 
F(4) 5602(1) 10751(3) -945(1) 51(1) 
F(5) 6507(1) 13494(3) -148(1) 40(1) 
F(6) 10432(1) 1092(3) 1997(1) 39(1) 
F(7) 11306(1) 3749(3) 2817(1) 50(1) 
F(8) 12089(1) 7949(3) 2633(1) 46(1) 
F(9) 12021(1) 9335(3) 1622(1) 37(1) 
F(10) 11146(1) 6721(2) 795(1) 30(1) 
F(11) 7936(1) 3148(3) 2835(1) 52(1) 
F(12) 8020(1) 1273(3) 3816(1) 73(1) 
F(13) 8918(1) 3539(4) 4677(1) 85(1) 
F(14) 9722(1) 7802(4) 4551(1) 78(1) 
F(15) 9642(1) 9668(3) 3568(1) 53(1) 
 
 
Table 3. Bond lengths for 1. 
Atoms Å Atoms Å
S(1)-C(1)  1.7484(18) 
S(1)-C(4)  1.822(2) 
S(2)-C(2)  1.7474(18) 
S(2)-C(11)  1.815(2) 
S(3)-C(3)  1.7420(18) 
S(3)-C(18)  1.822(2) 
N(1)-C(1)  1.328(2) 
N(1)-C(2)  1.345(2) 
N(2)-C(2)  1.321(2) 
N(2)-C(3)  1.347(2) 
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Table 3 Continued.  
Atoms Å Atoms Å
N(3)-C(3)  1.328(2) 
N(3)-C(1)  1.342(2) 
C(4)-C(5)  1.501(3) 
C(4)-H(4A)  0.98(2) 
C(4)-H(4B)  0.89(2) 
C(5)-C(6)  1.382(3) 
C(5)-C(10)  1.387(3) 
C(6)-F(1)  1.346(2) 
C(6)-C(7)  1.372(3) 
C(7)-F(2)  1.339(2) 
C(7)-C(8)  1.377(3) 
C(8)-F(3)  1.333(2) 
C(8)-C(9)  1.378(3) 
C(9)-F(4)  1.336(2) 
C(9)-C(10)  1.375(3) 
C(10)-F(5)  1.345(2) 
C(11)-C(12)  1.499(3) 
C(11)-H(11A)  0.94(2) 
C(11)-H(11B)  0.96(2) 
C(12)-C(17)  1.385(3) 
C(12)-C(13)  1.389(3) 
C(13)-F(6)  1.342(2) 
C(13)-C(14)  1.378(3) 
C(14)-F(7)  1.336(2) 
C(14)-C(15)  1.374(3) 
C(15)-F(8)  1.339(2) 
C(15)-C(16)  1.374(3) 
C(16)-F(9)  1.337(2) 
C(16)-C(17)  1.378(3) 
C(17)-F(10)  1.345(2) 
C(18)-C(19)  1.502(3) 
C(18)-H(18A)  0.96(3) 
C(18)-H(18B)  0.98(3) 
C(19)-C(24)  1.375(3) 
C(19)-C(20)  1.380(3) 
C(20)-F(11)  1.342(2) 
C(20)-C(21)  1.374(3) 
C(21)-F(12)  1.340(3) 
C(21)-C(22)  1.361(4) 
C(22)-F(13)  1.336(2) 
C(22)-C(23)  1.366(4) 
C(23)-F(14)  1.328(3) 
C(23)-C(24)  1.387(3) 
C(24)-F(15)  1.338(2) 
 
Table 4. Bond angles for 1. 

















































Table 4 Continued.  












































Table 5. Torsion angles for 1. 



















































Table 5 Continued.  






















































Table 6. Anisotropic displacement parameters (Å2 x 103) for 1. The anisotropic 
displacement factor exponent takes the form: -2p2[h2a*2U11 + ... + 2hka*b*U12]. 
Atom U11 U22 U33 U23 U13 U12
S(1) 26(1)  27(1) 25(1)  3(1) 7(1)  4(1) 
S(2) 24(1)  33(1) 21(1)  -5(1) 9(1)  -1(1) 
S(3) 34(1)  36(1) 22(1)  7(1) 13(1)  12(1) 
N(1) 23(1)  26(1) 20(1)  0(1) 7(1)  -2(1) 
N(2) 23(1)  28(1) 22(1)  1(1) 8(1)  1(1) 
N(3) 26(1)  25(1) 21(1)  2(1) 9(1)  3(1) 
C(1) 21(1)  20(1) 24(1)  -1(1) 5(1)  -3(1) 
C(2) 22(1)  22(1) 21(1)  -4(1) 7(1)  -5(1) 
C(3) 23(1)  26(1) 21(1)  0(1) 7(1)  -2(1) 
C(4) 28(1)  27(1) 27(1)  6(1) 6(1)  -2(1) 
C(5) 28(1)  24(1) 23(1)  9(1) 7(1)  0(1) 
C(6) 31(1)  28(1) 25(1)  10(1) 11(1)  4(1) 
C(7) 44(1)  30(1) 25(1)  3(1) 14(1)  -1(1) 
C(8) 41(1)  38(1) 26(1)  2(1) 4(1)  -11(1) 
C(9) 24(1)  40(1) 38(1)  12(1) 4(1)  -1(1) 
C(10) 30(1)  27(1) 30(1)  5(1) 11(1)  2(1) 
C(11) 27(1)  24(1) 34(1)  -6(1) 12(1)  0(1) 
C(12) 23(1)  22(1) 26(1)  -1(1) 9(1)  5(1) 
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Table 6 Continued.  
Atom U11 U22 U33 U23 U13 U12
C(13) 31(1)  25(1) 34(1)  7(1) 15(1)  7(1) 
C(14) 39(1)  36(1) 23(1)  7(1) 9(1)  14(1) 
C(15) 31(1)  33(1) 24(1)  -4(1) -1(1)  8(1) 
C(16) 24(1)  26(1) 32(1)  -1(1) 7(1)  2(1) 
C(17) 24(1)  25(1) 23(1)  1(1) 7(1)  5(1) 
C(18) 43(1)  39(1) 28(1)  8(1) 20(1)  16(1) 
C(19) 28(1)  27(1) 25(1)  4(1) 14(1)  7(1) 
C(20) 28(1)  31(1) 40(1)  -1(1) 17(1)  5(1) 
C(21) 53(1)  33(1) 64(2)  14(1) 45(1)  12(1) 
C(22) 68(2)  51(2) 34(1)  18(1) 33(1)  30(1) 
C(23) 47(1)  58(2) 26(1)  -9(1) 3(1)  21(1) 
C(24) 29(1)  32(1) 38(1)  -4(1) 13(1)  4(1) 
F(1) 33(1)  43(1) 35(1)  8(1) 15(1)  10(1) 
F(2) 68(1)  40(1) 34(1)  -6(1) 22(1)  1(1) 
F(3) 53(1)  61(1) 41(1)  -7(1) 2(1)  -22(1) 
F(4) 24(1)  65(1) 60(1)  7(1) 4(1)  0(1) 
F(5) 38(1)  37(1) 47(1)  0(1) 17(1)  9(1) 
F(6) 43(1)  33(1) 48(1)  14(1) 22(1)  4(1) 
F(7) 68(1)  55(1) 25(1)  13(1) 14(1)  16(1) 
F(8) 46(1)  49(1) 30(1)  -8(1) -7(1)  3(1) 
F(9) 30(1)  37(1) 42(1)  -5(1) 8(1)  -10(1) 
F(10) 32(1)  36(1) 24(1)  0(1) 11(1)  -4(1) 
F(11) 34(1)  49(1) 72(1)  -19(1) 11(1)  -6(1) 
F(12) 85(1)  40(1) 130(2)  22(1) 83(1)  7(1) 
F(13) 137(2)  90(1) 47(1)  37(1) 59(1)  62(1) 
F(14) 73(1)  100(1) 41(1)  -28(1) -11(1)  28(1) 
F(15) 38(1)  43(1) 80(1)  -14(1) 21(1)  -12(1) 
 
 
Table 7. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 103) 
for 1. 
Atom X Y Z U(eq)
H(4A) 7750(11) 14540(50) 103(9) 35(6) 
H(4B) 8261(11) 12140(50) 121(8) 35(6) 
H(11A) 10435(11) 1700(50) 663(8) 32(6) 
H(11B) 10008(11) 1030(50) 1032(9) 34(6) 
H(18A) 8843(13) 9510(60) 2623(10) 56(8) 








SUPPLEMENTARY INFORMATION FOR CHAPTER III 
 
C.1. General Experimental Details 
1H and 13C NMR spectra were obtained on a Varian Mercury 300 MHz 
spectrometer (1H: 300.09), Inova 500 MHz spectrometer (1H: 500.10 MHz, 13C: 125.75 
MHz), or Bruker Avance III HD 600 MHz NMR Spectrometer with Prodigy 
multinuclear broadband BBO CryoProbe (1H: 600.02 MHz, 13C: 150.89 MHz). 
Chemical shifts (δ) are expressed in ppm downfield from tetramethylsilane (TMS) using 
non-deuterated solvent present in the bulk deuterated solvent (CDCl3: 1H 7.26 ppm, 13C 
77.16 ppm; d6-DMSO: 1H 2.50 ppm 13C 39.52 ppm). All NMR spectra were processed 
using MestReNova NMR processing software. All materials were synthesized following 
literature procedures or were obtained from TCI-America, Sigma-Aldrich, or Acros and 
used as received. X-ray crystal data were obtained on a Bruker Apex CCD or a Bruker 
Apex2 CCD diffractometer. Characterization spectra corresponding to the synthetic 
procedures of Receptors 1 and 2 and precursors 3 and 4 presented in Chapter III are 




Figure 1. 1H NMR spectrum of 3 in CDCl3, 600 MHz. 
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Figure 4. High resolution ESI mass spectrum of 3. 
Watt, MMW_1_139, Haley, 212711, C42H42F3N3
m/z
























Watt, MMW_1_139, Haley, 212711, C42H42F3N3















Figure 5. 1H NMR spectrum of 4 in CDCl3, 600 MHz. 
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Figure 6. 13C NMR spectrum of 4 in CDCl3, 151 MHz. 
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Figure 8. High resolution ESI mass spectrum of 4. 
Watt, TR_040, Haley, 212711, C42H45N3
m/z














595.4 635.4 888.5849.2683.6 763.5700.6 798.5 986.4916.3 932.5 999.8
Watt, TR_040, Haley, 212711, C42H45N3
m/z














595.4 635.4 888.5849.2683.6 763.5700.6 798.5 986.4916.3 932.5 999.8
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Figure 9. 1H NMR spectrum of 1 in d6-DMSO, 600 MHz. 
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Figure 10. 13C NMR spectrum of 1 in d6-DMSO, 151 MHz. 
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Figure 12. High resolution ESI mass spectrum of 1. 
Watt, MMW_1_155, Haley, 212711, C63H54F3N9O9
m/z




































Watt, MMW_1_155, Haley, 212711, C63H54F3N9O9















Figure 13. 1H NMR spectrum of 2 in d6-DMSO, 600 MHz. 
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Figure 14. 13C NMR spectrum of 2 in d6-DMSO, 151 MHz. 
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Figure 16. High resolution ESI mass spectrum of 2. 
Watt, TR_042, Haley, 212711, C63H57N9O9
m/z























Watt, TR_042, Haley, 212711, C63H57N9O9
















C.2. X-ray Crystallography 
Diffraction intensities were collected at 173(2) K (1), 193(2) K (1•TBACl) and 
100(2) K (1•TBANO3) on a Bruker Apex CCD diffractometer using MoK radiation = 
0.71073 Å (1, 1•TBACl) and Bruker Apex2 CCD diffractometer using CuK radiation = 
1.54178 Å (1•TBANO3). Space groups were determined based on systematic absences 
(1•TBACl and 1•TBANO3) and intensity statistics (1). Absorption corrections were 
applied by SADABS.1 Structure was solved by direct methods and Fourier techniques 
and refined on F2 using full matrix least-squares procedures. All non-H atoms were 
refined with anisotropic thermal parameters. Some of the terminal –CH2-CH2-CH3 
groups in NBu4+ in 1•TBACl and 1•TBANO3 are disordered over two positions. These 
disordred groups were refined with restrictions; the standard C–C bond distances were 
used in the refinement as the targets for corresponding bond distances. All H atoms in 
1•TBACl, 1•TBANO3, and H atoms in solvent acetone molecules in 1 were refined in 
calculated positions in a rigid group model. Other H atoms in 1 were found from the 
residual density map and refined with isotropic thermal parameters. All calculations 
were performed by the Bruker SHELXTL (v. 6.10) package.2 
X-ray data for 1: C75H78F3N9O13, M = 1370.46, 0.26 x 0.26 x 0.06 mm, triclinic, 
space group P-1, (N 2), a = 13.1669(6) Å, b = 16.5153(7) Å, c = 18.4829(8) Å,  
α = 64.727(1)°, β = 77.710(1)°, γ = 81.612(1)°, V = 3544.3(3) Å3, Z = 2, Dc = 1.284 Mg/m3,  
μ = 0.094 mm–1, F(000) = 1444, 2Θmax = 50.00°, T = 173 K, 34533 reflections, 12473 
independent reflections [Rint = 0.0327], R1 = 0.0809, wR2 = 0.1694 and GOF = 1.144 for 
12473 reflections (1117 parameters) with I>2σ(I), R1 = 0.0930, wR2 = 0.1758 and GOF = 
1.144 for all reflections, max/min residual electron density +0.301/–0.335 eÅ3. CCDC 
928631 contains the supplementary crystallographic data for these compounds. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif. 
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X-ray data for 1•TBACl: C85H102ClF3N10O11, M = 1532.22, 0.26 x 0.17 x 0.05 
mm, orthorhombic, space group P212121 (N 19), a = 11.850(1) Å, b = 21.883(2) Å,  
c = 31.984(3) Å, V = 8294(1) Å3, Z = 4, Dc = 1.227 Mg/m3, μ = 0.117 mm–1, F(000) = 3256, 
2Θmax = 50.00°, T = 193 K, 58785 reflections, 14595 independent reflections [Rint = 
0.0716], R1 = 0.0579, wR2 = 0.1261 and GOF = 1.021 for 14595 reflections (1001 
parameters) with I>2σ(I), R1 = 0.1054, wR2 = 0.1529 and GOF = 1.023 for all reflections, 
the Flack = 0.01(8), max/min residual electron density +0.289/–0.269 eÅ3. CCDC 
928629 contains the supplementary crystallographic data for these compounds. These 
data can be obtained free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif. 
X-ray data for 1•TBANO3: C82H96F3N11O13, M = 1500.70, 0.42 x 0.27 x 0.18 
mm, orthorhombic, space group P212121 (N 19), a = 11.1237(3) Å, b = 21.7241(5) Å,  
c = 32.5573(8) Å, V = 7867.5(3) Å3, Z = 4, Dc = 1.267 Mg/m3, μ = 0.752 mm–1, F(000) = 
3184, 2Θmax = 130.00°, T = 100 K, 41890 reflections, 10960 independent reflections [Rint 
= 0.0502], R1 = 0.0723, wR2 = 0.1952 and GOF = 1.045 for 10960 reflections (942  
parameters) with I>2σ(I), R1 = 0.0859, wR2 = 0.2106 and GOF = 1.049 for all 
reflections, the Flack = 0.1(2), max/min residual electron density +0.563/–0.498 eÅ3. 
CCDC 928630 contains the supplementary crystallographic data for these compounds. 
These data can be obtained free of charge from The Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif. 
C.3. Titration Details 
Tetrabutylammonium salts were dried at 50 °C under vacuum and stored in a 
calcium carbonate filled dessicator. In all titrations the receptor concentration was kept 
constant during the titration. A stock solution of receptor was prepared and the host-
guest solution was prepared with the stock receptor solution. All additions were 
 138 
performed with a Hamilton μL syringe. Titrations were carried out in triplicate and the 
reported binding constants represent the average of the fits from three titrations. 
Association constants (Ka) were calculated by nonlinear curve fitting of the obtained 
titration isotherms using Thordarson fitting programs via Matlab. Representative data 
are provided for each set. 
C.3.1. NMR Titration Conditions 
1H NMR titrations in 10 % DMSO-d6/CDCl3 were carried out on an Inova 500 
MHz spectrometer (1H 500.10 MHz) at 298 K. 1H NMR titrations in acetone-d6 were 
carried out on an Agilent VNMRS 600 spectrometer (1H: 600.02 MHz, 13C: 150.89 
MHz) at 298 K. Chemical shifts (δ) are expressed in ppm downfield from 
tetramethylsilane (TMS) using non-deuterated solvent present in the bulk deuterated 
solvent (Acetone-d6: 1H 2.05 ppm; CDCl3: 1H 7.26 ppm).  














0 0 0.000E+00 0 8.084 9.191 8.102 7.726 
5 5 9.212E-05 0.187 8.198 9.588 8.062 7.749 
5 10 1.824E-04 0.369 8.284 9.970 8.032 7.789 
5 15 2.710E-04 0.549 8.359 10.352 8.012 7.846 
5 20 3.578E-04 0.725 8.422 10.704 8.000 7.913 
5 25 4.430E-04 0.897 8.493 10.925 7.998 7.937 
5 30 5.266E-04 1.067 8.564 11.083 7.996 7.949 
5 35 6.087E-04 1.233 8.626 11.229 7.995 7.958 
10 45 7.682E-04 1.556 8.724 11.442 7.993 7.973 
10 55 9.220E-04 1.867 8.794 11.592 7.993 7.982 
10 65 1.070E-03 2.168 8.840 11.690 7.993 7.990 
20 85 1.352E-03 2.738 8.895 11.804 7.994 7.994 
20 105 1.615E-03 3.270 8.925 11.862 7.996 7.996 
20 125 1.861E-03 3.768 8.949 11.902 7.997 7.997 
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C.3.2. NMR Titrations of 1 in Acetone-d6  
Tetrabutylammonium chloride. A 5 mL stock solution of 1 (2.81 mg, [R] = 
0.49 mM) in acetone-d6 was prepared and used in the preparation of a 3.5 mL TBACl 
guest solution (9.05 mg, [G] = 9.30 mM). Starting volume of 500 μL. (Table 1, Figures 
17 and 18) 
Tetrabutylammonium bromide and nitrate. Titrations were as listed with 
tetrabutylammonium chloride, but the data could not be fit in a reliable fashion. A 
comparison was performed for the change in chemical shift of the urea protons in 1 for 
the titration of chloride, bromide and nitrate. (Figure 19) 
 
Figure 17. Example stacked spectra from the titration for the addition of 
tetrabutylammonium chloride to 1 in d6-acetone. 
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Figure 18. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium chloride into 1 in d6-acetone. 
C.3.3. NMR Titrations of 1 in 2 % DMSO-d6/CDCl3 
Tetrabutylammonium nitrate. A 3 mL stock solution of 1 (3.42 mg, [R] = 1.00 
mM) in 2 % DMSO-d6/CDCl3 was prepared and used in the preparation of a 2.5 mL 
TBANO3 guest solution (10.35 mg, [G] = 13.6 mM). Starting volume of 500 μL.  
C.3.4. NMR Titrations of 1 in 5 % DMSO-d6/CDCl3 
Tetrabutylammonium nitrate. A 3 mL stock solution of 1 (3.42 mg, [R] = 1.00 
mM) in 5 % DMSO-d6/CDCl3 was prepared and used in the preparation of a 2.5 mL 
TBANO3 guest solution (4.87 mg, [G] = 6.40 mM). Starting volume of 500 μL.  
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Figure 19. Comparison of the change in chemical shifts for the titration of tetrabutylammonium chloride, bromide, and nitrate 
into 1 in d6-acetone. 
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C.3.5. NMR Titrations of 1 in 10 % DMSO-d6/CDCl3 
Tetrabutylammonium nitrate. A 3 mL stock solution of 1 (3.34 mg, [R] = 0.98 
mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the preparation of a 2 mL 
TBANO3 guest solution (4.36 mg, [G] = 6.23 mM). Starting volume of 500 μL. (Table 2, 
Figure 20) 
Tetrabutylammonium chloride. A 3 mL stock solution of 1 (3.51 mg, [R] = 
1.03 mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the preparation of a 2 
mL TBACl guest solution (2.72 mg, [G] = 4.89 mM). Starting volume of 500 μL. (Table 
3, Figures 21 and 22) 
Tetrabutylammonium bromide. A 3 mL stock solution of 1 (3.59 mg, [R] = 
1.05 mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the preparation of a 2 
mL TBABr guest solution (3.47 mg, [G] = 5.38 mM). Starting volume of 500 μL. (Table 
4, Figures 23 and 24) 
















0 0 0.000E+00 0 7.878 9.365 7.433 7.889 
10 10 1.221E-04 0.125 7.915 9.417 7.447 7.872 
10 20 2.395E-04 0.245 7.950 9.468 7.460 7.856 
10 30 3.524E-04 0.360 7.982 9.517 7.474 7.843 
15 45 5.141E-04 0.526 8.022 9.578 7.491 7.828 
15 60 6.671E-04 0.682 8.053 9.625 7.504 7.818 
15 75 8.121E-04 0.830 8.074 9.659 7.513 7.810 
20 95 9.941E-04 1.016 8.092 9.686 7.521 7.805 
20 115 1.164E-03 1.190 8.103 9.704 7.525 7.801 
30 145 1.400E-03 1.431 8.113 9.718 7.529 7.798 
50 195 1.747E-03 1.786 8.121 9.732 7.532 7.795 
100 295 2.310E-03 2.362 8.128 9.743 7.535 7.794 
200 495 3.097E-03 3.166 8.135 9.753 7.538 7.792 
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Figure 20. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium nitrate into 1 in 10 % d6-DMSO/CDCl3. 
Table 3. Example titration for the addition of tetrabutylammonium chloride to 1 in  













0 0 0.000E+00 0 7.884 9.378 7.437 7.888 
25 25 2.330E-04 0.227 7.925 9.553 7.466 7.859 
25 50 4.449E-04 0.433 7.966 9.732 7.496 7.831 
25 75 6.383E-04 0.621 8.001 9.897 7.525 7.808 
25 100 8.156E-04 0.793 8.027 10.030 7.549 7.791 
40 140 1.070E-03 1.041 8.053 10.164 7.574 7.775 
50 190 1.347E-03 1.311 8.068 10.242 7.589 7.766 
75 265 1.695E-03 1.649 8.077 10.289 7.596 7.760 
100 365 2.065E-03 2.009 8.084 10.315 7.600 7.756 
200 565 2.596E-03 2.525 8.089 10.336 7.601 7.753 








Figure 22. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium chloride into 1 in 10 % d6-DMSO/CDCl3. 
 
Table 4. Example titration for the addition of tetrabutylammonium bromide to 1 in  














0 0 0.000E+00 0 7.880 9.362 7.436 7.893 
10 10 1.055E-04 0.100 7.895 9.414 7.451 7.883 
10 20 2.070E-04 0.197 7.909 9.468 7.466 7.872 
15 35 3.521E-04 0.335 7.930 9.544 7.487 7.858 
15 50 4.893E-04 0.465 7.948 9.612 7.506 7.846 
20 70 6.609E-04 0.629 7.967 9.684 7.526 7.833 
20 90 8.210E-04 0.781 7.981 9.740 7.542 7.824 
30 120 1.042E-03 0.991 7.996 9.797 7.558 7.815 
40 160 1.305E-03 1.241 8.009 9.846 7.571 7.807 
50 210 1.592E-03 1.514 8.017 9.881 7.581 7.800 
75 285 1.954E-03 1.858 8.025 9.913 7.589 7.795 
150 435 2.504E-03 2.381 8.032 9.941 7.596 7.789 
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Figure 23. Example stacked spectra from the titration for the addition of tetrabutylammonium bromide to 1 in 10 %  
d6-DMSO/CDCl3. 
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Tetrabutylammonium iodide. A 3 mL stock solution of 1 (3.35 mg, [R] = 0.98 
mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the preparation of a 2 mL 
TBAI guest solution (11.67 mg, [G] = 15.8 mM). Starting volume of 500 μL. (Table 5, 
Figures 25 and 26) 
 
Figure 24. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium bromide into 1 in 10 % d6-DMSO/CDCl3. 














0 0 0.000E+00 0 7.879 9.359 7.434 7.892 
5 5 1.564E-04 0.159 7.889 9.388 7.447 7.887 
10 15 4.601E-04 0.469 7.903 9.421 7.465 7.877 
15 30 8.942E-04 0.911 7.920 9.458 7.486 7.870 
20 50 1.436E-03 1.464 7.933 9.488 7.503 7.863 
25 75 2.061E-03 2.100 7.944 9.513 7.517 7.857 
30 105 2.742E-03 2.794 7.953 9.533 7.530 7.852 
40 145 3.551E-03 3.620 7.960 9.551 7.539 7.847 
50 195 4.432E-03 4.518 7.967 9.567 7.548 7.844 
50 245 5.195E-03 5.295 7.972 9.578 7.554 7.841 
100 345 6.450E-03 6.574 7.978 9.591 7.562 7.836 
150 495 7.859E-03 8.010 7.983 9.603 7.570 7.835 
200 695 9.187E-03 9.364 7.987 9.611 7.575 7.834 
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Figure 26. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium iodide into 1 in 10 % d6-DMSO/CDCl3. 
C.3.5. NMR Titrations of 2 in 10 % DMSO-d6/CDCl3 
Tetrabutylammonium nitrate. A 3 mL stock solution of 2 (2.99 mg, [R] = 0.92 
mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the preparation of a 2 mL 
TBANO3 guest solution (3.58 mg, [G] = 5.88 mM). Starting volume of 500 μL. (Table 6, 
Figures 27 and 28) 
Tetrabutylammonium chloride. A 3 mL stock solution of 2 (3.24 mg, [R] = 
1.00 mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the preparation of a 2 
mL TBACl guest solution (3.86 mg, [G] = 6.94 mM). Starting volume of 500 μL. (Table 
7, Figures 29 and 30) 
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0 0 0.000E+00 0 7.980 9.595 7.464 7.894 
10 10 1.153E-04 0.125 8.002 9.626 7.478 7.887 
10 20 2.261E-04 0.246 8.023 9.656 7.492 7.881 
15 35 3.846E-04 0.418 8.052 9.696 7.510 7.873 
15 50 5.345E-04 0.581 8.075 9.730 7.526 7.867 
20 70 7.220E-04 0.785 8.101 9.766 7.543 7.860 
20 90 8.968E-04 0.976 8.118 9.791 7.554 7.855 
25 115 1.099E-03 1.196 8.132 9.812 7.564 7.851 
35 150 1.357E-03 1.476 8.144 9.828 7.572 7.847 
50 200 1.680E-03 1.827 8.153 9.840 7.576 7.844 
75 275 2.086E-03 2.269 8.159 9.847 7.580 7.841 
100 375 2.520E-03 2.741 8.163 9.853 7.581 7.839 
200 575 3.145E-03 3.421 8.166 9.856 7.582 7.836 
 
 
Figure 27. Example stacked spectra from the titration for the addition of 
tetrabutylammonium nitrate to 2 in 10 % d6-DMSO/CDCl3. 
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Figure 28. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium nitrate into 2 in 10 % d6-DMSO/CDCl3. 
 
Table 7. Example titration for the addition of tetrabutylammonium chloride to 2 in  













0 0 0.000E+00 0 7.979 9.582 7.461 7.894 
10 10 1.362E-04 0.137 7.996 9.724 7.492 7.884 
10 20 2.671E-04 0.268 8.014 9.866 7.524 7.873 
10 30 3.931E-04 0.395 8.031 10.004 7.555 7.864 
10 40 5.144E-04 0.516 8.045 10.134 7.583 7.855 
15 55 6.882E-04 0.691 8.064 10.300 7.620 7.844 
15 70 8.528E-04 0.856 8.078 10.417 7.647 7.836 
20 90 1.059E-03 1.063 8.086 10.501 7.665 7.830 
20 110 1.252E-03 1.257 8.091 10.538 7.673 7.827 
25 135 1.476E-03 1.482 8.095 10.562 7.677 7.825 
35 170 1.762E-03 1.769 8.099 10.580 7.679 7.822 
50 220 2.122E-03 2.130 8.103 10.595 7.680 7.820 
 152 
 




Figure 30. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium chloride into 2 in 10 % d6-DMSO/CDCl3. 
C.4. Computational Details 
For the purposes of obtaining a simple 
visual representation of the electron density in 
host 1, a geometry was used where the arms are 
spread out and more planar. In addition, methyl 
groups were used in place of the t-butyl units for 
ease of computation. Minimization of this 
geometry was performed at PM6 and the 
electrostatic potential surface map was calculated 
using Spartan’10 (Wavefunction, Inc.). In the 
following figure red represents areas of high electron density and blue represents low. 
Figure 31. Electrostatic potential 
map of 1 showing the electron 
deficient core. 
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Table 8. X, Y, Z Coordinates for PM6 minimized geometry. 
Atom X Y Z Atom X Y Z
C 1.890855      0.979702     -6.982650 
H        1.801835      3.485213     -4.002144 
H        1.915697      0.284210     -7.831580 
H        2.306606      2.690815     -8.213154 
C        3.119799     -8.057940      1.648831 
H        4.077418     -8.362654      2.097616 
H        2.503954     -8.964972      1.554009 
C        2.344480      4.701296     -6.387923 
H        1.523203      5.172357     -6.959015 
H        2.464230      5.287826     -5.468182 
C       -2.665317      5.885364      6.564716 
H       -1.938443      6.629955      6.925184 
H       -2.499599      4.969349      7.147195 
H       -3.666112      6.255997      6.832444 
N       -2.225023      5.047726      0.907490 
H       -2.286263      4.062244      0.639049 
C       -2.048380      6.040488     -0.079319 
O       -2.005127      7.232511      0.137840 
N       -1.909284      5.466371     -1.388213 
H       -2.157129      4.481976     -1.526065 
H        3.258554      4.855020     -6.981149 
H        2.409514     -5.516783      0.925471 
N        1.424543     -0.883447     -5.397083 
H        1.358523     -1.127745     -4.405309 
C        1.304634     -1.893766     -6.378598 
O        1.359053     -1.700572     -7.575628 
N        1.106514     -3.192292     -5.807127 
H        1.088189     -3.293328     -4.788854 
C        0.928291     -4.388909     -6.552064 
C        0.560646     -6.813138     -7.876639 
C        0.922179     -4.422305     -7.961094 
C        0.749311     -5.581076     -5.805912 
C        0.566694     -6.785745     -6.470306 
C        0.738581     -5.631223     -8.619102 
H        1.062077     -3.500317     -8.541899 
H        0.753165     -5.564931     -4.717817 
H        0.426301     -7.719552     -5.912161 
H        0.730353     -5.675270     -9.715795 
C       -1.437017      6.148805     -2.535853 
C       -0.405205      7.321946     -4.842182 
C       -1.112853      7.521120     -2.536101 
C       -1.268508      5.370107     -3.709886 
C       -0.752051      5.957753     -4.854075 
C       -0.600769      8.103638     -3.687296 
H       -1.264848      8.126469     -1.632420 
H       -1.533435      4.313936     -3.722543 
H       -0.605387      5.369443     -5.768603 
H       -0.341121      9.169627     -3.706640 
N        0.170708      7.927225     -6.047156 
O        0.370649      9.130375     -6.048204 
O        0.423269      7.182947     -6.986925 
N        0.366248     -8.091187     -8.575214 
O        0.362299     -8.078315     -9.795882 
O        0.219710     -9.093346     -7.891232 
H        3.340929     -7.714256      0.629836 
N        0.504875     -4.072841      4.857123 
H        0.355085     -3.178921      4.380291 
C        0.077937     -4.230434      6.196012 
O        0.208256     -5.247672      6.845523 
N       -0.535521     -3.046007      6.717143 
H       -0.618171     -2.219984      6.117695 
C       -1.055130     -2.911806      8.032501 
C       -2.112464     -2.498871     10.577700 
C       -1.016586     -3.951613      8.983209 
C       -1.629358     -1.658489      8.363673 
C       -2.154606     -1.458047      9.632417 
C       -1.543757     -3.743689     10.250901 
H       -0.573130     -4.924054      8.729071 
H       -1.664144     -0.850581      7.635509 
H       -2.603513     -0.496329      9.909199 
H       -1.521579     -4.542249     11.003528 
N       -2.668771     -2.280951     11.920083 
O       -2.612426     -3.204069     12.716698 







SUPPLEMENTARY INFORMATION FOR CHAPTER IV 
 
D.1. General Experimental Details 
1H and 13C NMR spectra were obtained on a Varian Mercury 300 MHz 
spectrometer (1H: 300.09), Inova 500 MHz spectrometer (1H: 500.10 MHz, 13C: 125.75 
MHz), or Bruker Avance III HD 600 MHz NMR Spectrometer with Prodigy 
multinuclear broadband BBO CryoProbe (1H: 600.02 MHz, 13C: 150.89 MHz). 
Chemical shifts (δ) are expressed in ppm downfield from tetramethylsilane (TMS) using 
non-deuterated solvent present in the bulk deuterated solvent (CDCl3: 1H 7.26 ppm, 13C 
77.16 ppm; d6-DMSO: 1H 2.50 ppm 13C 39.52 ppm). All NMR spectra were processed 
using MestReNova NMR processing software. All materials were synthesized following 
literature procedures or were obtained from TCI-America, Sigma-Aldrich, or Acros and 
used as received. X-ray crystal data were obtained on a Bruker Apex CCD 
diffractometer. 
D.2. Synthesis of Receptor 3 
In oven dried glassware, trisaniline 4 (300 mg, 0.507 mmol) and p-
methoxyphenyl isocyanate (0.40 mL, 3.04 mmol) were dissolved in freshly distilled 
toluene (50 mL) (Scheme 1). The reaction mixture was stirred overnight, quenched with 
acetone, and product 3 was obtained cleanly by repeated precipitation from acetone 
with hexanes (300 mg, 57 % yield). 1H NMR (600 MHz, d6-DMSO) δ 9.26 (s, 3H),  
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Scheme 1. Synthesis of receptor 3 from previously reported core molecule 4. 
 
8.13 (s, 3H), 8.05 (d, J = 8.8 Hz, 3H), 8.04 (s, 3H), 7.54 (d, J = 2.4 Hz, 3H), 7.45 (dd,  
J = 8.8, 2.4 Hz, 3H), 7.37 (d, J = 9.0 Hz, 6H), 6.83 (d, J = 9.0 Hz, 6H), 3.69 (s, 9H), 1.30 
(s, 27H). 13C NMR (151 MHz, d6-DMSO) δ 154.63, 152.40, 144.44, 138.19, 134.09, 132.35, 
128.83, 127.25, 123.64, 120.28, 119.72, 114.01, 110.48, 92.81, 87.65, 55.10, 33.96, 31.01. 
LRMS (ESI) m/e 1039.5 (M+, 100). HRMS (ESI) for C66H67N6O6 [M+]: calcd 1039.5122, 
found 1039.5084. (Figures 1-4) 
D.3. Titration Details 
Tetrabutylammonium salts were dried at 50 °C under vacuum and stored in a 
calcium carbonate filled desiccator. Tetrabutylammonium sulfate was purchased as a  
50 % solution in water. In all titrations the receptor concentration was kept constant 
during the titration. A stock solution of receptor was prepared and the host-guest 
solution was prepared with the stock receptor solution. Final guest amounts were 
obtained through drying an aliquot of a freshly prepared stock solution for each 
titration unless desires masses could accurately be weighed out. All additions were 
performed with a Hamilton μL syringe. Titrations were carried out in at least triplicate 





























Figure 1. 1H NMR spectrum of 3 in CDCl3, 600 MHz. 
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Figure 2. 13C NMR spectrum of 3 in CDCl3, 151 MHz. 
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Figure 3. Low resolution ESI mass spectrum of 3. 
 
 
Figure 4. High resolution ESI mass spectrum of 3.
Watt, TR_044, Haley, 212711, C66H66N6O6
m/z





















Watt, TR_044, Haley, 212711, C66H66N6O6














Association constants (Ka) were calculated by nonlinear curve fitting of the obtained 
titration isotherms using Thordarson fitting programs via Matlab. Representative data 
are provided for each set. 
1H NMR titrations were carried out on an Inova 500 MHz spectrometer (1H 
500.10 MHz) at 298 K unless otherwise noted. Chemical shifts (δ) are expressed in ppm 
downfield from tetramethylsilane (TMS) using non-deuterated solvent present in the 
bulk deuterated solvent (CDCl3: 1H 7.26 ppm). Chemical shifts of urea protons 
broadened into the baseline were determined using line broadening. 
D.3.1. NMR Titrations of 3 
Tetrabutylammonium nitrate, 10 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 3 (3.24 mg, [R] = 1.04 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBANO3 guest solution (5.00 mg, [G] = 8.21 mM). Starting 
volume of 500 μL. (Table 1, Figures 5 and 6) 




















0 0 0.00E+00 0 7.696 8.675 7.150 6.590 6.590 
10 10 1.61E-04 0.15 7.710 8.704 7.160 6.593 6.593 
10 20 3.16E-04 0.30 7.720 8.729 7.164 6.589 6.589 
10 30 4.64E-04 0.45 7.736 8.752 7.169 6.585 6.585 
10 40 6.08E-04 0.58 7.741 8.770 7.172 6.581 6.581 
10 50 7.46E-04 0.72 7.744 8.787 7.176 6.578 6.578 
15 65 9.44E-04 0.91 7.761 8.809 7.179 6.574 6.574 
15 80 1.13E-03 1.09 7.770 8.827 7.182 6.570 6.570 
20 100 1.37E-03 1.32 7.780 8.848 7.186 6.566 6.566 
20 120 1.59E-03 1.53 7.788 8.862 7.189 6.563 6.563 
25 145 1.84E-03 1.78 7.797 8.880 7.192 6.559 6.559 
35 180 2.17E-03 2.09 7.806 8.894 7.197 6.557 6.557 








Figure 6. Example 1:1 fitting using non-linear regression from the data obtained for the titration of tetrabutylammonium nitrate 
into 3 in 10 % d6-DMSO/CDCl3. 
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Tetrabutylammonium chloride, 10 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 3 (3.51 mg, [R] = 1.13 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBACl guest solution (5.24 mg, [G] = 9.43 mM). Starting 
volume of 500 μL. (Table 2, Figures 7 and 8) 
Tetrabutylammonium bromide, 10 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 3 (3.31 mg, [R] = 1.06 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBABr guest solution (5.04 mg, [G] = 7.81 mM). Starting 
volume of 500 μL. (Table 3, Figures 9 and 10) 
Tetrabutylammonium iodide, 10 % DMSO-d6/CDCl3. A 3 mL stock solution 
of 3 (6.47 mg, [R] = 2.08 mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the 
preparation of a 2 mL TBAI guest solution (81.49 mg, [G] = 110.3 mM). Starting volume 
of 500 μL. (Table 4, Figures 11 and 12) 
Table 2. Example titration for the addition of tetrabutylammonium chloride to 3 in  















0 0 0.00E+00 0 7.713 8.693 7.187 6.614 7.741 
10 10 1.85E-04 0.16 7.727 8.793 7.200 6.606 7.775 
10 20 3.63E-04 0.32 7.739 8.891 7.213 6.595 7.810 
10 30 5.34E-04 0.47 7.751 8.978 7.225 6.587 7.842 
10 40 6.99E-04 0.62 7.763 9.057 7.236 6.580 7.870 
10 50 8.58E-04 0.76 7.771 9.116 7.245 6.574 7.894 
15 65 1.09E-03 0.96 7.782 9.198 — 6.568 7.926 
15 80 1.30E-03 1.16 7.791 9.258 — 6.561 7.945 
20 100 1.57E-03 1.40 7.800 9.328 7.273 6.556 7.973 
20 120 1.83E-03 1.62 7.807 9.379 7.276 6.551 7.992 
25 145 2.12E-03 1.88 7.814 9.422 7.285 6.546 8.010 
35 180 2.50E-03 2.22 7.822 9.473 7.293 6.542 8.030 





Figure 7. Example stacked spectra from the titration for the addition of 
tetrabutylammonium chloride to 3 in 10 % d6-DMSO/CDCl3. 
 
Figure 8. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium chloride into 3 in 10 % d6-DMSO/CDCl3. 
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0 0 0.00E+00 0 7.712 8.696 7.168 6.614 7.740 
10 10 1.53E-04 0.14 7.716 8.725 7.174 6.609 7.753 
10 20 3.00E-04 0.28 7.719 8.751 7.178 6.605 7.764 
10 30 4.42E-04 0.42 7.721 8.770 7.182 6.602 7.773 
10 40 5.78E-04 0.54 7.723 8.791 7.186 6.599 7.781 
15 55 7.74E-04 0.73 7.726 8.814 7.190 6.595 7.792 
15 70 9.59E-04 0.90 7.728 8.834 7.194 6.592 7.802 
20 90 1.19E-03 1.12 7.731 8.861 7.198 6.589 7.813 
20 110 1.41E-03 1.33 7.733 8.879 7.203 6.586 7.822 
25 135 1.66E-03 1.56 7.735 8.903 7.206 6.582 7.832 
25 160 1.89E-03 1.78 7.736 8.921 7.209 6.579 7.841 
35 195 2.19E-03 2.06 7.739 8.943 7.214 6.575 7.850 
50 245 2.57E-03 2.42 7.742 8.965 7.218 6.572 7.861 
 
Figure 9. Example stacked spectra from the titration for the addition of 
tetrabutylammonium bromide to 3 in 10 % d6-DMSO/CDCl3. 
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Figure 10. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium bromide into 3 in 10 % d6-DMSO/CDCl3. 
















0 0 0.00E+00 0 7.707 8.689 7.159 6.607 7.736 
5 5 1.09E-03 0.53 7.708 8.699 7.163 6.603 7.747 
10 15 3.21E-03 1.55 7.709 8.716 7.168 6.598 7.755 
10 25 5.25E-03 2.53 7.710 8.729 7.173 6.595 7.770 
15 40 8.17E-03 3.94 7.711 8.745 7.180 6.590 7.789 
20 60 1.18E-02 5.70 7.711 8.763 7.186 6.584 7.811 
20 80 1.52E-02 7.33 7.712 8.776 7.191 6.578 7.828 
25 105 1.91E-02 9.23 7.712 8.792 7.196 6.573 7.845 
25 130 2.28E-02 10.97 7.713 8.803 7.199 6.570 7.859 
35 165 2.74E-02 13.19 7.712 8.814 7.201 6.564 7.876 
35 200 3.15E-02 15.19 7.712 8.825 7.206 6.561 7.888 
50 250 3.68E-02 17.72 7.712 8.840 7.208 6.555 7.898 
75 325 4.35E-02 20.94 7.710 8.852 7.211 6.547 7.911 
 167 
 
Figure 11. Example stacked spectra from the titration for the addition of 
tetrabutylammonium iodide to 3 in 10 % d6-DMSO/CDCl3. 
 
Figure 12. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium iodide into 3 in 10 % d6-DMSO/CDCl3. 
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D.3.2. NMR Titrations of 1 
Tetrabutylammonium perchlorate, 10 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 1 (3.49 mg, [R] = 1.02 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBAClO4 guest solution (9.29 mg, [G] = 13.59 mM). 
Starting volume of 500 μL. (Table 5, Figures 13 and 14) 
Tetrabutylammonium perrhenate, 10 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 1 (3.51 mg, [R] = 1.03 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBAReO4 guest solution (11.62 mg, [G] = 13.52 mM). 
Starting volume of 500 μL. (Table 6, Figures 15 and 16) 
Tetrabutylammonium hydrogen sulfate, 10 % DMSO-d6/CDCl3. A 3 mL 
stock solution of 1 (3.27 mg, [R] = 0.96 mM) in 10 % DMSO-d6/CDCl3 was prepared 
and used in the preparation of a 2 mL TBAHSO4 guest solution (4.32 mg, [G] = 6.36 
mM). Starting volume of 500 μL. (Table 7, Figures 17 and 18) 
Table 5. Example titration for the addition of tetrabutylammonium perchlorate to 1 in 















0 0 0.00E+00 0 7.895 9.416 7.442 7.881 
15 15 3.96E-04 0.39 7.893 9.400 7.449 7.878 
15 30 7.69E-04 0.75 7.893 9.389 7.454 7.875 
20 50 1.24E-03 1.21 7.891 9.378 7.459 7.872 
20 70 1.67E-03 1.63 7.889 9.368 7.462 7.870 
25 95 2.17E-03 2.12 7.890 9.361 7.466 7.867 
30 125 2.72E-03 2.66 7.890 9.354 7.469 7.864 
35 160 3.29E-03 3.22 7.890 9.347 7.471 7.863 
40 200 3.88E-03 3.80 7.890 9.341 7.474 7.861 
50 250 4.53E-03 4.43 7.890 9.336 7.476 7.859 
60 310 5.20E-03 5.09 7.890 9.329 7.477 7.856 
80 390 5.95E-03 5.83 7.889 9.325 7.479 7.853 
125 515 6.90E-03 6.75 7.890 9.320 7.480 7.851 





Figure 13. Example stacked spectra from the titration for the addition of 
tetrabutylammonium perchlorate to 1 in 10 % d6-DMSO/CDCl3. 
 
Figure 14. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium perchlorate into 1 in 10 % d6-DMSO/CDCl3. 
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Table 6. Example titration for the addition of tetrabutylammonium perrhenate to 1 in 















0 0 0.00E+00 0 7.916 9.440 7.445 7.872 
15 15 3.94E-04 0.38 7.921 9.419 7.454 7.869 
20 35 8.85E-04 0.86 7.924 9.402 7.461 7.866 
25 60 1.45E-03 1.41 7.927 9.387 7.468 7.864 
30 90 2.06E-03 2.01 7.930 9.375 7.472 7.861 
35 125 2.70E-03 2.63 7.930 9.364 7.478 7.857 
40 165 3.36E-03 3.26 7.933 9.356 7.483 7.858 
50 215 4.07E-03 3.96 7.933 9.347 7.484 7.860 
60 275 4.80E-03 4.67 7.934 9.341 7.486 7.855 
80 355 5.62E-03 5.46 7.934 9.334 7.487 7.854 
100 455 6.44E-03 6.27 7.934 9.329 7.490 7.854 
150 605 7.40E-03 7.20 7.934 9.324 7.489 7.854 
 
Figure 15. Example stacked spectra from the titration for the addition of 
tetrabutylammonium perrhenate to 1 in 10 % d6-DMSO/CDCl3. 
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Figure 16. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium perrhenate into 1 in 10 % d6-DMSO/CDCl3. 
Table 7. Example titration for the addition of tetrabutylammonium hydrogen sulfate to 















0 0 0.00E+00 0 7.889 9.367 7.434 7.882 
10 10 1.25E-04 0.13 7.908 9.406 7.460 7.871 
10 20 2.45E-04 0.26 7.939 9.449 7.489 7.854 
10 30 3.60E-04 0.38 7.968 9.494 7.517 7.839 
10 40 4.71E-04 0.49 7.997 9.537 7.544 7.826 
10 50 5.78E-04 0.60 8.024 9.577 7.570 7.818 
15 65 7.32E-04 0.76 8.059 9.631 7.602 7.807 
15 80 8.77E-04 0.92 8.084 9.669 7.626 7.800 
20 100 1.06E-03 1.11 8.102 9.697 7.644 7.795 
20 120 1.23E-03 1.29 8.111 9.711 7.652 7.792 
25 145 1.43E-03 1.49 8.115 9.719 7.656 7.790 
50 195 1.78E-03 1.86 8.120 9.725 7.660 7.787 
100 295 2.36E-03 2.46 8.122 9.730 7.662 7.784 
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Figure 17. Example stacked spectra from the titration for the addition of 
tetrabutylammonium hydrogen sulfate to 1 in 10 % d6-DMSO/CDCl3. 
 
Figure 18. Plot of the change in chemical shift versus equivalents added of TBAHSO4 
during the titration in 10 % DMSO-d6/CDCl3. 
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Tetrabutylammonium hydrogen sulfate, 15 % DMSO-d6/CDCl3. A 3 mL 
stock solution of 1 (3.35 mg, [R] = 0.98 mM) in 15 % DMSO-d6/CDCl3 was prepared 
and used in the preparation of a 2 mL TBAHSO4 guest solution (3.92 mg, [G] = 5.77 
mM). Starting volume of 500 μL. (Table 8, Figures 19 and 20) 
Tetrabutylammonium hydrogen sulfate, 20 % DMSO-d6/CDCl3. A 3 mL 
stock solution of 1 (3.43 mg, [R] = 1.00 mM) in 20 % DMSO-d6/CDCl3 was prepared 
and used in the preparation of a 2 mL TBAHSO4 guest solution (4.98 mg, [G] = 7.34 
mM). Starting volume of 500 μL. (Table 9, Figures 21 and 22) 
Tetrabutylammonium sulfate, 10 % DMSO-d6/CDCl3, 25 °C. A 3 mL stock 
solution of 1 (3.34 mg, [R] = 1.03 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBASO4 guest solution (10.0 μL, 9.9 mg, [G] = 8.53 mM). 
Starting volume of 500 μL. 1H NMR spectra were taken of 0.0 μL (0.0 μL total, 0.0 mM 
[TBASO4]), 15.0 μL (15.0 μL total, 0.25 mM [TBASO4]), and then 20.0 μL (35.0 μL total, 
0.56 mM [TBASO4]) additions of the sulfate•host solution. (Figures 23) 
Table 8. Example titration for the addition of tetrabutylammonium hydrogen sulfate to 















0 0 0.00E+00 0 7.871 9.543 7.378 7.758 
10 10 1.13E-04 0.12 7.886 9.578 7.393 7.750 
10 20 2.22E-04 0.23 7.901 9.608 7.408 7.742 
15 35 3.78E-04 0.39 7.924 9.647 7.431 7.730 
15 50 5.25E-04 0.54 7.946 9.678 7.454 7.722 
20 70 7.09E-04 0.72 7.969 9.705 7.477 7.711 
20 90 8.81E-04 0.90 7.987 9.719 7.497 7.706 
20 110 1.04E-03 1.06 7.999 9.725 7.510 7.702 
30 140 1.26E-03 1.29 8.010 9.732 7.523 7.697 
40 180 1.53E-03 1.56 8.019 9.724 7.533 7.693 
50 230 1.82E-03 1.85 8.025 9.716 7.540 7.690 
60 290 2.12E-03 2.16 8.029 9.709 7.544 7.688 
75 365 2.44E-03 2.48 8.031 9.700 7.548 7.687 
100 465 2.78E-03 2.84 8.033 9.695 7.549 7.685 
 174 
 
Figure 19. Example stacked spectra from the titration for the addition of 
tetrabutylammonium hydrogen sulfate to 1 in 15 % d6-DMSO/CDCl3. 
 
Figure 20. Plot of the change in chemical shift versus equivalents added of TBAHSO4 
during the titration in 15 % DMSO-d6/CDCl3. 
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Table 9. Example titration for the addition of tetrabutylammonium hydrogen sulfate to 















0 0 0.00E+00 0 7.772 9.329 7.249 7.672 
10 10 1.44E-04 0.14 7.792 9.358 7.271 7.661 
10 20 2.82E-04 0.28 7.812 9.387 7.294 7.651 
15 35 4.80E-04 0.48 7.838 9.423 7.323 7.637 
15 50 6.67E-04 0.66 7.860 9.451 7.346 7.627 
15 65 8.44E-04 0.84 7.876 9.472 7.365 7.619 
20 85 1.07E-03 1.06 7.891 9.492 7.383 7.610 
20 105 1.27E-03 1.27 7.903 9.506 7.396 7.605 
25 130 1.51E-03 1.51 7.911 9.517 7.405 7.600 
35 165 1.82E-03 1.81 7.918 9.525 7.414 7.595 
50 215 2.21E-03 2.20 7.925 9.532 7.421 7.591 
70 285 2.66E-03 2.65 7.928 9.536 7.426 7.588 
100 385 3.19E-03 3.18 7.933 9.539 7.431 7.585 
 
Figure 21. Example stacked spectra from the titration for the addition of 
tetrabutylammonium hydrogen sulfate to 1 in 20 % d6-DMSO/CDCl3. 
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Figure 22. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium hydrogen sulfate into 1 in 20 % d6-DMSO/CDCl3. 
 
Figure 23. Example stacked spectra taken at 25 °C from the titration for the addition 
of tetrabutylammonium sulfate to 1 in 10 % d6-DMSO/CDCl3. 
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Tetrabutylammonium sulfate, 10 % DMSO-d6/CDCl3, -20 °C. A 3 mL stock 
solution of 1 (3.58 mg, [R] = 1.05 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBASO4 guest solution (10.0 μL, 9.9 mg, [G] = 8.53 mM). 
Starting volume of 500 μL. 1H and 19F NMR spectra were taken of 0.0 μL (0.0 μL total, 
0.0 mM [TBASO4]), 35.0 mL (35.0 mL total, 0.56 mM [TBASO4]), 35.0 μL (70.0 μL 
total, 1.05 mM [TBASO4]), and lastly 45.0 μL (115.0 μL total, 1.60 mM [TBASO4]) 
additions of the sulfate•host solution. 19F NMR spectra are shown with line broadening 
applied (0.3). (Figures 24 and 25) 
Tetrabutylammonium acetate, 10 % DMSO-d6/CDCl3. A 3 mL stock solution 
of 1 (3.53 mg, [R] = 1.03 mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the 
preparation of a 2 mL TBAOAc guest solution (4.13 mg, [G] = 6.86 mM). Starting 
volume of 500 μL. (Table 10, Figures 26 and 27) 
Tetrabutylammonium acetate, 20 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 1 (3.36 mg, [R] = 0.98 mM) in 20 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBAOAc guest solution (5.86 mg, [G] = 9.72 mM). 
Starting volume of 500 μL. (Table 11, Figures 28 and 29) 
Tetrabutylammonium acetate, 50 % DMSO-d6/CDCl3. A 3 mL stock solution 
of 1 (3.39 mg, [R] = 0.99 mM) in 50 % DMSO-d6/CDCl3 was prepared and used in the 
preparation of a 2 mL TBAOAc guest solution (6.44 mg, [G] = 10.68 mM). Starting 
volume of 500 μL. (Table 12, Figures 30, 31, and 32) 
Tetrabutylammonium dihydrogen phosphate, 10 % DMSO-d6/CDCl3. A 3 
mL stock solution of 1 (3.28 mg, [R] = 0.96 mM) in 10 % DMSO-d6/CDCl3 was 
prepared and used in the preparation of a 2 mL TBAH2PO4 guest solution (2.68 mg, 
[G] = 6.94 mM). Starting volume of 500 μL. Reliable data is unobtainable near 
saturation of the host’s binding sites. (Table 13, Figure 33 and 34) 
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Figure 24. Example stacked 1H NMR spectra taken at -20 °C from the titration for the addition of tetrabutylammonium sulfate to 
1 in 10 % d6-DMSO/CDCl3. 
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Figure 25. Example stacked 19F NMR spectra taken at -20 °C from the titration for the addition of tetrabutylammonium sulfate to 
1 in 10 % d6-DMSO/CDCl3. 
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Table 10. Example titration for the addition of tetrabutylammonium acetate to 1 in  















0 0 0.00E+00 0 7.902 9.372 7.437 7.887 
10 10 1.34E-04 0.13 7.986 9.545 7.436 7.853 
10 20 2.64E-04 0.26 8.086 9.732 7.440 7.822 
10 30 3.88E-04 0.38 8.177 9.934 7.448 7.797 
10 40 5.08E-04 0.49 8.264 10.130 7.465 7.780 
10 50 6.23E-04 0.60 8.336 10.315 7.487 7.776 
15 65 7.89E-04 0.76 8.434 10.587 7.524 7.776 
15 80 9.46E-04 0.91 8.515 10.828 7.557 7.781 
20 100 1.14E-03 1.11 8.596 11.000 7.583 7.785 
20 120 1.33E-03 1.28 8.654 11.071 7.591 7.783 
25 145 1.54E-03 1.49 8.713 11.129 7.597 7.781 
35 180 1.81E-03 1.76 8.781 11.192 7.603 7.779 




Figure 26. Example stacked spectra from the titration for the addition of 
tetrabutylammonium acetate to 1 in 10 % d6-DMSO/CDCl3. 
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Figure 27. Plot of the change in chemical shift versus equivalents added of TBAOAc during the titration in 10 %  
DMSO-d6/CDCl3. 
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0 0 0.00E+00 0 7.761 9.288 7.240 7.675 
10 10 1.91E-04 0.19 7.871 9.528 7.260 7.650 
10 20 3.74E-04 0.38 7.993 9.816 7.280 7.628 
10 30 5.50E-04 0.56 8.107 10.097 7.305 7.611 
10 40 7.20E-04 0.73 8.210 10.339 7.329 7.597 
15 55 9.63E-04 0.98 8.340 10.656 7.364 7.584 
15 70 1.19E-03 1.21 8.420 10.814 7.381 7.579 
15 85 1.41E-03 1.44 8.468 10.874 7.387 7.576 
20 105 1.69E-03 1.71 8.521 10.929 7.390 7.573 
25 130 2.01E-03 2.04 8.580 10.986 7.395 7.568 
35 165 2.41E-03 2.45 8.648 11.051 7.400 7.564 
 
Figure 28. Example stacked spectra from the titration for the addition of 




Figure 29. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium acetate into 1 in 20 % d6-DMSO/CDCl3. 
Table 12. Example titration for the addition of tetrabutylammonium acetate to 1 in  















0 0 0.00E+00 0 7.498 9.031 6.837 7.252 
10 10 2.09E-04 0.21 7.580 9.221 6.851 7.239 
10 20 4.11E-04 0.41 7.675 9.442 6.869 7.225 
10 30 6.05E-04 0.61 7.763 9.640 6.886 7.213 
10 40 7.91E-04 0.80 7.844 9.826 6.901 7.200 
10 50 9.71E-04 0.98 7.913 9.977 6.914 7.191 
10 60 1.14E-03 1.15 7.971 10.104 6.923 7.182 
15 75 1.39E-03 1.40 8.038 10.235 6.935 7.176 
20 95 1.71E-03 1.72 8.102 10.345 6.943 7.167 
30 125 2.14E-03 2.15 8.168 10.441 6.950 7.162 
40 165 2.65E-03 2.67 8.233 10.519 6.956 7.158 
50 215 3.21E-03 3.23 8.293 10.591 6.961 7.153 
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Figure 30. Stacked spectra from the titration for the addition of tetrabutylammonium 
acetate to 1 in 50 % d6-DMSO/CDCl3. 
 
Figure 31. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium acetate into 1 in 50 % d6-DMSO/CDCl3. 
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Figure 32. Host 1 in 50 % d6-DMSO/CDCl3 before addition of tetrabutylammonium acetate (bottom) and after saturation (top). 
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Table 13. Example titration for the addition of tetrabutylammonium dihydrogen 















0 0 0.00E+00 0 7.880 9.365 7.433 7.890 
20 20 1.52E-04 0.16 7.994 9.600 7.465 7.850 
20 40 2.92E-04 0.30 8.094 9.828 7.493 7.814 
20 60 4.22E-04 0.44 8.182 10.018 7.516 7.789 
20 80 5.44E-04 0.57 8.250 10.184 7.543 7.771 
25 105 6.84E-04 0.71 8.311 10.368 7.552 7.747 
25 130 8.14E-04 0.85 8.364 10.523 7.563 7.729 
30 160 9.56E-04 1.00 8.411 — 7.579 7.709 
40 200 1.13E-03 1.17 8.454 — 7.602 7.692 
 
Figure 33. Example stacked spectra from the titration for the addition of 
tetrabutylammonium dihydrogen phosphate to 1 in 10 % d6-DMSO/CDCl3. Line 
broadening was employed elucidate chemical shifts of broadened peaks. 
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Tetrabutylammonium nitrate, 20 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 1 (3.27 mg, [R] = 0.96 mM) in 20 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBANO3 guest solution (6.00 mg, [G] = 9.95 mM). 
Starting volume of 500 μL. (Table 14, Figures 34 and 35) 
Table 14. Example titration for the addition of tetrabutylammonium nitrate to 1 in  















0 0 0.00E+00 0 7.765 9.298 7.244 7.677 
10 10 1.95E-04 0.20 7.789 9.334 7.255 7.667 
10 20 3.83E-04 0.40 7.808 9.363 7.260 7.658 
10 30 5.63E-04 0.59 7.825 9.388 7.269 7.651 
15 45 8.21E-04 0.86 7.843 9.417 7.277 7.641 
15 60 1.07E-03 1.11 7.858 9.439 7.281 7.635 
20 80 1.37E-03 1.43 7.873 9.462 7.289 7.629 
20 100 1.66E-03 1.73 7.884 9.477 7.292 7.623 
25 125 1.99E-03 2.08 7.895 9.494 7.297 7.619 
35 160 2.41E-03 2.52 7.902 9.506 7.300 7.614 
50 210 2.94E-03 3.07 7.913 9.520 7.303 7.609 
70 280 3.57E-03 3.73 7.919 9.527 7.304 7.603 
 
Figure 34. Example stacked spectra from the titration for the addition of 
tetrabutylammonium nitrate to 1 in 20 % d6-DMSO/CDCl3. 
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Figure 35. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium nitrate into 1 in 20 % d6-DMSO/CDCl3. 
D.3.3. NMR Titrations of 2 
Tetrabutylammonium bromide, 10 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 2 (3.36 mg, [R] = 1.03 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBABr guest solution (5.44 mg, [G] = 8.44 mM). Starting 
volume of 500 μL. (Table 15, Figures 36 and 37) 
Tetrabutylammonium iodide, 10 % DMSO-d6/CDCl3. A 3 mL stock solution 
of 2 (3.07 mg, [R] = 0.94 mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the 
preparation of a 2 mL TBAI guest solution (36.63 mg, [G] = 49.58 mM). Starting 
volume of 500 μL. (Table 16, Figures 38 and 39) 
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Table 15. Example titration for the addition of tetrabutylammonium bromide to 2 in  















0 0 0.00E+00 0 7.975 9.590 7.457 7.887 7.805 
10 10 1.65E-04 0.16 7.983 9.681 7.493 7.879 7.846 
10 20 3.24E-04 0.31 7.990 9.758 7.525 7.873 7.882 
10 30 4.77E-04 0.46 7.995 9.824 7.551 7.867 7.913 
10 40 6.25E-04 0.60 8.001 9.876 7.572 7.864 7.939 
15 55 8.36E-04 0.81 8.005 9.938 7.596 7.858 7.967 
15 70 1.04E-03 1.00 8.009 9.979 7.613 7.854 7.989 
15 85 1.23E-03 1.19 8.011 10.011 7.624 7.851 8.004 
20 105 1.46E-03 1.42 8.015 10.039 7.635 7.848 8.016 
20 125 1.69E-03 1.63 8.016 10.058 7.644 7.846 8.026 
25 150 1.95E-03 1.88 8.018 10.076 7.650 7.844 8.034 
25 175 2.19E-03 2.12 8.019 10.086 7.655 7.843 8.039 
50 225 2.62E-03 2.53 8.020 10.104 7.659 7.841 8.047 
 
Figure 36. Example stacked spectra from the titration for the addition of 
tetrabutylammonium bromide to 2 in 10 % d6-DMSO/CDCl3. 
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Figure 37. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium bromide into 2 in 10 % d6-DMSO/CDCl3. 
Table 16. Example titration for the addition of tetrabutylammonium iodide to 2 in  















0 0 0.00E+00 0 7.982 9.642 7.468 7.884 7.821 
5 5 4.91E-04 0.52 7.986 9.677 7.495 7.880 7.844 
10 15 1.44E-03 1.53 7.988 9.707 7.524 7.870 7.870 
10 25 2.36E-03 2.50 7.989 9.730 7.541 7.870 7.886 
10 35 3.24E-03 3.44 7.991 9.747 7.555 7.867 7.896 
10 45 4.09E-03 4.34 7.993 9.762 7.564 7.864 7.905 
15 60 5.31E-03 5.63 7.995 9.777 7.574 7.863 7.913 
15 75 6.47E-03 6.85 7.997 9.789 7.581 7.859 7.920 
15 90 7.56E-03 8.01 8.000 9.807 7.587 7.856 7.925 
20 110 8.94E-03 9.47 8.001 9.817 7.592 7.853 7.929 
25 135 1.05E-02 11.17 8.003 9.825 7.597 7.850 7.935 
35 170 1.26E-02 13.33 8.004 9.839 7.602 7.847 7.940 
50 220 1.52E-02 16.05 8.002 9.843 7.606 7.841 7.944 
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Figure 38. Example stacked spectra from the titration for the addition of 
tetrabutylammonium iodide to 2 in 10 % d6-DMSO/CDCl3. 
 
Figure 39. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium iodide into 2 in 10 % d6-DMSO/CDCl3. 
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Tetrabutylammonium perchlorate, 10 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 2 (3.23 mg, [R] = 0.99 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBAReO4 guest solution (77.46 mg, [G] = 0.113 M). 
Starting volume of 500 μL. (Table 17, Figures 40 and 41) 
Tetrabutylammonium perrhenate, 10 % DMSO-d6/CDCl3. A 3 mL stock 
solution of 2 (3.49 mg, [R] = 1.07 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBAReO4 guest solution (60.26 mg, [G] = 70.12 mM). 
Starting volume of 500 μL. (Table 18, Figures 42 and 43) 
Tetrabutylammonium hydrogen sulfate, 20 % DMSO-d6/CDCl3. A 3 mL 
stock solution of 2 (3.14 mg, [R] = 0.97 mM) in 20 % DMSO-d6/CDCl3 was prepared 
and used in the preparation of a 2 mL TBAHSO4 guest solution (10.10 mg, [G] = 14.87 
mM). Starting volume of 500 μL. (Table 19, Figures 44 and 45) 
Tetrabutylammonium hydrogen sulfate, 30 % DMSO-d6/CDCl3. A 3 mL 
stock solution of 2 (3.33 mg, [R] = 1.02 mM) in 30 % DMSO-d6/CDCl3 was prepared 
and used in the preparation of a 2 mL TBAHSO4 guest solution (9.59 mg, [G] = 14.12 
mM). Starting volume of 500 μL. (Table 20, Figures 46 and 47) 
Table 17. Example titration for the addition of tetrabutylammonium perchlorate to 2 in 



















0 0 0.00E+00 0 7.977 9.599 7.459 7.887 7.808 
5 5 1.12E-03 1.28 7.973 9.579 7.467 7.886 7.808 
5 10 2.22E-03 2.51 7.971 9.568 7.471 7.884 7.809 
10 20 4.36E-03 3.70 7.968 9.551 7.478 7.882 7.809 
10 30 6.41E-03 4.84 7.966 9.540 7.482 7.880 7.808 
10 40 8.39E-03 5.94 7.965 9.531 7.486 7.878 7.808 
10 50 1.03E-02 7.00 7.964 9.524 7.488 7.877 7.808 
15 65 1.30E-02 8.52 7.962 9.515 7.492 7.875 7.807 
15 80 1.56E-02 10.43 7.961 9.508 7.494 7.873 7.807 
20 100 1.89E-02 12.22 7.960 9.499 7.496 7.871 7.806 




Figure 40. Example stacked spectra from the titration for the addition of 
tetrabutylammonium perchlorate to 2 in 10 % d6-DMSO/CDCl3. 
 
Figure 41. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium perchlorate into 2 in 10 % d6-DMSO/CDCl3. 
 194 
Table 18. Example titration for the addition of tetrabutylammonium perrhenate to 2 in 



















0 0 0.00E+00 0 7.975 9.599 7.456 7.882 7.804 
10 10 1.37E-03 1.28 7.981 9.565 7.470 7.881 7.798 
10 20 2.70E-03 2.51 7.985 9.547 7.479 7.879 7.795 
10 30 3.97E-03 3.70 7.987 9.533 7.484 7.878 7.792 
10 40 5.19E-03 4.84 7.989 9.523 7.488 7.876 7.789 
10 50 6.37E-03 5.94 7.991 9.516 7.492 7.876 7.788 
10 60 7.51E-03 7.00 7.992 9.510 7.494 7.874 7.786 
15 75 9.15E-03 8.52 7.995 9.504 7.499 7.873 7.784 
20 95 1.12E-02 10.43 7.997 9.494 7.501 7.872 7.781 
20 115 1.31E-02 12.22 7.997 9.486 7.503 7.870 7.779 
25 140 1.53E-02 14.30 7.998 9.481 7.504 7.867 7.776 
 
Figure 42. Example stacked spectra from the titration for the addition of 
tetrabutylammonium perrhenate to 2 in 10 % d6-DMSO/CDCl3. 
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Figure 43. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium perrhenate into 2 in 10 % d6-DMSO/CDCl3. 
Table 19. Example titration for the addition of tetrabutylammonium hydrogen sulfate 



















0 0 0.00E+00 0 7.859 9.569 7.299 7.689 7.669 
10 10 2.92E-04 0.30 7.912 9.605 7.347 7.684 7.697 
10 20 5.72E-04 0.59 7.962 9.639 7.391 7.681 7.713 
10 30 8.42E-04 0.87 7.999 9.661 7.421 7.676 7.727 
10 40 1.10E-03 1.14 8.023 9.672 7.442 7.676 7.735 
15 55 1.47E-03 1.53 8.045 9.678 7.459 7.674 7.741 
15 70 1.83E-03 1.89 8.058 9.682 7.469 7.672 7.745 
15 85 2.16E-03 2.24 8.065 9.683 7.475 7.670 7.746 
20 105 2.58E-03 2.67 8.071 9.682 7.480 7.669 7.747 
20 125 2.97E-03 3.08 8.074 9.682 7.482 7.668 7.747 
25 150 3.43E-03 3.56 8.078 9.680 7.484 7.667 7.747 
35 185 4.02E-03 4.16 8.081 9.680 7.486 7.666 7.747 
50 235 4.76E-03 4.93 8.084 9.678 7.487 7.664 7.745 
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Figure 44. Example stacked spectra from the titration for the addition of 
tetrabutylammonium hydrogen sulfate to 2 in 20 % d6-DMSO/CDCl3. 
 
Figure 45. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium perrhenate into 2 in 10 % d6-DMSO/CDCl3. 
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Table 20. Example titration for the addition of tetrabutylammonium hydrogen sulfate 



















0 0 0.00E+00 0 7.705 9.397 7.096 7.485 7.469 
10 10 2.77E-04 0.27 7.724 9.410 7.115 7.480 7.480 
10 20 5.43E-04 0.53 7.740 9.418 7.130 7.484 7.484 
10 30 7.99E-04 0.78 7.754 9.429 7.145 7.481 7.494 
10 40 1.05E-03 1.02 7.765 9.437 7.156 7.480 7.496 
15 55 1.40E-03 1.37 7.780 9.445 7.170 7.480 7.500 
15 70 1.73E-03 1.69 7.792 9.450 7.182 7.477 7.506 
15 85 2.05E-03 2.00 7.802 9.454 7.190 7.476 7.513 
20 105 2.45E-03 2.39 7.813 9.460 7.201 7.473 7.519 
20 125 2.82E-03 2.76 7.820 9.462 7.208 7.473 7.521 
25 150 3.26E-03 3.18 7.828 9.465 7.216 7.472 7.525 
35 185 3.81E-03 3.72 7.834 9.469 7.224 7.472 7.527 
 
 
Figure 46. Example stacked spectra from the titration for the addition of 
tetrabutylammonium hydrogen sulfate to 2 in 30 % d6-DMSO/CDCl3. 
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Figure 47. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium perrhenate into 2 in 10 % d6-DMSO/CDCl3. 
Tetrabutylammonium sulfate, 10 % DMSO-d6/CDCl3. A 3 mL stock solution 
of 2 (3.21 mg, [R] = 0.99 mM) in 10 % DMSO-d6/CDCl3 was prepared and used in the 
preparation of a 2 mL TBASO4 guest solution (10.0 μL, 9.9 mg, [G] = 8.53 mM). 
Starting volume of 500 μL. (Table 21, Figures 48) 





















0 0 0.00E+00 0.25 7.977 9.604 7.460 7.885 7.809 
15 15 2.49E-04 0.49 7.983 9.628 7.468 7.886 7.816 
15 30 4.83E-04 0.79 7.992 9.663 7.469 7.884 7.829 
20 50 7.76E-04 1.44 — — — — — 
50 100 1.42E-03 2.47 — — — — — 
100 200 2.44E-03 3.24 — — — — — 
100 300 3.20E-03 4.32 — — — — — 
200 500 4.27E-03 5.77 — — — — — 
500 1000 5.69E-03 0.25 — — — — — 
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Figure 48. Example stacked spectra from the titration for the addition of tetrabutylammonium sulfate to 2 in 10 %  
d6-DMSO/CDCl3. 
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Tetrabutylammonium acetate, 10 % DMSO-d6/CDCl3, 25 °C. A 3 mL stock 
solution of 2 (3.20 mg, [R] = 0.98 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBAOAc guest solution (8.97 mg, [G] = 14.88 mM). 
Starting volume of 500 μL. (Table 22, Figures 49 and 50) 
Tetrabutylammonium acetate, 10 % DMSO-d6/CDCl3, 30 °C. A 3 mL stock 
solution of 2 (3.17 mg, [R] = 0.97 mM) in 10 % DMSO-d6/CDCl3 was prepared and used 
in the preparation of a 2 mL TBAOAc guest solution (7.42 mg, [G] = 12.31 mM). 
Starting volume of 500 μL. (Table 23, Figures 51 and 52) 
Tetrabutylammonium dihydrogen phosphate, 10 % DMSO-d6/CDCl3. A 3 
mL stock solution of 2 (3.19 mg, [R] = 0.98 mM) in 10 % DMSO-d6/CDCl3 was 
prepared and used in the preparation of a 2 mL TBAHPO4 guest solution (9.22 mg, [G] 
= 13.58 mM). Starting volume of 500 μL. (Table 24, Figures W1 and W2) 
Tetrabutylammonium dihydrogen phosphate, 20 % DMSO-d6/CDCl3. A 3 
mL stock solution of 2 (3.17 mg, [R] = 0.97 mM) in 20 % DMSO-d6/CDCl3 was prepared 
and used in the preparation of a 2 mL TBAHPO4 guest solution (6.29 mg, [G] = 9.26 
mM). Starting volume of 500 μL. (Table 25, Figures X1 and X2) 
Table 22. Example titration for the addition of tetrabutylammonium acetate to 2 in  



















0 0 0.00E+00 0 7.976 9.597 7.458 7.885 7.806 
10 10 2.92E-04 0.30 8.195 10.024 7.498 7.854 7.804 
10 20 5.72E-04 0.58 8.416 10.485 7.540 7.826 7.812 
10 30 8.42E-04 0.86 8.618 10.878 7.579 7.806 7.821 
10 40 1.10E-03 1.12 8.767 11.086 7.589 7.794 7.805 
10 50 1.35E-03 1.37 8.867 11.181 7.595 7.791 7.801 
10 60 1.59E-03 1.62 8.951 11.257 7.599 7.785 7.799 
10 70 1.83E-03 1.86 9.022 11.323 7.605 7.781 7.798 
15 85 2.16E-03 2.20 9.110 11.405 7.610 7.776 7.797 
15 100 2.48E-03 2.52 9.182 11.464 7.614 7.772 7.798 




Figure 49. Example stacked spectra from the titration for the addition of 
tetrabutylammonium acetate to 2 in 10 % d6-DMSO/CDCl3 taken at 25 °C. 
 
Figure 50. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium acetate into 2 in 10 % d6-DMSO/CDCl3 taken at 
25 °C. 
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Table 23. Example titration for the addition of tetrabutylammonium acetate to 2 in  



















0 0 0.00E+00 0.00 7.965 9.574 7.461 7.888 7.802 
10 10 2.41E-04 0.25 8.147 9.929 7.494 7.862 7.802 
10 20 4.73E-04 0.49 8.332 10.308 7.529 7.837 7.807 
10 30 6.97E-04 0.71 8.514 10.675 7.564 7.816 7.816 
10 40 9.12E-04 0.94 8.672 10.973 7.591 7.800 7.818 
10 50 1.12E-03 1.15 8.780 11.098 7.595 7.793 7.811 
10 60 1.32E-03 1.35 8.857 11.172 7.600 7.789 7.806 
10 70 1.51E-03 1.55 8.924 11.234 7.604 7.785 7.803 
15 85 1.79E-03 1.83 9.009 11.312 7.610 7.781 7.800 
15 100 2.05E-03 2.10 9.078 11.375 7.615 7.777 7.804 
20 120 2.38E-03 2.44 9.154 11.446 7.620 7.773 7.804 
 
Figure 51. Example stacked spectra from the titration for the addition of 




Figure 52. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium acetate into 2 in 10 % d6-DMSO/CDCl3 taken at 
30 °C. 
Table 24. Example titration for the addition of tetrabutylammonium hydrogen 



















0 0 0.00E+00 0 7.978 9.598 7.461 7.889 7.809 
10 10 2.66E-04 0.27 8.143 9.936 7.512 7.868 7.837 
10 20 5.22E-04 0.53 8.326 10.312 7.568 7.849 7.868 
10 30 7.69E-04 0.78 8.499 10.677 7.621 7.834 7.905 
10 40 1.01E-03 1.03 8.647 10.968 7.661 7.823 7.927 
10 50 1.23E-03 1.26 8.741 11.152 7.685 7.814 7.923 
10 60 1.46E-03 1.48 8.789 11.261 7.700 7.806 7.897 
10 70 1.67E-03 1.70 8.817 11.333 7.713 7.797 7.867 
15 85 1.97E-03 2.01 8.851 11.434 7.733 7.785 7.834 




Figure 53. Example stacked spectra from the titration for the addition of tetrabutylammonium dihydrogen phosphate to 2 in 10 % 




Figure 54. Example stacked spectra from the titration for the addition of 
tetrabutylammonium dihydrogen phosphate to 2 in 10 % d6-DMSO/CDCl3. 
Table 25. Example titration for the addition of tetrabutylammonium hydrogen 



















0 0 0.00E+00 0 7.840 9.508 7.271 7.675 7.636 
15 15 2.70E-04 0.28 7.988 9.773 7.319 7.664 7.669 
15 30 5.24E-04 0.54 8.177 10.193 7.375 7.651 7.710 
15 45 7.65E-04 0.78 8.365 10.600 7.427 7.640 7.745 
15 60 9.92E-04 1.02 8.525 10.921 7.473 7.631 7.776 
15 75 1.21E-03 1.24 8.628 11.121 7.501 7.623 7.789 
15 90 1.41E-03 1.45 8.653 11.173 7.508 7.616 7.777 
15 105 1.61E-03 1.65 8.668 11.203 7.515 7.609 7.758 
20 125 1.85E-03 1.90 8.683 11.245 7.522 7.599 7.736 
20 145 2.08E-03 2.14 8.691 11.270 7.528 7.591 7.715 
25 170 2.35E-03 2.41 8.697 11.323 7.537 7.584 7.696 




Figure 55. Example stacked spectra from the titration for the addition of 
tetrabutylammonium dihydrogen phosphate to 2 in 20 % d6-DMSO/CDCl3. Line 
broadening was employed elucidate chemical shifts of broadened peaks. 
 
Figure 56. Example stacked spectra from the titration for the addition of 
tetrabutylammonium dihydrogen phosphate to 2 in 20 % d6-DMSO/CDCl3. 
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D.4. X-ray Crystallography 
Table 26. Crystal data and structure refinement for 2•Acetone. 
Identification code  mh82 
Empirical formula  C75 H81 N9 O13 
Formula weight  1316.49 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 12.2820(17) Å a= 83.428(2)°. 
 b = 13.7330(19) Å b= 78.604(2)°. 
 c = 21.485(3) Å g = 87.611(2)°. 
Volume 3528.4(8) Å3 
Z 2 
Density (calculated) 1.239 Mg/m3 
Absorption coefficient 0.086 mm-1 
F(000) 1396 
Crystal size 0.42 x 0.27 x 0.18 mm3 
Theta range for data collection 1.49 to 27.00°. 
Index ranges -15<=h<=15, -17<=k<=17, -27<=l<=27 
Reflections collected 39977 
Independent reflections 15274 [R(int) = 0.0363] 
Completeness to theta = 27.00° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9847 and 0.9649 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 15274 / 0 / 898 
Goodness-of-fit on F2 1.019 
Final R indices [I>2sigma(I)] R1 = 0.0540, wR2 = 0.1325 
R indices (all data) R1 = 0.0804, wR2 = 0.1512 
Largest diff. peak and hole 0.421 and -0.322 e.Å-3 
 
 
Table 27. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 2•Acetone. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
Atom X Y Z U(eq)
O(1) 13138(1) 5084(1) 2533(1) 46(1) 
O(2) 14058(2) 10002(1) 1793(1) 91(1) 
O(3) 12918(2) 10324(1) 1141(1) 95(1) 
O(4) 545(1) 3985(1) 4525(1) 49(1) 
O(5) -945(2) 8303(1) 2406(1) 66(1) 
O(6) -2071(2) 7102(1) 2552(1) 79(1) 
O(7) 3583(1) 7121(1) 24(1) 48(1) 
O(8) 332(2) 3452(2) -1052(1) 96(1) 
O(9) -142(2) 4952(2) -1293(1) 78(1) 
N(1) 11711(1) 4252(1) 2319(1) 33(1) 
N(2) 11977(1) 5853(1) 1912(1) 35(1) 
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Table 27 Continued.  
Atom X Y Z U(eq)
N(3) 13356(2) 9757(2) 1507(1) 67(1) 
N(4) 2409(1) 3914(1) 4503(1) 33(1) 
N(5) 1657(1) 5201(1) 3956(1) 33(1) 
N(6) -1209(2) 7462(1) 2615(1) 50(1) 
N(7) 4705(1) 6416(1) 687(1) 35(1) 
N(8) 3418(1) 5498(1) 384(1) 37(1) 
N(9) 395(2) 4331(2) -1016(1) 61(1) 
C(1) 7804(1) 3637(1) 2782(1) 26(1) 
C(2) 6960(1) 3198(1) 3249(1) 27(1) 
C(3) 5869(1) 3549(1) 3304(1) 25(1) 
C(4) 5608(1) 4321(1) 2871(1) 25(1) 
C(5) 6445(1) 4760(1) 2400(1) 25(1) 
C(6) 7540(1) 4420(1) 2362(1) 28(1) 
C(7) 8934(1) 3314(1) 2766(1) 29(1) 
C(8) 9862(1) 3057(1) 2803(1) 29(1) 
C(9) 10952(1) 2730(1) 2884(1) 28(1) 
C(10) 11097(2) 1801(1) 3193(1) 31(1) 
C(11) 12124(2) 1444(1) 3303(1) 32(1) 
C(12) 13011(2) 2068(1) 3096(1) 37(1) 
C(13) 12898(2) 2996(1) 2785(1) 36(1) 
C(14) 11871(1) 3342(1) 2667(1) 29(1) 
C(15) 12222(2) 418(1) 3656(1) 39(1) 
C(16) 11768(2) -346(2) 3320(1) 57(1) 
C(17) 11543(2) 419(2) 4336(1) 58(1) 
C(18) 13421(2) 138(2) 3703(1) 62(1) 
C(19) 12345(1) 5064(1) 2276(1) 32(1) 
C(20) 12367(2) 6812(1) 1821(1) 35(1) 
C(21) 13242(2) 7100(2) 2078(1) 45(1) 
C(22) 13551(2) 8069(2) 1977(1) 53(1) 
C(23) 13005(2) 8737(2) 1619(1) 49(1) 
C(24) 12146(2) 8468(2) 1356(1) 54(1) 
C(25) 11825(2) 7508(2) 1460(1) 47(1) 
C(26) 5035(1) 3145(1) 3823(1) 27(1) 
C(27) 4362(1) 2827(1) 4275(1) 28(1) 
C(28) 3488(1) 2489(1) 4793(1) 26(1) 
C(29) 3616(1) 1632(1) 5189(1) 28(1) 
C(30) 2762(1) 1263(1) 5673(1) 28(1) 
C(31) 1774(2) 1812(1) 5756(1) 33(1) 
C(32) 1630(2) 2680(1) 5384(1) 34(1) 
C(33) 2483(1) 3030(1) 4891(1) 28(1) 
C(34) 2922(2) 313(1) 6098(1) 33(1) 
C(35) 1810(2) -138(2) 6419(1) 59(1) 
C(36) 3532(2) 552(2) 6615(1) 57(1) 
C(37) 3616(2) -440(1) 5711(1) 51(1) 
C(38) 1460(2) 4333(1) 4343(1) 31(1) 
C(39) 897(1) 5745(1) 3647(1) 29(1) 
C(40) -59(2) 5342(1) 3532(1) 34(1) 
C(41) -744(2) 5910(2) 3192(1) 38(1) 
C(42) -480(2) 6867(1) 2970(1) 35(1) 
C(43) 460(2) 7283(1) 3080(1) 34(1) 
C(44) 1141(2) 6719(1) 3424(1) 32(1) 
C(45) 6212(1) 5571(1) 1962(1) 28(1) 
C(46) 6099(1) 6275(1) 1595(1) 30(1) 
C(47) 6020(2) 7159(1) 1180(1) 30(1) 
C(48) 6666(2) 7947(1) 1226(1) 34(1) 
C(49) 6638(2) 8835(1) 847(1) 39(1) 
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Table 27 Continued.  
Atom X Y Z U(eq) 
C(50) 5914(2) 8906(1) 424(1) 45(1) 
C(51) 5259(2) 8138(1) 368(1) 41(1) 
C(52) 5311(2) 7243(1) 735(1) 33(1) 
C(53) 7368(2) 9674(2) 915(1) 47(1) 
C(54) 7113(2) 9926(2) 1603(1) 55(1) 
C(55) 8590(2) 9352(2) 743(1) 74(1) 
C(56) 7148(3) 10606(2) 489(1) 89(1) 
C(57) 3881(2) 6407(1) 340(1) 35(1) 
C(58) 2630(2) 5254(2) 44(1) 36(1) 
C(59) 1982(2) 5945(2) -258(1) 46(1) 
C(60) 1245(2) 5636(2) -601(1) 50(1) 
C(61) 1143(2) 4655(2) -636(1) 47(1) 
C(62) 1753(2) 3955(2) -330(1) 47(1) 
C(63) 2491(2) 4260(2) 9(1) 42(1) 
O(1S) 4000(1) 5586(1) 3922(1) 54(1) 
C(1S) 4790(2) 6106(2) 3839(1) 47(1) 
C(2S) 4830(3) 7058(2) 3438(2) 93(1) 
C(3S) 5771(3) 5814(3) 4124(2) 109(1) 
O(2S) 4745(1) 4147(1) 1078(1) 57(1) 
C(4S) 4859(2) 3287(2) 1265(1) 46(1) 
C(5S) 3985(3) 2574(2) 1256(1) 70(1) 
C(6S) 5857(2) 2914(2) 1512(1) 60(1) 
O(3S) 7277(3) 2377(2) 5407(1) 150(1) 
C(7S) 7904(2) 2764(2) 4957(1) 66(1) 
C(8S) 8870(2) 2230(2) 4621(2) 78(1) 
C(9S) 7743(2) 3799(2) 4707(1) 63(1) 
O(4S) -937(2) 2035(2) 1291(2) 124(1) 
C(10S) -72(3) 1705(2) 1415(1) 72(1) 
C(11S) 1002(3) 2210(3) 1161(2) 118(1) 
C(12S) -19(3) 824(2) 1873(1) 81(1) 
 
 
Table 28. Bond lengths for 2•Acetone. 
Atoms Å Atoms Å
O(1)-C(19)  1.213(2) 
O(2)-N(3)  1.230(3) 
O(3)-N(3)  1.227(3) 
O(4)-C(38)  1.212(2) 
O(5)-N(6)  1.223(2) 
O(6)-N(6)  1.225(2) 
O(7)-C(57)  1.214(2) 
O(8)-N(9)  1.225(3) 
O(9)-N(9)  1.228(3) 
N(1)-C(19)  1.371(2) 
N(1)-C(14)  1.409(2) 
N(1)-H(1N)  0.89(2) 
N(2)-C(19)  1.377(2) 
N(2)-C(20)  1.399(2) 
N(2)-H(2N)  0.86(2) 
N(3)-C(23)  1.462(3) 
N(4)-C(38)  1.366(2) 
N(4)-C(33)  1.403(2) 
 
N(4)-H(4N)  0.86(2) 
N(5)-C(38)  1.374(2) 
N(5)-C(39)  1.394(2) 
N(5)-H(5N)  0.90(2) 
N(6)-C(42)  1.455(2) 
N(7)-C(57)  1.371(2) 
N(7)-C(52)  1.408(2) 
N(7)-H(7N)  0.87(2) 
N(8)-C(57)  1.378(3) 
N(8)-C(58)  1.394(2) 
N(8)-H(8N)  0.84(2) 
N(9)-C(61)  1.457(3) 
C(1)-C(6)  1.394(2) 
C(1)-C(2)  1.395(2) 
C(1)-C(7)  1.434(2) 
C(2)-C(3)  1.394(2) 
C(2)-H(2B)  0.9500 
C(3)-C(4)  1.398(2) 
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Table 28 Continued.  
Atoms Å Atoms Å
C(3)-C(26)  1.433(2) 
C(4)-C(5)  1.394(2) 
C(4)-H(4B)  0.9500 
C(5)-C(6)  1.395(2) 
C(5)-C(45)  1.430(2) 
C(6)-H(6A)  0.9500 
C(7)-C(8)  1.195(2) 
C(8)-C(9)  1.431(2) 
C(9)-C(10)  1.391(2) 
C(9)-C(14)  1.406(2) 
C(10)-C(11)  1.388(2) 
C(10)-H(10A)  0.9500 
C(11)-C(12)  1.386(3) 
C(11)-C(15)  1.534(3) 
C(12)-C(13)  1.384(3) 
C(12)-H(12A)  0.9500 
C(13)-C(14)  1.389(2) 
C(13)-H(13A)  0.9500 
C(15)-C(16)  1.521(3) 
C(15)-C(18)  1.527(3) 
C(15)-C(17)  1.533(3) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(16C)  0.9800 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(20)-C(25)  1.393(3) 
C(20)-C(21)  1.392(3) 
C(21)-C(22)  1.380(3) 
C(21)-H(21A)  0.9500 
C(22)-C(23)  1.369(3) 
C(22)-H(22A)  0.9500 
C(23)-C(24)  1.373(3) 
C(24)-C(25)  1.372(3) 
C(24)-H(24A)  0.9500 
C(25)-H(25A)  0.9500 
C(26)-C(27)  1.199(2) 
C(27)-C(28)  1.433(2) 
C(28)-C(29)  1.393(2) 
C(28)-C(33)  1.406(2) 
C(29)-C(30)  1.390(2) 
C(29)-H(29A)  0.9500 
C(30)-C(31)  1.393(2) 
C(30)-C(34)  1.533(2) 
C(31)-C(32)  1.383(2) 
C(31)-H(31A)  0.9500 
C(32)-C(33)  1.391(2) 
C(32)-H(32A)  0.9500 
C(34)-C(35)  1.525(3) 
C(34)-C(37)  1.527(3) 
C(34)-C(36)  1.528(3) 
C(35)-H(35A)  0.9800 
C(35)-H(35B)  0.9800 
C(35)-H(35C)  0.9800 
C(36)-H(36A)  0.9800 
C(36)-H(36B)  0.9800 
C(36)-H(36C)  0.9800 
C(37)-H(37A)  0.9800 
C(37)-H(37B)  0.9800 
C(37)-H(37C)  0.9800 
C(39)-C(44)  1.391(2) 
C(39)-C(40)  1.395(3) 
C(40)-C(41)  1.381(3) 
C(40)-H(40A)  0.9500 
C(41)-C(42)  1.376(3) 
C(41)-H(41A)  0.9500 
C(42)-C(43)  1.381(3) 
C(43)-C(44)  1.380(2) 
C(43)-H(43A)  0.9500 
C(44)-H(44A)  0.9500 
C(45)-C(46)  1.197(2) 
C(46)-C(47)  1.434(2) 
C(47)-C(48)  1.392(3) 
C(47)-C(52)  1.406(2) 
C(48)-C(49)  1.390(2) 
C(48)-H(48A)  0.9500 
C(49)-C(50)  1.386(3) 
C(49)-C(53)  1.526(3) 
C(50)-C(51)  1.382(3) 
C(50)-H(50A)  0.9500 
C(51)-C(52)  1.389(2) 
C(51)-H(51A)  0.9500 
C(53)-C(54)  1.526(3) 
C(53)-C(56)  1.532(3) 
C(53)-C(55)  1.533(4) 
C(54)-H(54A)  0.9800 
C(54)-H(54B)  0.9800 
C(54)-H(54C)  0.9800 
C(55)-H(55A)  0.9800 
C(55)-H(55B)  0.9800 
C(55)-H(55C)  0.9800 
C(56)-H(56A)  0.9800 
C(56)-H(56B)  0.9800 
C(56)-H(56C)  0.9800 
C(58)-C(63)  1.396(3) 
C(58)-C(59)  1.399(3) 
C(59)-C(60)  1.383(3) 
C(59)-H(59A)  0.9500 
C(60)-C(61)  1.370(3) 
C(60)-H(60A)  0.9500 
C(61)-C(62)  1.380(3) 
C(62)-C(63)  1.375(3) 
C(62)-H(62A)  0.9500 
C(63)-H(63A)  0.9500 
O(1S)-C(1S)  1.202(2) 
C(1S)-C(3S)  1.477(4) 
C(1S)-C(2S)  1.478(4) 
C(2S)-H(2SA)  0.9800 
C(2S)-H(2SB)  0.9800 
C(2S)-H(2SC)  0.9800 
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Table 28 Continued.  
Atoms Å Atoms Å
C(3S)-H(3SA)  0.9800 
C(3S)-H(3SB)  0.9800 
C(3S)-H(3SC)  0.9800 
O(2S)-C(4S)  1.214(2) 
C(4S)-C(6S)  1.479(3) 
C(4S)-C(5S)  1.488(3) 
C(5S)-H(5SA)  0.9800 
C(5S)-H(5SB)  0.9800 
C(5S)-H(5SC)  0.9800 
C(6S)-H(6SA)  0.9800 
C(6S)-H(6SB)  0.9800 
C(6S)-H(6SC)  0.9800 
O(3S)-C(7S)  1.198(3) 
C(7S)-C(8S)  1.475(4) 
C(7S)-C(9S)  1.480(4) 
C(8S)-H(8SA)  0.9800 
C(8S)-H(8SB)  0.9800 
C(8S)-H(8SC)  0.9800 
C(9S)-H(9SA)  0.9800 
C(9S)-H(9SB)  0.9800 
C(9S)-H(9SC)  0.9800 
O(4S)-C(10S)  1.205(4) 
C(10S)-C(12S)  1.477(4) 
C(10S)-C(11S)  1.492(4) 
C(11S)-H(11A)  0.9800 
C(11S)-H(11B)  0.9800 
C(11S)-H(11C)  0.9800 
C(12S)-H(12B)  0.9800 
C(12S)-H(12C)  0.9800 
C(12S)-H(12D)  0.9800 
 
 
Table 29. Bond angles for 2•Acetone. 









































































Table 29 Continued.  





















































































































Table 29 Continued.  
























































































































Table 30. Torsion angles for 2•Acetone. 





















































































































Table 30 Continued.  








































Table 31. Anisotropic displacement parameters (Å2 x 103) for 2•Acetone. The 
anisotropic displacement factor exponent takes the form: -2p2[h2a*2U11 + ... + 
2hka*b*U12]. 
Atom U11 U22 U33 U23 U13 U12
O(1) 34(1)  38(1) 70(1)  -3(1) -22(1)  -5(1) 
O(2) 78(1)  49(1) 145(2)  -6(1) -21(1)  -25(1) 
O(3) 147(2)  45(1) 91(2)  16(1) -25(2)  -28(1) 
O(4) 30(1)  48(1) 65(1)  22(1) -11(1)  -6(1) 
O(5) 70(1)  50(1) 77(1)  16(1) -28(1)  15(1) 
O(6) 70(1)  76(1) 105(2)  6(1) -60(1)  3(1) 
O(7) 65(1)  35(1) 52(1)  3(1) -34(1)  2(1) 
O(8) 88(2)  107(2) 110(2)  -36(1) -42(1)  -24(1) 
O(9) 55(1)  124(2) 56(1)  16(1) -25(1)  -27(1) 
N(1) 23(1)  32(1) 45(1)  0(1) -11(1)  -1(1) 
N(2) 32(1)  34(1) 39(1)  -2(1) -7(1)  -6(1) 
N(3) 76(2)  37(1) 79(2)  -4(1) 8(1)  -15(1) 
N(4) 25(1)  29(1) 40(1)  8(1) -2(1)  1(1) 
N(5) 26(1)  28(1) 42(1)  5(1) -9(1)  0(1) 
N(6) 51(1)  51(1) 50(1)  -3(1) -21(1)  14(1) 
N(7) 45(1)  29(1) 33(1)  3(1) -17(1)  2(1) 
N(8) 43(1)  36(1) 35(1)  2(1) -15(1)  2(1) 
N(9) 42(1)  100(2) 41(1)  -5(1) -5(1)  -22(1) 
C(1) 22(1)  26(1) 29(1)  1(1) -7(1)  -1(1) 
C(2) 27(1)  23(1) 30(1)  5(1) -8(1)  -1(1) 
C(3) 21(1)  24(1) 29(1)  1(1) -6(1)  -3(1) 
C(4) 20(1)  27(1) 29(1)  0(1) -8(1)  0(1) 
C(5) 26(1)  24(1) 25(1)  2(1) -9(1)  -1(1) 
C(6) 23(1)  30(1) 28(1)  5(1) -3(1)  -4(1) 
C(7) 27(1)  26(1) 33(1)  5(1) -6(1)  -3(1) 
C(8) 25(1)  26(1) 34(1)  1(1) -5(1)  -2(1) 
C(9) 22(1)  31(1) 33(1)  -5(1) -8(1)  2(1) 
C(10) 26(1)  32(1) 37(1)  -3(1) -7(1)  0(1) 
C(11) 30(1)  31(1) 37(1)  -6(1) -12(1)  6(1) 
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Atom U11 U22 U33 U23 U13 U12
C(12) 26(1)  37(1) 50(1)  -7(1) -16(1)  7(1) 
C(13) 23(1)  36(1) 51(1)  -7(1) -11(1)  -1(1) 
C(14) 25(1)  30(1) 35(1)  -6(1) -8(1)  2(1) 
C(15) 42(1)  32(1) 46(1)  -3(1) -19(1)  8(1) 
C(16) 67(2)  37(1) 73(2)  -10(1) -31(1)  5(1) 
C(17) 73(2)  49(1) 50(1)  6(1) -17(1)  7(1) 
C(18) 52(1)  46(1) 90(2)  3(1) -33(1)  15(1) 
C(19) 25(1)  33(1) 35(1)  -6(1) -2(1)  -2(1) 
C(20) 33(1)  33(1) 35(1)  -4(1) 5(1)  -4(1) 
C(21) 31(1)  36(1) 67(1)  -7(1) -4(1)  -2(1) 
C(22) 36(1)  39(1) 80(2)  -13(1) 1(1)  -7(1) 
C(23) 51(1)  35(1) 53(1)  -5(1) 11(1)  -12(1) 
C(24) 73(2)  38(1) 45(1)  7(1) -5(1)  -6(1) 
C(25) 60(1)  40(1) 39(1)  3(1) -8(1)  -10(1) 
C(26) 23(1)  24(1) 34(1)  4(1) -7(1)  1(1) 
C(27) 25(1)  24(1) 33(1)  3(1) -7(1)  0(1) 
C(28) 24(1)  25(1) 28(1)  -1(1) -2(1)  -2(1) 
C(29) 24(1)  25(1) 32(1)  1(1) -2(1)  1(1) 
C(30) 30(1)  25(1) 27(1)  -1(1) -3(1)  -2(1) 
C(31) 30(1)  33(1) 29(1)  2(1) 4(1)  0(1) 
C(32) 29(1)  33(1) 33(1)  -1(1) 2(1)  7(1) 
C(33) 28(1)  24(1) 29(1)  1(1) -5(1)  1(1) 
C(34) 33(1)  28(1) 34(1)  6(1) 0(1)  1(1) 
C(35) 44(1)  41(1) 76(2)  22(1) 10(1)  -3(1) 
C(36) 75(2)  49(1) 48(1)  7(1) -24(1)  8(1) 
C(37) 61(1)  29(1) 50(1)  7(1) 8(1)  8(1) 
C(38) 30(1)  28(1) 34(1)  1(1) -5(1)  2(1) 
C(39) 30(1)  28(1) 27(1)  -3(1) -3(1)  5(1) 
C(40) 37(1)  29(1) 38(1)  -3(1) -9(1)  -1(1) 
C(41) 35(1)  42(1) 42(1)  -6(1) -16(1)  1(1) 
C(42) 37(1)  37(1) 33(1)  -4(1) -11(1)  10(1) 
C(43) 38(1)  28(1) 33(1)  -1(1) -4(1)  5(1) 
C(44) 29(1)  29(1) 36(1)  -2(1) -6(1)  1(1) 
C(45) 25(1)  31(1) 29(1)  2(1) -9(1)  -2(1) 
C(46) 29(1)  31(1) 29(1)  1(1) -8(1)  0(1) 
C(47) 36(1)  29(1) 24(1)  2(1) -7(1)  5(1) 
C(48) 43(1)  31(1) 30(1)  3(1) -13(1)  2(1) 
C(49) 56(1)  29(1) 33(1)  3(1) -16(1)  0(1) 
C(50) 74(2)  29(1) 37(1)  7(1) -26(1)  -1(1) 
C(51) 60(1)  33(1) 35(1)  3(1) -24(1)  3(1) 
C(52) 43(1)  29(1) 27(1)  -1(1) -10(1)  4(1) 
C(53) 67(2)  33(1) 43(1)  7(1) -22(1)  -8(1) 
C(54) 64(2)  49(1) 59(2)  -10(1) -26(1)  -3(1) 
C(55) 71(2)  62(2) 82(2)  -12(1) 7(2)  -26(1) 
C(56) 159(3)  42(1) 82(2)  22(1) -74(2)  -35(2) 
C(57) 42(1)  34(1) 28(1)  -3(1) -9(1)  3(1) 
C(58) 34(1)  44(1) 29(1)  -1(1) -4(1)  -2(1) 
C(59) 43(1)  47(1) 49(1)  5(1) -14(1)  -4(1) 
C(60) 38(1)  67(2) 45(1)  12(1) -12(1)  -8(1) 
C(61) 34(1)  74(2) 31(1)  -2(1) -2(1)  -17(1) 
C(62) 42(1)  55(1) 43(1)  -11(1) -2(1)  -8(1) 
C(63) 39(1)  46(1) 40(1)  -4(1) -7(1)  0(1) 
O(1S) 41(1)  47(1) 73(1)  -17(1) -1(1)  -10(1) 
C(1S) 42(1)  50(1) 51(1)  -21(1) -4(1)  -8(1) 
C(2S) 98(2)  73(2) 97(2)  4(2) 7(2)  -28(2) 
C(3S) 89(2)  126(3) 141(3)  -59(3) -69(2)  15(2) 
O(2S) 73(1)  37(1) 63(1)  4(1) -23(1)  3(1) 
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Atom U11 U22 U33 U23 U13 U12
C(4S) 67(2)  37(1) 33(1)  -2(1) -10(1)  0(1) 
C(5S) 98(2)  63(2) 51(2)  1(1) -16(1)  -29(2) 
C(6S) 84(2)  54(1) 45(1)  -9(1) -24(1)  19(1) 
O(3S) 195(3)  85(2) 119(2)  5(2) 82(2)  -8(2) 
C(7S) 83(2)  62(2) 51(2)  -11(1) 3(1)  -23(1) 
C(8S) 76(2)  51(2) 103(2)  -4(2) -5(2)  -11(1) 
C(9S) 67(2)  74(2) 46(1)  -9(1) -7(1)  3(1) 
O(4S) 127(2)  88(2) 173(3)  39(2) -87(2)  -39(2) 
C(10S) 96(2)  60(2) 66(2)  2(1) -29(2)  -25(2) 
C(11S) 106(3)  96(3) 127(3)  25(2) 17(2)  -19(2) 
C(12S) 92(2)  85(2) 70(2)  15(2) -35(2)  -31(2) 
 
 
Table 32. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 2•Acetone. 
Atom X Y Z U(eq) 
H(2B) 7132 2656 3533 32 
H(4B) 4860 4546 2897 30 
H(6A) 8112 4726 2046 33 
H(10A) 10469 1395 3334 38 
H(12A) 13723 1852 3171 44 
H(13A) 13529 3399 2650 43 
H(16A) 12201 -347 2885 85 
H(16B) 10989 -187 3302 85 
H(16C) 11822 -995 3556 85 
H(17A) 10770 605 4318 87 
H(17B) 11856 890 4560 87 
H(17C) 11570 -238 4566 87 
H(18A) 13871 127 3273 92 
H(18B) 13445 -513 3941 92 
H(18C) 13718 620 3925 92 
H(21A) 13624 6633 2322 54 
H(22A) 14142 8272 2155 63 
H(24A) 11780 8939 1106 64 
H(25A) 11226 7317 1283 56 
H(29A) 4310 1290 5127 33 
H(31A) 1172 1579 6082 39 
H(32A) 948 3038 5465 40 
H(35A) 1411 -295 6091 88 
H(35B) 1366 329 6682 88 
H(35C) 1939 -740 6690 88 
H(36A) 4248 844 6414 85 
H(36B) 3657 -52 6884 85 
H(36C) 3082 1016 6878 85 
H(37A) 3232 -603 5379 76 
H(37B) 3718 -1035 5994 76 
H(37C) 4342 -167 5512 76 
H(40A) -238 4681 3687 41 
H(41A) -1396 5640 3111 46 
H(43A) 635 7944 2922 41 
H(44A) 1783 6998 3509 38 
H(48A) 7143 7875 1527 41 
H(50A) 5866 9506 161 54 
H(51A) 4767 8224 75 50 
H(54A) 7256 9348 1890 82 
 
 218 
Table 32 Continued.  
Atom X Y Z U(eq) 
H(54B) 6332 10131 1716 82 
H(54C) 7589 10460 1646 82 
H(55A) 8723 8760 1021 110 
H(55B) 9064 9877 803 110 
H(55C) 8765 9213 297 110 
H(56A) 6366 10806 603 133 
H(56B) 7319 10475 41 133 
H(56C) 7620 11131 550 133 
H(59A) 2048 6624 -228 55 
H(60A) 809 6102 -812 60 
H(62A) 1663 3277 -353 56 
H(63A) 2915 3786 222 51 
H(2SA) 4136 7169 3278 140 
H(2SB) 5457 7052 3077 140 
H(2SC) 4922 7585 3694 140 
H(3SA) 5644 5175 4379 164 
H(3SB) 5894 6304 4399 164 
H(3SC) 6426 5767 3783 164 
H(5SA) 3372 2915 1086 105 
H(5SB) 3706 2272 1692 105 
H(5SC) 4300 2064 985 105 
H(6SA) 6361 3456 1493 90 
H(6SB) 6236 2415 1250 90 
H(6SC) 5636 2624 1955 90 
H(8SA) 8890 1556 4827 117 
H(8SB) 9553 2559 4639 117 
H(8SC) 8807 2218 4174 117 
H(9SA) 7080 4076 4966 94 
H(9SB) 7647 3832 4263 94 
H(9SC) 8394 4174 4727 94 
H(11A) 882 2781 863 176 
H(11B) 1537 1756 938 176 
H(11C) 1293 2423 1515 176 
H(12B) -755 531 1999 121 
H(12C) 219 1008 2252 121 
H(12D) 514 347 1672 121 
H(1N) 11066(19) 4351(15) 2190(10) 47(6) 
H(2N) 11436(18) 5741(15) 1729(10) 43(6) 
H(4N) 3034(18) 4151(15) 4301(10) 44(6) 
H(5N) 2342(19) 5444(15) 3899(10) 45(6) 
H(7N) 4861(16) 5875(15) 905(10) 37(6) 




Table 33. Crystal data and structure refinement for 2•DMSO. 
Identification code  mh82 
Empirical formula  C75 H81 N9 O13 
Formula weight  1316.49 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
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Unit cell dimensions a = 12.2820(17) Å a= 83.428(2)°. 
 b = 13.7330(19) Å b= 78.604(2)°. 
 c = 21.485(3) Å g = 87.611(2)°. 
Volume 3528.4(8) Å3 
Z 2 
Density (calculated) 1.239 Mg/m3 
Absorption coefficient 0.086 mm-1 
F(000) 1396 
Crystal size 0.42 x 0.27 x 0.18 mm3 
Theta range for data collection 1.49 to 27.00°. 
Index ranges -15<=h<=15, -17<=k<=17, -27<=l<=27 
Reflections collected 39977 
Independent reflections 15274 [R(int) = 0.0363] 
Completeness to theta = 27.00° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9847 and 0.9649 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 15274 / 0 / 898 
Goodness-of-fit on F2 1.019 
Final R indices [I>2sigma(I)] R1 = 0.0540, wR2 = 0.1325 
R indices (all data) R1 = 0.0804, wR2 = 0.1512 




Table 34. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for 2•DMSO. U(eq) is defined as one third of the trace of the orthogonalized 
Uij tensor. 
Atom X Y Z U(eq)
O(1) -6508(2) 5447(2) 2601(1) 45(1) 
O(2) -7565(3) 10308(2) 1963(2) 81(1) 
O(3) -5854(3) 10861(2) 1567(2) 75(1) 
O(4) 4656(2) 3787(2) 4657(1) 60(1) 
O(5) 7613(2) 8331(2) 2469(2) 72(1) 
O(6) 8712(2) 7165(2) 2748(2) 72(1) 
O(7) 5778(2) 5917(2) 492(1) 48(1) 
O(8) 8550(3) 1366(3) 1569(2) 86(1) 
O(9) 9584(3) 2321(2) 714(2) 84(1) 
N(1) -4800(2) 4746(2) 2362(1) 36(1) 
N(2) -4938(2) 6393(2) 2034(1) 37(1) 
N(3) -6550(3) 10184(2) 1797(2) 58(1) 
N(4) 2848(2) 3733(2) 4579(1) 40(1) 
N(5) 3961(3) 5086(2) 4042(1) 39(1) 
N(6) 7770(3) 7497(2) 2756(2) 55(1) 
N(7) 3859(2) 5774(2) 850(1) 38(1) 
N(8) 4923(3) 4418(2) 917(1) 41(1) 
N(9) 8668(3) 2073(3) 1112(2) 64(1) 
C(1) -1202(2) 3892(2) 2843(1) 31(1) 
C(2) -737(2) 3388(2) 3336(2) 30(1) 
C(3) 314(2) 3662(2) 3379(1) 31(1) 
C(4) 923(3) 4425(2) 2899(2) 33(1) 
C(5) 479(2) 4918(2) 2392(2) 32(1) 
C(6) -596(2) 4666(2) 2371(2) 34(1) 
C(7) -2305(3) 3631(2) 2824(2) 34(1) 
C(8) -3244(3) 3415(2) 2843(2) 34(1) 
C(9) -4373(2) 3112(2) 2897(2) 34(1) 
C(10) -4702(3) 2146(3) 3184(2) 38(1) 
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Atom X Y Z U(eq) 
C(11) -5781(3) 1791(2) 3258(2) 39(1) 
C(12) -6513(3) 2461(3) 3008(2) 43(1) 
C(13) -6210(3) 3419(3) 2711(2) 39(1) 
C(14) -5143(2) 3774(2) 2663(2) 34(1) 
C(15) -6112(3) 736(3) 3606(2) 47(1) 
C(16) -5344(4) 75(3) 3262(3) 62(1) 
C(17) -6017(5) 585(4) 4308(2) 69(1) 
C(18) -7340(4) 512(3) 3635(3) 68(2) 
C(16A) -7000(20) 594(19) 4215(15) 62(1) 
C(17A) -6500(30) 230(20) 3133(14) 69(1) 
C(18A) -5090(20) 30(19) 3756(17) 68(2) 
C(19) -5499(3) 5521(2) 2352(2) 34(1) 
C(20) -5391(3) 7315(2) 1983(1) 36(1) 
C(21) -6544(3) 7487(3) 2159(2) 45(1) 
C(22) -6915(3) 8427(3) 2095(2) 50(1) 
C(23) -6153(3) 9192(3) 1863(2) 46(1) 
C(24) -5014(3) 9043(3) 1686(2) 50(1) 
C(25) -4639(3) 8112(3) 1745(2) 45(1) 
C(26) 751(2) 3177(2) 3918(2) 36(1) 
C(27) 1094(3) 2793(2) 4377(2) 35(1) 
C(28) 1568(2) 2359(2) 4909(2) 34(1) 
C(29) 1130(3) 1481(2) 5341(2) 39(1) 
C(30) 1577(3) 1031(2) 5852(2) 39(1) 
C(31) 2493(3) 1506(3) 5920(2) 44(1) 
C(32) 2939(3) 2380(3) 5508(2) 41(1) 
C(33) 2480(3) 2826(2) 4997(2) 35(1) 
C(34) 1072(3) 80(3) 6336(2) 50(1) 
C(35) 1971(4) -557(3) 6567(3) 90(2) 
C(36) 234(5) 322(4) 6913(3) 120(3) 
C(37) 474(5) -519(3) 6023(3) 94(2) 
C(38) 3886(3) 4168(2) 4442(2) 39(1) 
C(39) 4923(3) 5670(2) 3760(2) 36(1) 
C(40) 6004(3) 5287(3) 3653(2) 42(1) 
C(41) 6923(3) 5890(3) 3332(2) 45(1) 
C(42) 6784(3) 6874(2) 3117(2) 42(1) 
C(43) 5728(3) 7273(3) 3227(2) 43(1) 
C(44) 4803(3) 6670(2) 3550(2) 39(1) 
C(45) 1134(2) 5683(2) 1892(2) 35(1) 
C(46) 1721(3) 6292(2) 1475(2) 38(1) 
C(47) 2468(3) 7009(2) 984(2) 36(1) 
C(48) 2118(3) 7963(2) 815(2) 40(1) 
C(49) 2795(3) 8681(2) 346(2) 41(1) 
C(50) 3854(3) 8401(3) 54(2) 46(1) 
C(51) 4241(3) 7475(3) 214(2) 43(1) 
C(52) 3554(3) 6749(2) 681(2) 36(1) 
C(53) 2392(3) 9722(2) 133(2) 49(1) 
C(54) 1333(3) 9938(3) 622(2) 69(1) 
C(55) 2124(4) 9828(3) -524(2) 67(1) 
C(56) 3317(3) 10461(2) 62(2) 54(1) 
C(57) 4925(3) 5414(2) 730(2) 37(1) 
C(58) 5859(3) 3838(2) 939(2) 41(1) 
C(59) 6931(3) 4130(3) 534(2) 51(1) 
C(60) 7832(3) 3539(3) 578(2) 56(1) 
C(61) 7682(3) 2655(3) 1037(2) 51(1) 
C(62) 6625(3) 2328(3) 1420(2) 51(1) 
C(63) 5718(3) 2912(3) 1359(2) 46(1) 
S(1S) 1717(1) 3387(1) 1250(1) 40(1) 
O(1S) 2623(2) 3859(2) 1425(1) 49(1) 
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Atom X Y Z U(eq) 
C(1S) 2415(4) 2601(3) 761(2) 47(1) 
C(2S) 1077(4) 2470(3) 1949(2) 49(1) 
S(2S) 8018(1) 6793(1) 984(1) 52(1) 
O(2S) 7451(2) 6200(2) 1651(1) 56(1) 
C(3S) 8878(4) 5983(3) 586(2) 81(1) 
C(4S) 9114(3) 7468(3) 1083(2) 61(1) 
S(3S) 628(2) 6185(2) 4225(1) 50(1) 
O(3S) 1642(2) 5500(2) 4106(1) 60(1) 
C(5S) 1005(8) 7327(6) 3824(4) 42(2) 
C(6S) -571(14) 5614(12) 4199(8) 56(4) 
S(3SA) 999(1) 6115(1) 3672(1) 44(1) 
O(3SA) 1642(2) 5500(2) 4106(1) 60(1) 
C(5SA) 895(10) 7105(8) 3553(6) 118(4) 
C(6SA) -436(10) 5801(8) 4093(6) 67(4) 
S(4S) 7316(2) 2355(1) 5078(1) 111(1) 
O(4S) 7263(5) 2066(4) 5711(3) 76(2) 
O(4SA) 8196(6) 1878(5) 4986(3) 92(2) 
C(7S) 6369(5) 2078(3) 4668(3) 86(2) 




Table 35. Bond lengths for 2•DMSO. 
Atoms Å Atoms Å
O(1)-C(19)  1.216(4) 
O(2)-N(3)  1.223(4) 
O(3)-N(3)  1.230(4) 
O(4)-C(38)  1.214(4) 
O(5)-N(6)  1.229(4) 
O(6)-N(6)  1.228(4) 
O(7)-C(57)  1.214(4) 
O(8)-N(9)  1.215(4) 
O(9)-N(9)  1.236(4) 
N(1)-C(19)  1.367(4) 
N(1)-C(14)  1.403(4) 
N(1)-H(1N)  0.77(3) 
N(2)-C(19)  1.373(4) 
N(2)-C(20)  1.389(4) 
N(2)-H(2N)  0.79(4) 
N(3)-C(23)  1.456(5) 
N(4)-C(38)  1.367(4) 
N(4)-C(33)  1.398(4) 
N(4)-H(4N)  0.81(4) 
N(5)-C(38)  1.371(4) 
N(5)-C(39)  1.384(4) 
N(5)-H(5N)  0.78(3) 
N(6)-C(42)  1.457(4) 
N(7)-C(57)  1.370(4) 
N(7)-C(52)  1.402(4) 
N(7)-H(7N)  0.81(3) 
N(8)-C(57)  1.370(4) 
N(8)-C(58)  1.390(4) 
N(8)-H(8N)  0.74(4) 
N(9)-C(61)  1.458(5) 
C(1)-C(2)  1.384(4) 
C(1)-C(6)  1.393(4) 
C(1)-C(7)  1.432(4) 
C(2)-C(3)  1.395(4) 
C(2)-H(2)  0.92(3) 
C(3)-C(4)  1.393(4) 
C(3)-C(26)  1.433(4) 
C(4)-C(5)  1.387(4) 
C(4)-H(4)  0.87(3) 
C(5)-C(6)  1.396(4) 
C(5)-C(45)  1.435(4) 
C(6)-H(6)  0.92(3) 
C(7)-C(8)  1.193(4) 
C(8)-C(9)  1.434(4) 
C(9)-C(10)  1.388(4) 
C(9)-C(14)  1.407(4) 
C(10)-C(11)  1.391(4) 
C(10)-H(10)  0.90(3) 
C(11)-C(12)  1.394(5) 
C(11)-C(15)  1.521(5) 
C(12)-C(13)  1.374(5) 
C(12)-H(12)  0.94(3) 
C(13)-C(14)  1.391(4) 
C(13)-H(13)  0.92(3) 
C(15)-C(16A)  1.46(3) 
C(15)-C(16)  1.500(6) 
C(15)-C(17)  1.538(6) 
C(15)-C(18)  1.536(5) 
C(15)-C(18A)  1.62(3) 
C(15)-C(17A)  1.57(3) 
C(16)-H(16A)  0.9800 
C(16)-H(16B)  0.9800 
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Atoms Å Atoms Å
C(16)-H(16C)  0.9800 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(16A)-H(16D)  0.9800 
C(16A)-H(16E)  0.9800 
C(16A)-H(16F)  0.9800 
C(17A)-H(17D)  0.9800 
C(17A)-H(17E)  0.9800 
C(17A)-H(17F)  0.9800 
C(18A)-H(18D)  0.9800 
C(18A)-H(18E)  0.9800 
C(18A)-H(18F)  0.9800 
C(20)-C(25)  1.395(5) 
C(20)-C(21)  1.396(5) 
C(21)-C(22)  1.378(5) 
C(21)-H(21)  0.95(3) 
C(22)-C(23)  1.369(5) 
C(22)-H(22)  0.91(3) 
C(23)-C(24)  1.373(5) 
C(24)-C(25)  1.368(5) 
C(24)-H(24)  0.95(4) 
C(25)-H(25)  0.91(4) 
C(26)-C(27)  1.193(4) 
C(27)-C(28)  1.432(4) 
C(28)-C(29)  1.397(4) 
C(28)-C(33)  1.403(4) 
C(29)-C(30)  1.381(5) 
C(29)-H(29)  0.91(3) 
C(30)-C(31)  1.392(5) 
C(30)-C(34)  1.535(5) 
C(31)-C(32)  1.379(5) 
C(31)-H(31)  0.92(3) 
C(32)-C(33)  1.387(4) 
C(32)-H(32)  0.94(3) 
C(34)-C(35)  1.508(5) 
C(34)-C(36)  1.516(6) 
C(34)-C(37)  1.527(6) 
C(35)-H(35A)  0.9800 
C(35)-H(35B)  0.9800 
C(35)-H(35C)  0.9800 
C(36)-H(36A)  0.9800 
C(36)-H(36B)  0.9800 
C(36)-H(36C)  0.9800 
C(37)-H(37A)  0.9800 
C(37)-H(37B)  0.9800 
C(37)-H(37C)  0.9800 
C(39)-C(44)  1.393(5) 
C(39)-C(40)  1.398(5) 
C(40)-C(41)  1.369(5) 
C(40)-H(40)  0.94(4) 
C(41)-C(42)  1.377(5) 
C(41)-H(41)  0.96(3) 
C(42)-C(43)  1.381(5) 
C(43)-C(44)  1.374(5) 
C(43)-H(43)  0.92(3) 
C(44)-H(44)  1.01(3) 
C(45)-C(46)  1.193(4) 
C(46)-C(47)  1.437(4) 
C(47)-C(48)  1.393(5) 
C(47)-C(52)  1.408(4) 
C(48)-C(49)  1.379(4) 
C(48)-H(48)  0.97(3) 
C(49)-C(50)  1.384(5) 
C(49)-C(53)  1.537(5) 
C(50)-C(51)  1.372(5) 
C(50)-H(50)  0.88(3) 
C(51)-C(52)  1.388(4) 
C(51)-H(51)  0.90(3) 
C(53)-C(56)  1.530(5) 
C(53)-C(54)  1.533(5) 
C(53)-C(55)  1.533(5) 
C(54)-H(54A)  0.9800 
C(54)-H(54B)  0.9800 
C(54)-H(54C)  0.9800 
C(55)-H(55A)  0.9800 
C(55)-H(55B)  0.9800 
C(55)-H(55C)  0.9800 
C(56)-H(56A)  0.9800 
C(56)-H(56B)  0.9800 
C(56)-H(56C)  0.9800 
C(58)-C(63)  1.395(5) 
C(58)-C(59)  1.397(5) 
C(59)-C(60)  1.370(5) 
C(59)-H(59)  1.01(3) 
C(60)-C(61)  1.387(5) 
C(60)-H(60)  0.95(5) 
C(61)-C(62)  1.379(5) 
C(62)-C(63)  1.376(5) 
C(62)-H(62)  0.93(4) 
C(63)-H(63)  0.93(3) 
S(1S)-O(1S)  1.498(2) 
S(1S)-C(2S)  1.773(4) 
S(1S)-C(1S)  1.780(4) 
C(1S)-H(1SA)  0.94(4) 
C(1S)-H(1SB)  1.00(4) 
C(1S)-H(1SC)  0.96(4) 
C(2S)-H(2SA)  0.94(4) 
C(2S)-H(2SB)  0.91(4) 
C(2S)-H(2SC)  0.92(4) 
S(2S)-O(2S)  1.502(2) 
S(2S)-C(3S)  1.767(5) 
S(2S)-C(4S)  1.769(4) 
C(3S)-H(3SA)  0.9800 
C(3S)-H(3SB)  0.9800 
C(3S)-H(3SC)  0.9800 
C(4S)-H(4SA)  0.9800 
C(4S)-H(4SB)  0.9800 
C(4S)-H(4SC)  0.9800 
S(3S)-O(3S)  1.557(3) 
S(3S)-C(5S)  1.661(9) 
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Atoms Å Atoms Å
S(3S)-C(6S)  1.728(16) 
C(5S)-H(5SA)  0.9800 
C(5S)-H(5SB)  0.9800 
C(5S)-H(5SC)  0.9800 
C(6S)-H(6SA)  0.9800 
C(6S)-H(6SB)  0.9800 
C(6S)-H(6SC)  0.9800 
S(3SA)-C(5SA)  1.371(12) 
S(3SA)-C(6SA)  1.783(11) 
C(5SA)-H(5SD)  0.9800 
C(5SA)-H(5SE)  0.9800 
C(5SA)-H(5SF)  0.9800 
C(6SA)-H(6SD)  0.9800 
C(6SA)-H(6SE)  0.9800 
C(6SA)-H(6SF)  0.9800 
S(4S)-O(4SA)  1.249(7) 
S(4S)-O(4S)  1.335(6) 
S(4S)-C(7S)  1.752(5) 
S(4S)-C(8S)  1.764(4) 
O(4S)-O(4SA)  1.778(9) 
C(7S)-H(7SA)  0.9800 
C(7S)-H(7SB)  0.9800 
C(7S)-H(7SC)  0.9800 
C(8S)-H(8SA)  0.9800 
C(8S)-H(8SB)  0.9800 
C(8S)-H(8SC)  0.9800 
 
 
Table 36. Bond angles for 2•DMSO. 















































































Table 36 Continued.  





















































































































Table 36 Continued.  





















































































































Table 36 Continued.  



















































Table 37. Torsion angles for 2•DMSO. 























































Table 37 Continued.  


















































































































Table 38. Anisotropic displacement parameters (Å2 x 103) for 2•DMSO. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2a*2U11 + ... + 2hka*b*U12 ]. 
Atom U11 U22 U33 U23 U13 U12 
O(1) 27(1)  42(1) 61(2)  -7(1) -8(1)  -2(1) 
O(2) 69(2)  52(2) 110(3)  -8(2) -16(2)  17(2) 
O(3) 82(2)  42(2) 91(2)  2(2) -23(2)  -4(2) 
O(4) 41(1)  58(2) 74(2)  16(1) -28(1)  -11(1) 
O(5) 70(2)  57(2) 75(2)  6(2) -11(2)  -19(2) 
O(6) 43(2)  78(2) 85(2)  -7(2) -10(2)  -12(2) 
O(7) 33(1)  47(1) 57(2)  -8(1) -2(1)  -11(1) 
O(8) 91(2)  78(2) 86(2)  -7(2) -32(2)  27(2) 
O(9) 45(2)  76(2) 122(3)  -18(2) -13(2)  8(2) 
N(1) 22(2)  43(2) 44(2)  -13(1) -6(1)  -4(1) 
N(2) 26(2)  44(2) 39(2)  -10(1) -4(1)  -2(1) 
N(3) 69(2)  45(2) 56(2)  -2(2) -19(2)  7(2) 
N(4) 34(2)  40(2) 44(2)  1(1) -18(1)  -3(1) 
N(5) 33(2)  38(2) 45(2)  -4(1) -14(1)  -1(1) 
N(6) 53(2)  56(2) 52(2)  -7(2) -10(2)  -15(2) 
N(7) 32(2)  38(2) 40(2)  -2(1) -4(1)  -9(1) 
N(8) 30(2)  41(2) 48(2)  -9(1) -7(1)  -7(1) 
N(9) 59(2)  58(2) 80(3)  -21(2) -22(2)  12(2) 
C(1) 22(2)  32(2) 39(2)  -8(1) -8(1)  1(1) 
C(2) 24(2)  30(2) 34(2)  -4(1) -3(1)  -3(1) 
C(3) 24(2)  32(2) 35(2)  -6(1) -7(1)  3(1) 
C(4) 20(2)  36(2) 44(2)  -10(1) -8(1)  -2(1) 
C(5) 25(2)  30(2) 37(2)  -7(1) -4(1)  1(1) 
C(6) 25(2)  37(2) 37(2)  -6(2) -9(1)  2(1) 
C(7) 30(2)  34(2) 37(2)  -5(1) -10(1)  -1(1) 
C(8) 29(2)  35(2) 37(2)  -7(1) -10(1)  3(1) 
C(9) 23(2)  43(2) 37(2)  -13(1) -8(1)  -5(1) 
C(10) 32(2)  44(2) 41(2)  -13(2) -13(2)  3(2) 
C(11) 33(2)  43(2) 42(2)  -14(2) -5(1)  -9(2) 
C(12) 27(2)  50(2) 57(2)  -22(2) -10(2)  -3(2) 
C(13) 29(2)  42(2) 51(2)  -17(2) -13(2)  3(2) 
C(14) 25(2)  39(2) 38(2)  -14(1) -7(1)  -1(1) 
C(15) 40(2)  43(2) 55(2)  -11(2) -9(2)  -8(2) 
C(16) 55(3)  43(3) 94(4)  -29(3) -17(3)  -2(2) 
C(17) 84(4)  49(3) 65(3)  2(2) -15(3)  -18(3) 
C(18) 47(3)  44(3) 105(4)  -13(3) -10(3)  -15(2) 
C(16A) 55(3)  43(3) 94(4)  -29(3) -17(3)  -2(2) 
C(17A) 84(4)  49(3) 65(3)  2(2) -15(3)  -18(3) 
C(18A) 47(3)  44(3) 105(4)  -13(3) -10(3)  -15(2) 
C(19) 29(2)  40(2) 34(2)  -8(1) -12(1)  -1(1) 
C(20) 38(2)  40(2) 30(2)  -7(1) -10(1)  -2(2) 
C(21) 36(2)  44(2) 54(2)  -9(2) -15(2)  -2(2) 
C(22) 38(2)  50(2) 58(2)  -6(2) -16(2)  4(2) 
C(23) 51(2)  44(2) 41(2)  -5(2) -13(2)  5(2) 
C(24) 60(2)  39(2) 45(2)  0(2) -9(2)  -7(2) 
C(25) 37(2)  48(2) 47(2)  -6(2) -6(2)  -3(2) 
C(26) 25(2)  37(2) 44(2)  -5(2) -9(1)  -4(1) 
C(27) 28(2)  36(2) 40(2)  -5(1) -8(1)  -3(1) 
C(28) 29(2)  36(2) 36(2)  -6(1) -10(1)  4(1) 
C(29) 27(2)  43(2) 48(2)  -8(2) -13(2)  0(2) 
C(30) 34(2)  37(2) 41(2)  -6(2) -5(1)  5(1) 
C(31) 43(2)  46(2) 41(2)  -1(2) -19(2)  2(2) 
C(32) 35(2)  47(2) 42(2)  -5(2) -14(2)  -5(2) 
C(33) 32(2)  35(2) 36(2)  -7(1) -10(1)  3(1) 
C(34) 48(2)  38(2) 57(2)  -1(2) -10(2)  1(2) 
C(35) 81(3)  53(3) 121(4)  22(3) -43(3)  5(2) 
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Atom U11 U22 U33 U23 U13 U12 
C(36) 139(5)  55(3) 102(4)  3(3) 65(4)  -18(3) 
C(37) 105(4)  55(3) 117(4)  22(3) -56(3)  -28(3) 
C(38) 36(2)  42(2) 40(2)  -9(2) -12(2)  -1(2) 
C(39) 39(2)  40(2) 31(2)  -10(1) -11(1)  -2(2) 
C(40) 44(2)  40(2) 42(2)  -14(2) -9(2)  0(2) 
C(41) 38(2)  48(2) 46(2)  -14(2) -7(2)  2(2) 
C(42) 45(2)  45(2) 36(2)  -10(2) -8(2)  -10(2) 
C(43) 54(2)  36(2) 40(2)  -5(2) -17(2)  -4(2) 
C(44) 42(2)  40(2) 36(2)  -7(2) -11(2)  0(2) 
C(45) 26(2)  34(2) 42(2)  -6(2) -7(1)  1(1) 
C(46) 30(2)  39(2) 43(2)  -7(2) -9(2)  -1(2) 
C(47) 36(2)  36(2) 35(2)  -5(1) -9(1)  -8(1) 
C(48) 34(2)  39(2) 44(2)  -10(2) -6(2)  -6(2) 
C(49) 45(2)  35(2) 42(2)  -6(2) -10(2)  -11(2) 
C(50) 44(2)  39(2) 43(2)  0(2) -1(2)  -13(2) 
C(51) 35(2)  43(2) 45(2)  -8(2) 0(2)  -6(2) 
C(52) 36(2)  40(2) 33(2)  -8(1) -8(1)  -8(1) 
C(53) 52(2)  35(2) 55(2)  -7(2) -10(2)  -6(2) 
C(54) 57(3)  38(2) 103(4)  -12(2) -8(2)  1(2) 
C(55) 77(3)  47(2) 79(3)  -7(2) -34(2)  -1(2) 
C(56) 64(2)  35(2) 57(2)  -7(2) -8(2)  -12(2) 
C(57) 34(2)  43(2) 32(2)  -8(1) -7(1)  -6(2) 
C(58) 38(2)  44(2) 43(2)  -16(2) -10(2)  -3(2) 
C(59) 39(2)  50(2) 58(2)  -6(2) -7(2)  -7(2) 
C(60) 37(2)  52(2) 73(3)  -12(2) -7(2)  -4(2) 
C(61) 40(2)  53(2) 64(2)  -23(2) -16(2)  6(2) 
C(62) 63(3)  44(2) 42(2)  -12(2) -7(2)  7(2) 
C(63) 46(2)  45(2) 44(2)  -15(2) 1(2)  -3(2) 
S(1S) 33(1)  32(1) 51(1)  -7(1) -8(1)  -1(1) 
O(1S) 39(1)  41(1) 68(2)  -16(1) -9(1)  -10(1) 
C(1S) 48(2)  46(2) 43(2)  -9(2) -4(2)  -1(2) 
C(2S) 47(2)  42(2) 50(2)  -12(2) 2(2)  -8(2) 
S(2S) 36(1)  66(1) 46(1)  -2(1) -9(1)  -3(1) 
O(2S) 36(1)  71(2) 48(2)  3(1) -5(1)  -7(1) 
C(3S) 98(4)  71(3) 65(3)  -21(2) 1(3)  -16(3) 
C(4S) 55(2)  53(2) 70(3)  -4(2) -16(2)  -11(2) 
S(3S) 46(1)  52(2) 52(2)  -14(1) -15(1)  11(1) 
O(3S) 53(2)  53(2) 75(2)  -14(1) -24(1)  18(1) 
S(3SA) 43(1)  44(1) 48(1)  -14(1) -14(1)  12(1) 
O(3SA) 53(2)  53(2) 75(2)  -14(1) -24(1)  18(1) 
S(4S) 209(2)  67(1) 92(1)  -30(1) -97(1)  47(1) 
C(7S) 114(4)  50(3) 95(4)  -17(2) -31(3)  -2(3) 
C(8S) 69(3)  61(3) 62(3)  -23(2) -27(2)  6(2) 
N(7) 45(1)  29(1) 33(1)  3(1) -17(1)  2(1) 
N(8) 43(1)  36(1) 35(1)  2(1) -15(1)  2(1) 
N(9) 42(1)  100(2) 41(1)  -5(1) -5(1)  -22(1) 
C(1) 22(1)  26(1) 29(1)  1(1) -7(1)  -1(1) 
 
 
Table 39. Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 
103) for 2•DMSO. 
Atom X Y Z U(eq) 
H(16A) -5540 77 2856 93 
H(16B) -5430 -587 3540 93 
H(16C) -4561 305 3164 93 
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Atom X Y Z U(eq) 
H(17A) -6621 931 4545 104 
H(17B) -5284 839 4303 104 
H(17C) -6086 -111 4521 104 
H(18A) -7704 1116 3474 101 
H(18B) -7746 215 4085 101 
H(18C) -7355 60 3364 101 
H(16D) -7652 976 4138 93 
H(16E) -6710 808 4537 93 
H(16F) -7217 -97 4377 93 
H(17D) -7127 587 2991 104 
H(17E) -6743 -441 3359 104 
H(17F) -5867 235 2754 104 
H(18D) -4743 260 4050 101 
H(18E) -4520 41 3348 101 
H(18F) -5384 -636 3959 101 
H(35A) 2372 -207 6779 135 
H(35B) 2504 -723 6195 135 
H(35C) 1619 -1154 6877 135 
H(36A) 616 703 7116 180 
H(36B) -80 -282 7229 180 
H(36C) -377 700 6766 180 
H(37A) 159 -1121 6342 141 
H(37B) 1015 -680 5652 141 
H(37C) -136 -142 5875 141 
H(54A) 728 9472 675 104 
H(54B) 1092 10600 463 104 
H(54C) 1502 9880 1042 104 
H(55A) 1527 9357 -477 100 
H(55B) 2803 9706 -842 100 
H(55C) 1871 10489 -674 100 
H(56A) 3486 10393 483 81 
H(56B) 3059 11121 -86 81 
H(56C) 3998 10345 -256 81 
H(3SA) 8401 5530 490 121 
H(3SB) 9333 5616 867 121 
H(3SC) 9377 6353 180 121 
H(4SA) 8787 7975 1304 92 
H(4SB) 9606 7771 656 92 
H(4SC) 9554 7033 1344 92 
H(5SA) 1688 7510 3925 64 
H(5SB) 394 7760 3955 64 
H(5SC) 1155 7384 3356 64 
H(6SA) -699 4991 4526 84 
H(6SB) -473 5499 3767 84 
H(6SC) -1221 6029 4291 84 
H(5SD) 1630 7422 3319 177 
H(5SE) 624 7294 3965 177 
H(5SF) 355 7308 3288 177 
H(6SD) -582 5115 4125 101 
H(6SE) -931 6207 3856 101 
H(6SF) -585 5910 4530 101 
H(7SA) 6292 1370 4747 129 
H(7SB) 6653 2363 4201 129 
H(7SC) 5632 2346 4827 129 
H(8SA) 7757 3928 5024 91 
H(8SB) 6482 3836 4988 91 
H(8SC) 7500 3847 4361 91 
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Table 39 Continued.  
Atom X Y Z U(eq) 
H(1N) -4160(30) 4820(20) 2256(15) 31(9) 
H(1SA) 1860(30) 2220(30) 701(18) 60(12) 
H(1SC) 2910(30) 2240(30) 1003(17) 47(10) 
H(1SB) 2860(30) 3050(30) 358(18) 50(10) 
H(2) -1140(20) 2880(20) 3649(14) 28(8) 
H(2N) -4280(30) 6360(30) 1901(17) 43(11) 
H(2SA) 740(40) 2750(30) 2300(20) 71(13) 
H(2SB) 600(30) 2110(30) 1832(17) 52(11) 
H(2SC) 1620(30) 2120(30) 2122(18) 55(12) 
H(4) 1570(30) 4610(20) 2919(13) 24(8) 
H(4N) 2420(30) 4000(30) 4373(18) 50(11) 
H(5N) 3390(30) 5280(20) 3978(16) 39(10) 
H(6) -910(30) 4980(20) 2040(15) 33(8) 
H(7N) 3360(30) 5370(20) 1050(16) 37(9) 
H(8N) 4360(30) 4180(30) 1082(17) 41(11) 
H(10) -4180(30) 1740(20) 3321(14) 28(8) 
H(12) -7240(30) 2250(20) 3026(15) 43(9) 
H(13) -6680(30) 3850(20) 2520(14) 32(8) 
H(21) -7080(30) 6970(20) 2330(15) 35(8) 
H(22) -7680(30) 8490(20) 2219(16) 41(9) 
H(24) -4480(40) 9570(30) 1530(20) 79(14) 
H(25) -3880(30) 8010(20) 1657(16) 48(10) 
H(29) 540(30) 1230(20) 5249(13) 25(7) 
H(31) 2810(30) 1270(20) 6264(16) 36(9) 
H(32) 3570(30) 2650(20) 5584(15) 40(9) 
H(40) 6060(30) 4600(30) 3779(18) 62(11) 
H(41) 7690(30) 5680(20) 3253(15) 41(9) 
H(43) 5670(30) 7940(30) 3085(16) 42(9) 
H(44) 4040(30) 6970(20) 3625(15) 41(9) 
H(48) 1370(30) 8120(20) 1038(15) 38(9) 
H(50) 4320(30) 8840(20) -250(17) 44(10) 
H(51) 4930(30) 7290(20) 36(14) 29(8) 
H(59) 7010(30) 4790(20) 219(16) 41(9) 
H(60) 8570(40) 3780(30) 320(20) 88(15) 
H(62) 6550(40) 1710(30) 1690(20) 78(14) 







SUPPLEMENTARY INFORMATION FOR CHAPTER V 
 
E.1. Synthesis 
E.1.1. General Methods 
1H and 13C NMR spectra were obtained on a Varian 300 MHz spectrometer (1H 
299.95 Hz, 13C 75.43 Hz), Inova 500 MHz spectrometer (1H 500.10 MHz, 13C 125.75 
MHz) or Bruker Avance III HD 600 MHz NMR Spectrometer with Prodigy 
multinuclear broadband BBO CryoProbe (1H: 600.02 MHz, 13C: 150.89 MHz). 
Chemical shifts (δ) are expressed in ppm from solvent signal using non-deuterated 
solvent present in the bulk deuterated solvent ((CD3)2SO: 1H 2.5 ppm, 13C 39.52 ppm). 
Unless otherwise specified, solvents were obtained from distillation using published 
literature procedures directly before use. Mass spectra were acquired Waters LCT 
Premier ESI-MS in positive mode using acetone as a solvent. UV-Vis spectra were 
acquired with a Hewlett-Packard 8453 UV-Visible spectrophotometer equipped with a 
250 nm cutoff filter. Fluorescence data was acquired with a Horiba Jobin-Yvon 
FluoroMax-4 fluorescence spectrophotometer. 
E.1.2. Synthesis of Compound 3 
To a stirred degassed solution of 2,6-dibromo-4-nitropyridine (0.298 g, 1.06 
mmol) in 1:1 THF/DIPA (70 mL) CuI (0.020 g 0.11 mmol) and Pd(PPh3)4 (0.073 g, 
0.064 mmol) were added at room temperature. The solution was degassed for an 
additional 30 min after which a degassed solution of alkyne 2ref (0.373 g, 2.33 mmol) in 
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THF (50 mL) was added via cannulation, and the reaction mixture was stirred for 3 h 
at room temp. Upon completion the crude reaction mixture was run through a pad of 
silica and eluted with MeCN to remove the organic byproducts. Compound 3 was 
eluted with DMF and precipitated via the addition of water. The precipitated product 
was filtered, rinsed thoroughly with water and dried via high vacuum. No further 
purification was needed. Product was a bright orange solid (0.426g, 91 % yield). m.p. 
198 °C (decomp.). 1H NMR (300 MHz, DMSO-d6) δ 8.55 (s, 2H), 8.19 (s, 2H), 8.13 (d, J 
= 8.3 Hz, 2H), 7.60 (d, J = 7.4 Hz, 2H), 7.41 (t, J = 7.8 Hz, 2H), 7.04 (t, J = 7.4 Hz, 2H), 
6.50 (s, 4H). 13C NMR (126 MHz, DMSO-d6) δ 155.55, 154.32, 144.85, 141.95, 132.97, 
130.94, 121.82, 119.88, 119.53, 109.22, 92.71, 88.18. UV-Vis (DMSO) λmax 297 nm (17103 
cm-1M-1), 379 nm (7234 cm-1M-1). HRMS (EI+) calcd for C23H17N6O4+ [MH+] 441.1311, 
found 441.1307. (Figures 1 and 2) 
E.1.3. Synthesis of Compound 1 
A suspension of compound 3 (0.408 g, 0.926 mmol) and potassium carbonate 
(0.640 g, 4.63 mmol) in N,N-dimethylethanolamine (9.28 mL, 92.6 mmol) was stirred at 
room temperature overnight. The mixture was concentrated under reduced pressure and 
purified by chromatography using a solution of 7:2:1 MeCN:H2O:TEA as eluent. The 
product was concentrated under reduced pressure affording an off-white solid (0.300 g, 
67 % yield). 1H NMR (300 MHz, DMSO-d6) δ 8.11 (d, J = 8.4 Hz, 2H), 8.03 (s, 2H), 7.52 
(d, J = 7.6 Hz, 2H), 7.45 (s, 2H), 7.36 (t, J = 7.9 Hz, 2H), 7.01 (t, J = 7.6 Hz, 2H), 6.49 
(s, 4H), 4.25 (t, J = 5.7 Hz, 2H), 2.67 (t, J = 5.4 Hz, 2H), 2.23 (s, 6H). HRMS (EI+) 












Figure 3. 1H NMR spectrum of 1 in CDCl3, 300 MHz. 
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E.1.4. Formation of 1+ 
Compound 1 was protonated through the addition of trifluoroacetic acid to a 
suspension in MeCN and solvent removed via reduced pressure and high vacuum. On 
small scales a film is typically formed with MeCN. Dissolving the film in acetone 
followed by addition of hexanes to crash 1+ with subsequent removal of solvent provides 
a dark yellow solid. 1H NMR (600 MHz, DMSO-d6) δ 9.63 (s, 1H), 8.10 (d, J = 5.8 Hz, 
2H), 8.09 (s, 2H), 7.52 (dd, J = 7.7, 1.6 Hz, 2H), 7.46 (s, 2H), 7.37 (ddd, J = 8.8, 7.4, 1.6 
Hz, 2H), 7.02 (td, J = 7.5, 1.2 Hz, 2H), 6.47 (s, 4H), 4.53 (t, J = 5.0 Hz, 2H), 3.58 (m, 
2H), 2.88 (s, 6H). 13C NMR (151 MHz, DMSO) δ 163.97, 155.62, 143.89, 141.62, 132.66, 
130.28, 121.67, 119.85, 114.22, 109.80, 93.58, 85.51, 63.05, 54.92, 42.81. UV-Vis (DMSO) 
λmax 292 nm (20296 cm-1M-1), 331 nm (15982 cm-1M-1). (Figures 4 and 5) 
E.2. Titration Details 
Tetrabutylammonium salts were dried at 50 °C under vacuum and stored in a 
calcium carbonate filled desiccator. In all titrations the receptor concentration was kept 
constant during the titration. A stock solution of receptor was prepared in DMSO-d6 
and spiked with 0.5 % H2O. The host-guest solution was prepared with the stock 
receptor solution. Final guest amounts were obtained through drying an aliquot of a 
freshly prepared stock solution for each titration unless desires masses could accurately 
be weighed out. All additions were performed with a Hamilton μL syringe. 
Representative data are provided for each set. 1H NMR titrations were carried out on 
an Bruker Avance III HD 600 MHz NMR Spectrometer with Prodigy multinuclear 
broadband BBO CryoProbe (1H: 600.02 MHz, 13C: 150.89 MHz). Chemical shifts (δ) are 
expressed in ppm downfield from tetramethylsilane (TMS) using non-deuterated solvent 
present in the bulk deuterated solvent (DMSO: 1H 2.50 ppm). Chemical shifts of urea 








Figure 5. 13C NMR spectrum of 1+ in CDCl3, 151 MHz. 
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E.2.1. NMR Titration of 1+ with Tetrabutylammonium Chloride 
A 3 mL stock solution of 1+ (3.18 mg, [R] = 1.49 mM) in 0.5 % H2O/DMSO-d6 
was prepared and used in the preparation of a 2 mL TBACl guest solution (21.43 mg, 
[G] = 47.0 mM). Starting volume of 500 μL. (Table 1, Figure 6) 
Table 1. Example titration for the addition of tetrabutylammonium chloride to 1+ in 














0 0 0.00E+00 0.00 9.625 7.462 8.096 6.474 
10 10 9.22E-04 0.62 9.742 7.491 8.110 6.491 
10 20 1.81E-03 1.21 9.846 7.517 8.123 6.506 
15 35 3.08E-03 2.06 9.956 7.545 8.137 6.521 
15 50 4.27E-03 2.87 10.053 7.569 8.151 6.535 
20 70 5.77E-03 3.87 10.143 7.594 8.164 6.551 
20 90 7.17E-03 4.81 10.209 7.612 8.174 6.562 
25 115 8.79E-03 5.89 10.284 7.632 8.185 6.573 
35 150 1.09E-02 7.27 10.361 7.654 8.197 6.586 
50 200 1.34E-02 9.01 10.431 7.674 8.208 6.599 
75 275 1.67E-02 11.18 10.519 7.701 8.224 6.617 
150 425 2.16E-02 14.48 10.609 7.730 8.242 6.634 
 
Figure 6. Example 1:1 fitting using non-linear regression from the data obtained for 
the titration of tetrabutylammonium chloride into 1+ in 0.5 % H2O/d6-DMSO. 
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E.2.2. NMR Titration of 1+ with Tetrabutylammonium Bromide 
A 3 mL stock solution of 1+ (1.00 mg, [R] = 0.47 mM) in 0.5 % H2O/DMSO-d6 
was prepared and used in the preparation of a 2 mL TBABr guest solution (0.151 g, [G] 
= 0.235 M). Starting volume of 500 μL. (Table 2, Figure 7 and 8) 
E.2.3. NMR Titration of 1+ with Tetrabutylammonium Nitrate, Hydrogen 
Sulfate, Iodide, Perchlorate 
1.5 mM 1+ in 0.5 % H2O/DMSO-d6 was titrated with a 1+•Guest solution up to 
21.4 equivalents of guest for TBANO3, TBAHSO4, TBAI, and TBAClO4. No changes in 
chemical shift were observed throughout the titrations. (Figure 9) 
E.2.4. NMR Titration of 1+ with Tetrabutylammonium Dihydrogen 
Phosphate 
1.5 mM 1+ in 0.5 % H2O/DMSO-d6 was titrated with a 1+•H2PO4¯ solution up to 
21.4 equivalents. (Figure 10) 
 
Table 2. Example titration for the addition of tetrabutylammonium bromide to 1+ in 














0 0 0.00E+00 0 9.775 7.481 8.108 6.485 
25 25 1.12E-02 2.38 9.806 7.521 8.121 6.505 
25 50 2.14E-02 4.54 9.831 7.547 8.130 6.516 
30 80 3.24E-02 6.89 9.854 7.570 8.138 6.526 
35 115 4.39E-02 9.33 9.875 7.589 8.144 6.536 
40 155 5.56E-02 11.81 9.892 7.606 8.150 6.545 
50 205 6.83E-02 14.52 9.909 7.622 8.156 6.554 
70 275 8.33E-02 17.71 9.928 7.639 8.162 6.562 
100 375 1.01E-01 21.39 9.948 7.656 8.169 6.568 
150 525 1.20E-01 25.57 9.965 7.671 8.174 6.576 










Figure 8. Example 1:1 fitting using non-linear regression from the data obtained for the titration of tetrabutylammonium bromide 




Figure 9. 1H NMR spectra of 1+ and 21.4 equivalents of TBA salts of perchlorate, nitrate, hydrogen sulfate, and iodide. Minimal to 




Figure 10. Stacked 1H NMR spectra for the titration of tetrabutylammonium 
dihydrogen phosphate into 1+. After the addition of 1 equivalent of guest, the R3N+H 
proton resonance disappears and the other resonances return to the approximate shifts 
of unprotonated 1 (shown for comparison). 
E.3. Determining the Fluorescent Character of 1+•Cl¯ Aggregates 
Lithium chloride solutions were prepared by dissolving 1.74 g and 1.78 g in 1 % 
TFA/DMSO (spectroscopic grade) and 1 % TFA/H2O (nanopure, 18 Ω) respectively 
(1.64 mM and 1.68 mM LiCl). 11.9 mg of 1 were protonated as previously noted and 
dissolved in 1 % TFA/DMSO. In each of ten vials, 0.3 mL of the 1+ solution was 
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pipetted and diluted with volumes of LiCl solutions corresponding to 0, 10, 20, 30, 40, 
50, 60, 70, 80, and 90 % water with 0.49 mM 1+ and 3000 equivalents of chloride. 
Fluorescence spectra were obtained from 440-835 nm by exciting at 425 nm with slit 
widths of 2 nm and 2 nm. Intensity values represent the sum of intensity from 440-740 
nm. Beyond 740 nm the fluorescence of each sample is in the baseline. (Figure 11) 
 
Figure 11. Observable color change based on the addition of chloride and variation in 
water percentage (0 – 90 % from left to right). Aggregates are clearly visible in the 80 
and 90 % water/DMSO solutions. 
E.3. SEM of 1+•Cl¯ Aggregates 
A 1+ 0.29 mM solution was prepared by pre-protonating 0.69 mg of 1 and, after 
application of high vacuum, was dissolved in 1 % TFA/H2O (nanopure, 18 Ω) 
respectively. This solution was mixed NaCl salt corresponding ~1200 and 2000 
equivalents of chloride. A 10 μl drop of each 1+•Cl¯ solution was pipette onto a 10 mm 
x 10 mm arsenic-doped silicon wafer and left to dry for 30 minutes. SEM images were 
taken using a Zeiss Ultra-55 SEM operating at 5 kV with a 20 μm aperture and an in-
lens detector. 
E.4. Dependence of 1+•Cl¯ Aggregate Fluorescence on Concentration of 1+ 
A 10 mL 0.36 mM 1+ solution was made in 1 % TFA/H2O (nanopure, 18 Ω) by 
protonating 1.76 mg of 1. This solution was used to prepare 0.17 M NaCl host•guest 
solution which demonstrated turn-on fluorescence with the presence of aggregates. 
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Fluorescence spectra were obtained by excitation at 316 and 425 nm. Successive 
dilutions of the 500 equivalent 1+•Cl¯ solution provided an assessment of turn-on 
fluorescence based on varying concentration in comparison to the simultaneous 
dilutions of a 0.36 mM 1+ solution without guest. Intensity ratios comparing 1+ with 
and without the presence of 500 equivalents of chloride were determined for each set 
(Figure 12). A sharp transition of turn-on fluorescence is observed between 0.25 and 
0.30 mM 1+. 
 
Figure 12. Plot of intensity ratios for fluorescence turn-on of 1+ with 500 equivalents of 
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